id	sid	tid	token	lemma	pos
aiua-11533	1	1	stesura	stesura	PROPN
aiua-11533	1	2	seveso	seveso	PROPN
aiua-11533	1	3	archivio	archivio	PROPN
aiua-11533	1	4	italiano	italiano	X
aiua-11533	1	5	di	di	X
aiua-11533	1	6	urologia	urologia	PROPN
aiua-11533	1	7	e	e	PROPN
aiua-11533	1	8	andrologia	andrologia	NOUN
aiua-11533	1	9	2023	2023	NUM
aiua-11533	1	10	;	;	PUNCT
aiua-11533	1	11	95(3):11533	95(3):11533	NUM
aiua-11533	1	12	1	1	NUM
aiua-11533	1	13	original	original	ADJ
aiua-11533	1	14	paper	paper	NOUN
aiua-11533	1	15	introduction	introduction	NOUN
aiua-11533	1	16	although	although	SCONJ
aiua-11533	1	17	uncommon	uncommon	ADJ
aiua-11533	1	18	,	,	PUNCT
aiua-11533	1	19	primary	primary	ADJ
aiua-11533	1	20	sarcoma	sarcoma	NOUN
aiua-11533	1	21	of	of	ADP
aiua-11533	1	22	the	the	DET
aiua-11533	1	23	urinary	urinary	ADJ
aiua-11533	1	24	bladder	bladder	NOUN
aiua-11533	1	25	(	(	PUNCT
aiua-11533	1	26	sub	sub	NOUN
aiua-11533	1	27	)	)	PUNCT
aiua-11533	1	28	is	be	AUX
aiua-11533	1	29	an	an	DET
aiua-11533	1	30	aggressive	aggressive	ADJ
aiua-11533	1	31	type	type	NOUN
aiua-11533	1	32	of	of	ADP
aiua-11533	1	33	bladder	bladder	NOUN
aiua-11533	1	34	cancer	cancer	NOUN
aiua-11533	1	35	(	(	PUNCT
aiua-11533	1	36	bca	bca	PROPN
aiua-11533	1	37	)	)	PUNCT
aiua-11533	1	38	,	,	PUNCT
aiua-11533	1	39	accounting	account	VERB
aiua-11533	1	40	for	for	ADP
aiua-11533	1	41	less	less	ADJ
aiua-11533	1	42	than	than	ADP
aiua-11533	1	43	1	1	NUM
aiua-11533	1	44	%	%	NOUN
aiua-11533	1	45	of	of	ADP
aiua-11533	1	46	all	all	DET
aiua-11533	1	47	bca	bca	PROPN
aiua-11533	1	48	.	.	PUNCT
aiua-11533	2	1	the	the	DET
aiua-11533	2	2	most	most	ADV
aiua-11533	2	3	common	common	ADJ
aiua-11533	2	4	risk	risk	NOUN
aiua-11533	2	5	factors	factor	NOUN
aiua-11533	2	6	for	for	ADP
aiua-11533	2	7	the	the	DET
aiua-11533	2	8	development	development	NOUN
aiua-11533	2	9	of	of	ADP
aiua-11533	2	10	this	this	DET
aiua-11533	2	11	disease	disease	NOUN
aiua-11533	2	12	is	be	AUX
aiua-11533	2	13	smoking	smoke	VERB
aiua-11533	2	14	and	and	CCONJ
aiua-11533	2	15	previous	previous	ADJ
aiua-11533	2	16	exposure	exposure	NOUN
aiua-11533	2	17	to	to	ADP
aiua-11533	2	18	radiotherapy	radiotherapy	NOUN
aiua-11533	2	19	(	(	PUNCT
aiua-11533	2	20	rt	rt	PROPN
aiua-11533	2	21	)	)	PUNCT
aiua-11533	2	22	and	and	CCONJ
aiua-11533	2	23	cyclophosphamide	cyclophosphamide	PROPN
aiua-11533	2	24	(	(	PUNCT
aiua-11533	2	25	1	1	NUM
aiua-11533	2	26	,	,	PUNCT
aiua-11533	2	27	2	2	NUM
aiua-11533	2	28	)	)	PUNCT
aiua-11533	2	29	.	.	PUNCT
aiua-11533	3	1	based	base	VERB
aiua-11533	3	2	on	on	ADP
aiua-11533	3	3	mesenchymal	mesenchymal	ADJ
aiua-11533	3	4	and	and	CCONJ
aiua-11533	3	5	epithelial	epithelial	ADJ
aiua-11533	3	6	components	component	NOUN
aiua-11533	3	7	,	,	PUNCT
aiua-11533	3	8	sub	sub	NOUN
aiua-11533	3	9	can	can	AUX
aiua-11533	3	10	be	be	AUX
aiua-11533	3	11	classified	classify	VERB
aiua-11533	3	12	as	as	ADP
aiua-11533	3	13	sarcomatoid	sarcomatoid	NOUN
aiua-11533	3	14	carcinoma	carcinoma	NOUN
aiua-11533	3	15	(	(	PUNCT
aiua-11533	3	16	sc	sc	NOUN
aiua-11533	3	17	)	)	PUNCT
aiua-11533	3	18	and	and	CCONJ
aiua-11533	3	19	carcinosarcoma	carcinosarcoma	NOUN
aiua-11533	3	20	(	(	PUNCT
aiua-11533	3	21	cs	cs	PROPN
aiua-11533	3	22	)	)	PUNCT
aiua-11533	3	23	,	,	PUNCT
aiua-11533	3	24	both	both	PRON
aiua-11533	3	25	considered	consider	VERB
aiua-11533	3	26	malignant	malignant	ADJ
aiua-11533	3	27	biphasic	biphasic	ADJ
aiua-11533	3	28	tumors	tumor	NOUN
aiua-11533	3	29	(	(	PUNCT
aiua-11533	3	30	mbt	mbt	PROPN
aiua-11533	3	31	)	)	PUNCT
aiua-11533	3	32	by	by	ADP
aiua-11533	3	33	the	the	DET
aiua-11533	3	34	world	world	PROPN
aiua-11533	3	35	health	health	NOUN
aiua-11533	3	36	organization	organization	NOUN
aiua-11533	3	37	having	have	VERB
aiua-11533	3	38	malignant	malignant	ADJ
aiua-11533	3	39	epithelial	epithelial	ADJ
aiua-11533	3	40	and	and	CCONJ
aiua-11533	3	41	mesenchymal	mesenchymal	ADJ
aiua-11533	3	42	elements	element	NOUN
aiua-11533	3	43	(	(	PUNCT
aiua-11533	3	44	3	3	NUM
aiua-11533	3	45	)	)	PUNCT
aiua-11533	3	46	.	.	PUNCT
aiua-11533	4	1	more	more	ADV
aiua-11533	4	2	recently	recently	ADV
aiua-11533	4	3	researchers	researcher	NOUN
aiua-11533	4	4	have	have	AUX
aiua-11533	4	5	cast	cast	VERB
aiua-11533	4	6	doubts	doubt	NOUN
aiua-11533	4	7	on	on	ADP
aiua-11533	4	8	the	the	DET
aiua-11533	4	9	significance	significance	NOUN
aiua-11533	4	10	of	of	ADP
aiua-11533	4	11	distinguishing	distinguish	VERB
aiua-11533	4	12	between	between	ADP
aiua-11533	4	13	these	these	DET
aiua-11533	4	14	two	two	NUM
aiua-11533	4	15	entities	entity	NOUN
aiua-11533	4	16	in	in	ADP
aiua-11533	4	17	both	both	PRON
aiua-11533	4	18	bladder	bladder	NOUN
aiua-11533	4	19	and	and	CCONJ
aiua-11533	4	20	other	other	ADJ
aiua-11533	4	21	solid	solid	ADJ
aiua-11533	4	22	malignancy	malignancy	NOUN
aiua-11533	4	23	as	as	SCONJ
aiua-11533	4	24	they	they	PRON
aiua-11533	4	25	consider	consider	VERB
aiua-11533	4	26	these	these	DET
aiua-11533	4	27	two	two	NUM
aiua-11533	4	28	histological	histological	ADJ
aiua-11533	4	29	subtypes	subtype	NOUN
aiua-11533	4	30	as	as	ADP
aiua-11533	4	31	separate	separate	ADJ
aiua-11533	4	32	moments	moment	NOUN
aiua-11533	4	33	between	between	ADP
aiua-11533	4	34	epithelial	epithelial	ADJ
aiua-11533	4	35	(	(	PUNCT
aiua-11533	4	36	sarcomatoid	sarcomatoid	NOUN
aiua-11533	4	37	carcinoma	carcinoma	NOUN
aiua-11533	4	38	)	)	PUNCT
aiua-11533	4	39	and	and	CCONJ
aiua-11533	4	40	mesenchymal	mesenchymal	ADJ
aiua-11533	4	41	differentiation	differentiation	NOUN
aiua-11533	4	42	(	(	PUNCT
aiua-11533	4	43	carcinosarcoma	carcinosarcoma	NOUN
aiua-11533	4	44	)	)	PUNCT
aiua-11533	4	45	(	(	PUNCT
aiua-11533	4	46	4	4	NUM
aiua-11533	4	47	)	)	PUNCT
aiua-11533	4	48	.	.	PUNCT
aiua-11533	5	1	usually	usually	ADV
aiua-11533	5	2	,	,	PUNCT
aiua-11533	5	3	the	the	DET
aiua-11533	5	4	epithelial	epithelial	ADJ
aiua-11533	5	5	element	element	NOUN
aiua-11533	5	6	contains	contain	VERB
aiua-11533	5	7	high	high	ADJ
aiua-11533	5	8	-	-	PUNCT
aiua-11533	5	9	grade	grade	NOUN
aiua-11533	5	10	transitional	transitional	ADJ
aiua-11533	5	11	-	-	PUNCT
aiua-11533	5	12	cell	cell	NOUN
aiua-11533	5	13	carcinoma	carcinoma	NOUN
aiua-11533	5	14	with	with	ADP
aiua-11533	5	15	some	some	DET
aiua-11533	5	16	epidermoid	epidermoid	NOUN
aiua-11533	5	17	and/or	and/or	CCONJ
aiua-11533	5	18	glandular	glandular	ADJ
aiua-11533	5	19	differentiation	differentiation	NOUN
aiua-11533	5	20	,	,	PUNCT
aiua-11533	5	21	while	while	SCONJ
aiua-11533	5	22	the	the	DET
aiua-11533	5	23	heterologous	heterologous	ADJ
aiua-11533	5	24	element	element	NOUN
aiua-11533	5	25	contains	contain	VERB
aiua-11533	5	26	chondrosarcoma	chondrosarcoma	NOUN
aiua-11533	5	27	,	,	PUNCT
aiua-11533	5	28	malignant	malignant	ADJ
aiua-11533	5	29	fibrous	fibrous	ADJ
aiua-11533	5	30	histiocytoma	histiocytoma	NOUN
aiua-11533	5	31	,	,	PUNCT
aiua-11533	5	32	osteosarcoma	osteosarcoma	ADJ
aiua-11533	5	33	,	,	PUNCT
aiua-11533	5	34	leiomyosarcoma	leiomyosarcoma	PROPN
aiua-11533	5	35	,	,	PUNCT
aiua-11533	5	36	fibrosarcoma	fibrosarcoma	ADJ
aiua-11533	5	37	,	,	PUNCT
aiua-11533	5	38	or	or	CCONJ
aiua-11533	5	39	rhabdomyosarcoma	rhabdomyosarcoma	NOUN
aiua-11533	5	40	.	.	PUNCT
aiua-11533	6	1	both	both	DET
aiua-11533	6	2	sc	sc	PROPN
aiua-11533	6	3	and	and	CCONJ
aiua-11533	6	4	cs	cs	PROPN
aiua-11533	6	5	cases	case	NOUN
aiua-11533	6	6	are	be	AUX
aiua-11533	6	7	most	most	ADV
aiua-11533	6	8	common	common	ADJ
aiua-11533	6	9	among	among	ADP
aiua-11533	6	10	older	old	ADJ
aiua-11533	6	11	men	man	NOUN
aiua-11533	6	12	,	,	PUNCT
aiua-11533	6	13	manifesting	manifest	VERB
aiua-11533	6	14	as	as	ADP
aiua-11533	6	15	fastgrowing	fastgrowe	VERB
aiua-11533	6	16	,	,	PUNCT
aiua-11533	6	17	advanced	advanced	ADJ
aiua-11533	6	18	-	-	PUNCT
aiua-11533	6	19	stage	stage	NOUN
aiua-11533	6	20	polypoid	polypoid	ADJ
aiua-11533	6	21	tumors	tumor	NOUN
aiua-11533	6	22	(	(	PUNCT
aiua-11533	6	23	1	1	NUM
aiua-11533	6	24	-	-	SYM
aiua-11533	6	25	4	4	NUM
aiua-11533	6	26	)	)	PUNCT
aiua-11533	6	27	.	.	PUNCT
aiua-11533	7	1	when	when	SCONJ
aiua-11533	7	2	the	the	DET
aiua-11533	7	3	mesenchymal	mesenchymal	NOUN
aiua-11533	7	4	element	element	NOUN
aiua-11533	7	5	lacks	lack	VERB
aiua-11533	7	6	epithelial	epithelial	ADJ
aiua-11533	7	7	components	component	NOUN
aiua-11533	7	8	,	,	PUNCT
aiua-11533	7	9	sub	sub	NOUN
aiua-11533	7	10	can	can	AUX
aiua-11533	7	11	be	be	AUX
aiua-11533	7	12	considered	consider	VERB
aiua-11533	7	13	a	a	DET
aiua-11533	7	14	true	true	ADJ
aiua-11533	7	15	heterologous	heterologous	ADJ
aiua-11533	7	16	sarcoma	sarcoma	NOUN
aiua-11533	7	17	(	(	PUNCT
aiua-11533	7	18	ts	ts	NOUN
aiua-11533	7	19	)	)	PUNCT
aiua-11533	7	20	.	.	PUNCT
aiua-11533	8	1	usually	usually	ADV
aiua-11533	8	2	,	,	PUNCT
aiua-11533	8	3	treatment	treatment	NOUN
aiua-11533	8	4	of	of	ADP
aiua-11533	8	5	sub	sub	NOUN
aiua-11533	8	6	has	have	AUX
aiua-11533	8	7	been	be	AUX
aiua-11533	8	8	deduced	deduce	VERB
aiua-11533	8	9	from	from	ADP
aiua-11533	8	10	the	the	DET
aiua-11533	8	11	management	management	NOUN
aiua-11533	8	12	of	of	ADP
aiua-11533	8	13	urothelial	urothelial	ADJ
aiua-11533	8	14	carcinoma	carcinoma	NOUN
aiua-11533	8	15	(	(	PUNCT
aiua-11533	8	16	uc	uc	NOUN
aiua-11533	8	17	)	)	PUNCT
aiua-11533	8	18	of	of	ADP
aiua-11533	8	19	the	the	DET
aiua-11533	8	20	bladder	bladder	NOUN
aiua-11533	8	21	.	.	PUNCT
aiua-11533	9	1	muscle	muscle	NOUN
aiua-11533	9	2	-	-	PUNCT
aiua-11533	9	3	invasive	invasive	ADJ
aiua-11533	9	4	uc	uc	NOUN
aiua-11533	9	5	of	of	ADP
aiua-11533	9	6	the	the	DET
aiua-11533	9	7	bladder	bladder	NOUN
aiua-11533	9	8	often	often	ADV
aiua-11533	9	9	results	result	VERB
aiua-11533	9	10	in	in	ADP
aiua-11533	9	11	distant	distant	ADJ
aiua-11533	9	12	metastasis	metastasis	NOUN
aiua-11533	9	13	after	after	ADP
aiua-11533	9	14	radical	radical	ADJ
aiua-11533	9	15	cystectomy	cystectomy	NOUN
aiua-11533	9	16	,	,	PUNCT
aiua-11533	9	17	and	and	CCONJ
aiua-11533	9	18	therefore	therefore	ADV
aiua-11533	9	19	,	,	PUNCT
aiua-11533	9	20	neoadjuvant	neoadjuvant	ADJ
aiua-11533	9	21	or	or	CCONJ
aiua-11533	9	22	adjuvant	adjuvant	ADJ
aiua-11533	9	23	chemotherapy	chemotherapy	NOUN
aiua-11533	9	24	has	have	AUX
aiua-11533	9	25	been	be	AUX
aiua-11533	9	26	recommended	recommend	VERB
aiua-11533	9	27	as	as	ADP
aiua-11533	9	28	a	a	DET
aiua-11533	9	29	part	part	NOUN
aiua-11533	9	30	of	of	ADP
aiua-11533	9	31	a	a	DET
aiua-11533	9	32	multimodal	multimodal	ADJ
aiua-11533	9	33	approach	approach	NOUN
aiua-11533	9	34	(	(	PUNCT
aiua-11533	9	35	5	5	NUM
aiua-11533	9	36	,	,	PUNCT
aiua-11533	9	37	6	6	NUM
aiua-11533	9	38	)	)	PUNCT
aiua-11533	9	39	.	.	PUNCT
aiua-11533	10	1	however	however	ADV
aiua-11533	10	2	,	,	PUNCT
aiua-11533	10	3	because	because	SCONJ
aiua-11533	10	4	of	of	ADP
aiua-11533	10	5	to	to	ADP
aiua-11533	10	6	the	the	DET
aiua-11533	10	7	rarity	rarity	NOUN
aiua-11533	10	8	of	of	ADP
aiua-11533	10	9	sub	sub	NOUN
aiua-11533	10	10	and	and	CCONJ
aiua-11533	10	11	the	the	DET
aiua-11533	10	12	absence	absence	NOUN
aiua-11533	10	13	of	of	ADP
aiua-11533	10	14	randomized	randomized	ADJ
aiua-11533	10	15	controlled	control	VERB
aiua-11533	10	16	trial	trial	NOUN
aiua-11533	10	17	in	in	ADP
aiua-11533	10	18	this	this	DET
aiua-11533	10	19	setting	setting	NOUN
aiua-11533	10	20	,	,	PUNCT
aiua-11533	10	21	definitive	definitive	ADJ
aiua-11533	10	22	conclusions	conclusion	NOUN
aiua-11533	10	23	about	about	ADP
aiua-11533	10	24	the	the	DET
aiua-11533	10	25	optimal	optimal	ADJ
aiua-11533	10	26	treatment	treatment	NOUN
aiua-11533	10	27	option	option	NOUN
aiua-11533	10	28	can	can	AUX
aiua-11533	10	29	not	not	PART
aiua-11533	10	30	be	be	AUX
aiua-11533	10	31	made	make	VERB
aiua-11533	10	32	.	.	PUNCT
aiua-11533	11	1	poor	poor	ADJ
aiua-11533	11	2	outcomes	outcome	NOUN
aiua-11533	11	3	have	have	AUX
aiua-11533	11	4	been	be	AUX
aiua-11533	11	5	reported	report	VERB
aiua-11533	11	6	in	in	ADP
aiua-11533	11	7	patients	patient	NOUN
aiua-11533	11	8	with	with	ADP
aiua-11533	11	9	sub	sub	NOUN
aiua-11533	11	10	,	,	PUNCT
aiua-11533	11	11	whatever	whatever	PRON
aiua-11533	11	12	the	the	DET
aiua-11533	11	13	treatment	treatment	NOUN
aiua-11533	11	14	used	use	VERB
aiua-11533	11	15	.	.	PUNCT
aiua-11533	12	1	even	even	ADV
aiua-11533	12	2	after	after	ADP
aiua-11533	12	3	adjustpurpose	adjustpurpose	ADV
aiua-11533	12	4	or	or	CCONJ
aiua-11533	12	5	objective	objective	NOUN
aiua-11533	12	6	:	:	PUNCT
aiua-11533	12	7	primary	primary	ADJ
aiua-11533	12	8	sarcoma	sarcoma	NOUN
aiua-11533	12	9	of	of	ADP
aiua-11533	12	10	the	the	DET
aiua-11533	12	11	urinary	urinary	ADJ
aiua-11533	12	12	bladder	bladder	NOUN
aiua-11533	12	13	(	(	PUNCT
aiua-11533	12	14	sub	sub	NOUN
aiua-11533	12	15	)	)	PUNCT
aiua-11533	12	16	is	be	AUX
aiua-11533	12	17	a	a	DET
aiua-11533	12	18	rare	rare	ADJ
aiua-11533	12	19	but	but	CCONJ
aiua-11533	12	20	aggressive	aggressive	ADJ
aiua-11533	12	21	form	form	NOUN
aiua-11533	12	22	of	of	ADP
aiua-11533	12	23	bladder	bladder	NOUN
aiua-11533	12	24	cancer	cancer	NOUN
aiua-11533	12	25	(	(	PUNCT
aiua-11533	12	26	bca	bca	PROPN
aiua-11533	12	27	)	)	PUNCT
aiua-11533	12	28	.	.	PUNCT
aiua-11533	13	1	available	available	ADJ
aiua-11533	13	2	evidence	evidence	NOUN
aiua-11533	13	3	on	on	ADP
aiua-11533	13	4	sub	sub	NOUN
aiua-11533	13	5	is	be	AUX
aiua-11533	13	6	limited	limit	VERB
aiua-11533	13	7	to	to	PART
aiua-11533	13	8	case	case	VERB
aiua-11533	13	9	reports	report	NOUN
aiua-11533	13	10	and	and	CCONJ
aiua-11533	13	11	small	small	ADJ
aiua-11533	13	12	series	series	NOUN
aiua-11533	13	13	.	.	PUNCT
aiua-11533	14	1	the	the	DET
aiua-11533	14	2	aim	aim	NOUN
aiua-11533	14	3	of	of	ADP
aiua-11533	14	4	the	the	DET
aiua-11533	14	5	present	present	ADJ
aiua-11533	14	6	multi	multi	ADJ
aiua-11533	14	7	-	-	ADJ
aiua-11533	14	8	institutional	institutional	ADJ
aiua-11533	14	9	study	study	NOUN
aiua-11533	14	10	was	be	AUX
aiua-11533	14	11	to	to	PART
aiua-11533	14	12	assess	assess	VERB
aiua-11533	14	13	the	the	DET
aiua-11533	14	14	clinical	clinical	ADJ
aiua-11533	14	15	features	feature	NOUN
aiua-11533	14	16	,	,	PUNCT
aiua-11533	14	17	treatments	treatment	NOUN
aiua-11533	14	18	,	,	PUNCT
aiua-11533	14	19	and	and	CCONJ
aiua-11533	14	20	outcomes	outcome	NOUN
aiua-11533	14	21	of	of	ADP
aiua-11533	14	22	patients	patient	NOUN
aiua-11533	14	23	with	with	ADP
aiua-11533	14	24	sub	sub	NOUN
aiua-11533	14	25	.	.	NOUN
aiua-11533	14	26	materials	material	NOUN
aiua-11533	14	27	and	and	CCONJ
aiua-11533	14	28	methods	method	NOUN
aiua-11533	14	29	:	:	PUNCT
aiua-11533	14	30	using	use	VERB
aiua-11533	14	31	a	a	DET
aiua-11533	14	32	standardized	standardized	ADJ
aiua-11533	14	33	database	database	NOUN
aiua-11533	14	34	,	,	PUNCT
aiua-11533	14	35	7	7	NUM
aiua-11533	14	36	institutions	institution	NOUN
aiua-11533	14	37	retrospectively	retrospectively	ADV
aiua-11533	14	38	collected	collect	VERB
aiua-11533	14	39	the	the	DET
aiua-11533	14	40	demographics	demographic	NOUN
aiua-11533	14	41	,	,	PUNCT
aiua-11533	14	42	risk	risk	NOUN
aiua-11533	14	43	factors	factor	NOUN
aiua-11533	14	44	,	,	PUNCT
aiua-11533	14	45	clinical	clinical	ADJ
aiua-11533	14	46	presentation	presentation	NOUN
aiua-11533	14	47	,	,	PUNCT
aiua-11533	14	48	treatment	treatment	NOUN
aiua-11533	14	49	modalities	modality	NOUN
aiua-11533	14	50	and	and	CCONJ
aiua-11533	14	51	follow	follow	VERB
aiua-11533	14	52	-	-	PUNCT
aiua-11533	14	53	up	up	ADP
aiua-11533	14	54	data	datum	NOUN
aiua-11533	14	55	on	on	ADP
aiua-11533	14	56	patients	patient	NOUN
aiua-11533	14	57	with	with	ADP
aiua-11533	14	58	sub	sub	NOUN
aiua-11533	14	59	between	between	ADP
aiua-11533	14	60	january	january	PROPN
aiua-11533	14	61	1994	1994	NUM
aiua-11533	14	62	and	and	CCONJ
aiua-11533	14	63	september	september	PROPN
aiua-11533	14	64	2021	2021	NUM
aiua-11533	14	65	.	.	PUNCT
aiua-11533	15	1	the	the	DET
aiua-11533	15	2	main	main	ADJ
aiua-11533	15	3	inclusion	inclusion	NOUN
aiua-11533	15	4	criteria	criterion	NOUN
aiua-11533	15	5	included	include	VERB
aiua-11533	15	6	bca	bca	PROPN
aiua-11533	15	7	with	with	ADP
aiua-11533	15	8	soft	soft	ADJ
aiua-11533	15	9	tissue	tissue	NOUN
aiua-11533	15	10	tumor	tumor	NOUN
aiua-11533	15	11	histology	histology	NOUN
aiua-11533	15	12	and	and	CCONJ
aiua-11533	15	13	sarcomatoid	sarcomatoid	NOUN
aiua-11533	15	14	differentiation	differentiation	NOUN
aiua-11533	15	15	.	.	PUNCT
aiua-11533	16	1	results	result	NOUN
aiua-11533	16	2	:	:	PUNCT
aiua-11533	16	3	fifty	fifty	NUM
aiua-11533	16	4	-	-	PUNCT
aiua-11533	16	5	three	three	NUM
aiua-11533	16	6	patients	patient	NOUN
aiua-11533	16	7	(	(	PUNCT
aiua-11533	16	8	38	38	NUM
aiua-11533	16	9	men	man	NOUN
aiua-11533	16	10	and	and	CCONJ
aiua-11533	16	11	15	15	NUM
aiua-11533	16	12	women	woman	NOUN
aiua-11533	16	13	)	)	PUNCT
aiua-11533	16	14	were	be	AUX
aiua-11533	16	15	identified	identify	VERB
aiua-11533	16	16	.	.	PUNCT
aiua-11533	17	1	median	median	ADJ
aiua-11533	17	2	follow	follow	NOUN
aiua-11533	17	3	-	-	PUNCT
aiua-11533	17	4	up	up	NOUN
aiua-11533	17	5	was	be	AUX
aiua-11533	17	6	18	18	NUM
aiua-11533	17	7	months	month	NOUN
aiua-11533	17	8	(	(	PUNCT
aiua-11533	17	9	range	range	NOUN
aiua-11533	17	10	1	1	NUM
aiua-11533	17	11	-	-	SYM
aiua-11533	17	12	263	263	NUM
aiua-11533	17	13	months	month	NOUN
aiua-11533	17	14	)	)	PUNCT
aiua-11533	17	15	.	.	PUNCT
aiua-11533	18	1	median	median	ADJ
aiua-11533	18	2	age	age	NOUN
aiua-11533	18	3	at	at	ADP
aiua-11533	18	4	presentation	presentation	NOUN
aiua-11533	18	5	was	be	AUX
aiua-11533	18	6	69	69	NUM
aiua-11533	18	7	years	year	NOUN
aiua-11533	18	8	(	(	PUNCT
aiua-11533	18	9	range	range	NOUN
aiua-11533	18	10	16	16	NUM
aiua-11533	18	11	-	-	SYM
aiua-11533	18	12	89	89	NUM
aiua-11533	18	13	years	year	NOUN
aiua-11533	18	14	)	)	PUNCT
aiua-11533	18	15	.	.	PUNCT
aiua-11533	19	1	twenty	twenty	NUM
aiua-11533	19	2	-	-	PUNCT
aiua-11533	19	3	six	six	NUM
aiua-11533	19	4	percent	percent	NOUN
aiua-11533	19	5	of	of	ADP
aiua-11533	19	6	patients	patient	NOUN
aiua-11533	19	7	had	have	VERB
aiua-11533	19	8	a	a	DET
aiua-11533	19	9	prior	prior	ADJ
aiua-11533	19	10	history	history	NOUN
aiua-11533	19	11	of	of	ADP
aiua-11533	19	12	pelvic	pelvic	ADJ
aiua-11533	19	13	radiotherapy	radiotherapy	NOUN
aiua-11533	19	14	(	(	PUNCT
aiua-11533	19	15	rt	rt	PROPN
aiua-11533	19	16	)	)	PUNCT
aiua-11533	19	17	,	,	PUNCT
aiua-11533	19	18	and	and	CCONJ
aiua-11533	19	19	37	37	NUM
aiua-11533	19	20	%	%	NOUN
aiua-11533	19	21	were	be	AUX
aiua-11533	19	22	previous	previous	ADJ
aiua-11533	19	23	smokers	smoker	NOUN
aiua-11533	19	24	.	.	PUNCT
aiua-11533	20	1	the	the	DET
aiua-11533	20	2	main	main	ADJ
aiua-11533	20	3	presenting	presenting	NOUN
aiua-11533	20	4	symptoms	symptom	NOUN
aiua-11533	20	5	at	at	ADP
aiua-11533	20	6	diagnosis	diagnosis	NOUN
aiua-11533	20	7	were	be	AUX
aiua-11533	20	8	hematuria	hematuria	NOUN
aiua-11533	20	9	(	(	PUNCT
aiua-11533	20	10	52	52	NUM
aiua-11533	20	11	%	%	NOUN
aiua-11533	20	12	)	)	PUNCT
aiua-11533	20	13	,	,	PUNCT
aiua-11533	20	14	pelvic	pelvic	ADJ
aiua-11533	20	15	pain	pain	NOUN
aiua-11533	20	16	(	(	PUNCT
aiua-11533	20	17	27	27	NUM
aiua-11533	20	18	%	%	NOUN
aiua-11533	20	19	)	)	PUNCT
aiua-11533	20	20	,	,	PUNCT
aiua-11533	20	21	and	and	CCONJ
aiua-11533	20	22	both	both	PRON
aiua-11533	20	23	hematuria	hematuria	NOUN
aiua-11533	20	24	and	and	CCONJ
aiua-11533	20	25	pelvic	pelvic	ADJ
aiua-11533	20	26	pain	pain	NOUN
aiua-11533	20	27	(	(	PUNCT
aiua-11533	20	28	10	10	NUM
aiua-11533	20	29	%	%	NOUN
aiua-11533	20	30	)	)	PUNCT
aiua-11533	20	31	.	.	PUNCT
aiua-11533	21	1	american	american	PROPN
aiua-11533	21	2	joint	joint	PROPN
aiua-11533	21	3	committee	committee	PROPN
aiua-11533	21	4	on	on	ADP
aiua-11533	21	5	cancer	cancer	NOUN
aiua-11533	21	6	(	(	PUNCT
aiua-11533	21	7	ajcc	ajcc	PROPN
aiua-11533	21	8	)	)	PUNCT
aiua-11533	21	9	8	8	NUM
aiua-11533	21	10	th	th	X
aiua-11533	21	11	edition	edition	NOUN
aiua-11533	21	12	stage	stage	PROPN
aiua-11533	21	13	ii	ii	PROPN
aiua-11533	21	14	,	,	PUNCT
aiua-11533	21	15	iii	iii	PROPN
aiua-11533	21	16	and	and	CCONJ
aiua-11533	21	17	iv	iv	NUM
aiua-11533	21	18	at	at	ADP
aiua-11533	21	19	diagnosis	diagnosis	NOUN
aiua-11533	21	20	were	be	AUX
aiua-11533	21	21	21	21	NUM
aiua-11533	21	22	%	%	NOUN
aiua-11533	21	23	,	,	PUNCT
aiua-11533	21	24	63	63	NUM
aiua-11533	21	25	%	%	NOUN
aiua-11533	21	26	and	and	CCONJ
aiua-11533	21	27	16	16	NUM
aiua-11533	21	28	%	%	NOUN
aiua-11533	21	29	,	,	PUNCT
aiua-11533	21	30	respectively	respectively	ADV
aiua-11533	21	31	.	.	PUNCT
aiua-11533	22	1	treatment	treatment	NOUN
aiua-11533	22	2	modalities	modality	NOUN
aiua-11533	22	3	included	include	VERB
aiua-11533	22	4	surgery	surgery	NOUN
aiua-11533	22	5	alone	alone	ADV
aiua-11533	22	6	(	(	PUNCT
aiua-11533	22	7	45	45	NUM
aiua-11533	22	8	%	%	NOUN
aiua-11533	22	9	)	)	PUNCT
aiua-11533	22	10	,	,	PUNCT
aiua-11533	22	11	surgery	surgery	NOUN
aiua-11533	22	12	plus	plus	CCONJ
aiua-11533	22	13	neoor	neoor	ADJ
aiua-11533	22	14	adjuvant	adjuvant	NOUN
aiua-11533	22	15	-	-	PUNCT
aiua-11533	22	16	chemotherapy	chemotherapy	NOUN
aiua-11533	22	17	(	(	PUNCT
aiua-11533	22	18	17	17	NUM
aiua-11533	22	19	%	%	NOUN
aiua-11533	22	20	)	)	PUNCT
aiua-11533	22	21	,	,	PUNCT
aiua-11533	22	22	surgery	surgery	NOUN
aiua-11533	22	23	plus	plus	CCONJ
aiua-11533	22	24	neoor	neoor	NOUN
aiua-11533	22	25	adjuvant	adjuvant	NOUN
aiua-11533	22	26	-	-	PUNCT
aiua-11533	22	27	rt	rt	PROPN
aiua-11533	22	28	(	(	PUNCT
aiua-11533	22	29	11	11	NUM
aiua-11533	22	30	%	%	NOUN
aiua-11533	22	31	)	)	PUNCT
aiua-11533	22	32	,	,	PUNCT
aiua-11533	22	33	rt	rt	PROPN
aiua-11533	22	34	with	with	ADP
aiua-11533	22	35	concurrent	concurrent	ADJ
aiua-11533	22	36	chemotherapy	chemotherapy	NOUN
aiua-11533	22	37	(	(	PUNCT
aiua-11533	22	38	4	4	NUM
aiua-11533	22	39	%	%	NOUN
aiua-11533	22	40	)	)	PUNCT
aiua-11533	22	41	,	,	PUNCT
aiua-11533	22	42	neo	neo	NOUN
aiua-11533	22	43	-	-	ADJ
aiua-11533	22	44	adjuvant	adjuvant	ADJ
aiua-11533	22	45	chemotherapy	chemotherapy	NOUN
aiua-11533	22	46	plus	plus	CCONJ
aiua-11533	22	47	surgery	surgery	NOUN
aiua-11533	22	48	plus	plus	CCONJ
aiua-11533	22	49	adjuvant	adjuvant	ADJ
aiua-11533	22	50	rt	rt	PROPN
aiua-11533	22	51	(	(	PUNCT
aiua-11533	22	52	2	2	NUM
aiua-11533	22	53	%	%	NOUN
aiua-11533	22	54	)	)	PUNCT
aiua-11533	22	55	and	and	CCONJ
aiua-11533	22	56	palliative	palliative	ADJ
aiua-11533	22	57	treatment	treatment	NOUN
aiua-11533	22	58	(	(	PUNCT
aiua-11533	22	59	21	21	NUM
aiua-11533	22	60	%	%	NOUN
aiua-11533	22	61	)	)	PUNCT
aiua-11533	22	62	.	.	PUNCT
aiua-11533	23	1	rates	rate	NOUN
aiua-11533	23	2	of	of	ADP
aiua-11533	23	3	local	local	ADJ
aiua-11533	23	4	and	and	CCONJ
aiua-11533	23	5	distant	distant	ADJ
aiua-11533	23	6	recurrences	recurrence	NOUN
aiua-11533	23	7	were	be	AUX
aiua-11533	23	8	49	49	NUM
aiua-11533	23	9	%	%	NOUN
aiua-11533	23	10	and	and	CCONJ
aiua-11533	23	11	37	37	NUM
aiua-11533	23	12	%	%	NOUN
aiua-11533	23	13	,	,	PUNCT
aiua-11533	23	14	respectively	respectively	ADV
aiua-11533	23	15	.	.	PUNCT
aiua-11533	24	1	five	five	NUM
aiua-11533	24	2	-	-	PUNCT
aiua-11533	24	3	year	year	NOUN
aiua-11533	24	4	overall	overall	ADJ
aiua-11533	24	5	survival	survival	NOUN
aiua-11533	24	6	and	and	CCONJ
aiua-11533	24	7	progression	progression	NOUN
aiua-11533	24	8	-	-	PUNCT
aiua-11533	24	9	free	free	ADJ
aiua-11533	24	10	survival	survival	NOUN
aiua-11533	24	11	(	(	PUNCT
aiua-11533	24	12	pfs	pfs	PROPN
aiua-11533	24	13	)	)	PUNCT
aiua-11533	24	14	were	be	AUX
aiua-11533	24	15	66.5	66.5	NUM
aiua-11533	24	16	%	%	NOUN
aiua-11533	24	17	and	and	CCONJ
aiua-11533	24	18	37.6	37.6	NUM
aiua-11533	24	19	%	%	NOUN
aiua-11533	24	20	,	,	PUNCT
aiua-11533	24	21	respectively	respectively	ADV
aiua-11533	24	22	.	.	PUNCT
aiua-11533	25	1	no	no	DET
aiua-11533	25	2	statistically	statistically	ADV
aiua-11533	25	3	significant	significant	ADJ
aiua-11533	25	4	differences	difference	NOUN
aiua-11533	25	5	in	in	ADP
aiua-11533	25	6	pfs	pfs	PROPN
aiua-11533	25	7	between	between	ADP
aiua-11533	25	8	the	the	DET
aiua-11533	25	9	treatment	treatment	NOUN
aiua-11533	25	10	modalities	modality	NOUN
aiua-11533	25	11	were	be	AUX
aiua-11533	25	12	observed	observe	VERB
aiua-11533	25	13	.	.	PUNCT
aiua-11533	26	1	conclusions	conclusion	NOUN
aiua-11533	26	2	:	:	PUNCT
aiua-11533	26	3	primary	primary	ADJ
aiua-11533	26	4	sub	sub	NOUN
aiua-11533	26	5	is	be	AUX
aiua-11533	26	6	a	a	DET
aiua-11533	26	7	heterogeneous	heterogeneous	ADJ
aiua-11533	26	8	disease	disease	NOUN
aiua-11533	26	9	group	group	NOUN
aiua-11533	26	10	,	,	PUNCT
aiua-11533	26	11	commonly	commonly	ADV
aiua-11533	26	12	presenting	present	VERB
aiua-11533	26	13	at	at	ADP
aiua-11533	26	14	advanced	advanced	ADJ
aiua-11533	26	15	stages	stage	NOUN
aiua-11533	26	16	and	and	CCONJ
aiua-11533	26	17	exhibiting	exhibit	VERB
aiua-11533	26	18	aggressive	aggressive	ADJ
aiua-11533	26	19	disease	disease	NOUN
aiua-11533	26	20	evolution	evolution	NOUN
aiua-11533	26	21	.	.	PUNCT
aiua-11533	27	1	in	in	ADP
aiua-11533	27	2	contrast	contrast	NOUN
aiua-11533	27	3	to	to	ADP
aiua-11533	27	4	urothelial	urothelial	ADJ
aiua-11533	27	5	carcinoma	carcinoma	NOUN
aiua-11533	27	6	,	,	PUNCT
aiua-11533	27	7	the	the	DET
aiua-11533	27	8	primary	primary	ADJ
aiua-11533	27	9	pattern	pattern	NOUN
aiua-11533	27	10	of	of	ADP
aiua-11533	27	11	recurrence	recurrence	NOUN
aiua-11533	27	12	of	of	ADP
aiua-11533	27	13	sub	sub	NOUN
aiua-11533	27	14	is	be	AUX
aiua-11533	27	15	local	local	ADJ
aiua-11533	27	16	,	,	PUNCT
aiua-11533	27	17	suggesting	suggest	VERB
aiua-11533	27	18	the	the	DET
aiua-11533	27	19	need	need	NOUN
aiua-11533	27	20	for	for	ADP
aiua-11533	27	21	multimodal	multimodal	NOUN
aiua-11533	27	22	approaches	approach	NOUN
aiua-11533	27	23	.	.	PUNCT
aiua-11533	28	1	continuous	continuous	ADJ
aiua-11533	28	2	international	international	ADJ
aiua-11533	28	3	collaborative	collaborative	ADJ
aiua-11533	28	4	efforts	effort	NOUN
aiua-11533	28	5	seem	seem	VERB
aiua-11533	28	6	warranted	warrant	VERB
aiua-11533	28	7	to	to	PART
aiua-11533	28	8	provide	provide	VERB
aiua-11533	28	9	guidance	guidance	NOUN
aiua-11533	28	10	on	on	ADP
aiua-11533	28	11	how	how	SCONJ
aiua-11533	28	12	to	to	PART
aiua-11533	28	13	best	good	ADJ
aiua-11533	28	14	tailor	tailor	NOUN
aiua-11533	28	15	treatments	treatment	NOUN
aiua-11533	28	16	based	base	VERB
aiua-11533	28	17	on	on	ADP
aiua-11533	28	18	sub	sub	ADJ
aiua-11533	28	19	-	-	ADJ
aiua-11533	28	20	specific	specific	ADJ
aiua-11533	28	21	indices	index	NOUN
aiua-11533	28	22	.	.	PUNCT
aiua-11533	29	1	key	key	ADJ
aiua-11533	29	2	words	word	NOUN
aiua-11533	29	3	:	:	PUNCT
aiua-11533	29	4	primary	primary	ADJ
aiua-11533	29	5	sarcoma	sarcoma	NOUN
aiua-11533	29	6	of	of	ADP
aiua-11533	29	7	the	the	DET
aiua-11533	29	8	urinary	urinary	ADJ
aiua-11533	29	9	bladder	bladder	NOUN
aiua-11533	29	10	(	(	PUNCT
aiua-11533	29	11	sub	sub	NOUN
aiua-11533	29	12	)	)	PUNCT
aiua-11533	29	13	;	;	PUNCT
aiua-11533	29	14	bladder	bladder	NOUN
aiua-11533	29	15	cancer	cancer	NOUN
aiua-11533	29	16	.	.	PUNCT
aiua-11533	29	17	submitted	submit	VERB
aiua-11533	29	18	19	19	NUM
aiua-11533	29	19	june	june	PROPN
aiua-11533	29	20	2023	2023	NUM
aiua-11533	29	21	;	;	PUNCT
aiua-11533	29	22	accepted	accept	VERB
aiua-11533	29	23	1	1	NUM
aiua-11533	29	24	july	july	PROPN
aiua-11533	29	25	2023	2023	NUM
aiua-11533	29	26	primary	primary	ADJ
aiua-11533	29	27	bladder	bladder	NOUN
aiua-11533	29	28	sarcoma	sarcoma	NOUN
aiua-11533	29	29	:	:	PUNCT
aiua-11533	29	30	a	a	DET
aiua-11533	29	31	multi	multi	ADJ
aiua-11533	29	32	-	-	ADJ
aiua-11533	29	33	institutional	institutional	ADJ
aiua-11533	29	34	experience	experience	NOUN
aiua-11533	29	35	from	from	ADP
aiua-11533	29	36	the	the	DET
aiua-11533	29	37	rare	rare	ADJ
aiua-11533	29	38	cancer	cancer	NOUN
aiua-11533	29	39	network	network	NOUN
aiua-11533	29	40	piero	piero	NOUN
aiua-11533	29	41	bettoli	bettoli	ADP
aiua-11533	29	42	1	1	NUM
aiua-11533	29	43	,	,	PUNCT
aiua-11533	29	44	2	2	NUM
aiua-11533	29	45	,	,	PUNCT
aiua-11533	29	46	zhihuiamy	zhihuiamy	PROPN
aiua-11533	29	47	liu	liu	PROPN
aiua-11533	29	48	3	3	PROPN
aiua-11533	29	49	,	,	PUNCT
aiua-11533	29	50	natalia	natalia	PROPN
aiua-11533	29	51	jara	jara	PROPN
aiua-11533	29	52	4	4	NUM
aiua-11533	29	53	,	,	PUNCT
aiua-11533	29	54	federico	federico	PROPN
aiua-11533	29	55	bakal	bakal	PROPN
aiua-11533	29	56	1	1	PROPN
aiua-11533	29	57	,	,	PUNCT
aiua-11533	29	58	william	william	PROPN
aiua-11533	29	59	wong	wong	PROPN
aiua-11533	29	60	5	5	PROPN
aiua-11533	29	61	,	,	PUNCT
aiua-11533	29	62	mario	mario	PROPN
aiua-11533	29	63	terlizzi	terlizzi	PROPN
aiua-11533	29	64	6	6	NUM
aiua-11533	29	65	,	,	PUNCT
aiua-11533	29	66	paul	paul	PROPN
aiua-11533	29	67	sargos	sargos	PROPN
aiua-11533	29	68	6	6	NUM
aiua-11533	29	69	,	,	PUNCT
aiua-11533	29	70	thomas	thomas	PROPN
aiua-11533	29	71	zilli	zilli	PROPN
aiua-11533	29	72	7	7	PROPN
aiua-11533	29	73	,	,	PUNCT
aiua-11533	29	74	juliette	juliette	PROPN
aiua-11533	29	75	thariat	thariat	NOUN
aiua-11533	29	76	8	8	NUM
aiua-11533	29	77	,	,	PUNCT
aiua-11533	29	78	sebastian	sebastian	PROPN
aiua-11533	29	79	sole	sole	ADJ
aiua-11533	29	80	4	4	NUM
aiua-11533	29	81	,	,	PUNCT
aiua-11533	29	82	9	9	NUM
aiua-11533	29	83	,	,	PUNCT
aiua-11533	29	84	guillaume	guillaume	PROPN
aiua-11533	29	85	ploussard	ploussard	PROPN
aiua-11533	29	86	10	10	NUM
aiua-11533	29	87	,	,	PUNCT
aiua-11533	29	88	sharad	sharad	PROPN
aiua-11533	29	89	goyal	goyal	PROPN
aiua-11533	29	90	11	11	NUM
aiua-11533	29	91	,	,	PUNCT
aiua-11533	29	92	peter	peter	PROPN
aiua-11533	29	93	chung	chung	PROPN
aiua-11533	29	94	3	3	NUM
aiua-11533	29	95	,	,	PUNCT
aiua-11533	29	96	alejandro	alejandro	PROPN
aiua-11533	29	97	berlin	berlin	PROPN
aiua-11533	29	98	3	3	NUM
aiua-11533	29	99	,	,	PUNCT
aiua-11533	29	100	claudio	claudio	NOUN
aiua-11533	29	101	v.	v.	ADP
aiua-11533	29	102	sole	sole	ADJ
aiua-11533	29	103	4	4	NUM
aiua-11533	29	104	,	,	PUNCT
aiua-11533	29	105	9	9	NUM
aiua-11533	29	106	1	1	NUM
aiua-11533	29	107	department	department	NOUN
aiua-11533	29	108	of	of	ADP
aiua-11533	29	109	radiation	radiation	NOUN
aiua-11533	29	110	oncology	oncology	NOUN
aiua-11533	29	111	,	,	PUNCT
aiua-11533	29	112	fundación	fundación	PROPN
aiua-11533	29	113	arturo	arturo	PROPN
aiua-11533	29	114	lópez	lópez	PROPN
aiua-11533	29	115	pérez	pérez	PROPN
aiua-11533	29	116	,	,	PUNCT
aiua-11533	29	117	santiago	santiago	PROPN
aiua-11533	29	118	,	,	PUNCT
aiua-11533	29	119	chile	chile	NOUN
aiua-11533	29	120	;	;	PUNCT
aiua-11533	29	121	2	2	NUM
aiua-11533	29	122	facultad	facultad	PROPN
aiua-11533	29	123	de	de	PROPN
aiua-11533	29	124	medicina	medicina	PROPN
aiua-11533	29	125	,	,	PUNCT
aiua-11533	29	126	universidad	universidad	PROPN
aiua-11533	29	127	de	de	X
aiua-11533	29	128	los	los	PROPN
aiua-11533	29	129	andes	andes	PROPN
aiua-11533	29	130	,	,	PUNCT
aiua-11533	29	131	santiago	santiago	PROPN
aiua-11533	29	132	,	,	PUNCT
aiua-11533	29	133	chile	chile	NOUN
aiua-11533	29	134	;	;	PUNCT
aiua-11533	29	135	3	3	NUM
aiua-11533	29	136	radiation	radiation	NOUN
aiua-11533	29	137	medicine	medicine	NOUN
aiua-11533	29	138	program	program	NOUN
aiua-11533	29	139	,	,	PUNCT
aiua-11533	29	140	princess	princess	PROPN
aiua-11533	29	141	margaret	margaret	PROPN
aiua-11533	29	142	cancer	cancer	PROPN
aiua-11533	29	143	centre	centre	PROPN
aiua-11533	29	144	,	,	PUNCT
aiua-11533	29	145	university	university	NOUN
aiua-11533	29	146	health	health	NOUN
aiua-11533	29	147	network	network	NOUN
aiua-11533	29	148	,	,	PUNCT
aiua-11533	29	149	university	university	PROPN
aiua-11533	29	150	of	of	ADP
aiua-11533	29	151	toronto	toronto	PROPN
aiua-11533	29	152	,	,	PUNCT
aiua-11533	29	153	toronto	toronto	PROPN
aiua-11533	29	154	,	,	PUNCT
aiua-11533	29	155	on	on	ADP
aiua-11533	29	156	,	,	PUNCT
aiua-11533	29	157	canada	canada	PROPN
aiua-11533	29	158	;	;	PUNCT
aiua-11533	29	159	4	4	NUM
aiua-11533	29	160	department	department	NOUN
aiua-11533	29	161	of	of	ADP
aiua-11533	29	162	radiation	radiation	NOUN
aiua-11533	29	163	oncology	oncology	NOUN
aiua-11533	29	164	,	,	PUNCT
aiua-11533	29	165	instituto	instituto	PROPN
aiua-11533	29	166	de	de	PROPN
aiua-11533	29	167	radiomedicina	radiomedicina	PROPN
aiua-11533	29	168	,	,	PUNCT
aiua-11533	29	169	santiago	santiago	PROPN
aiua-11533	29	170	,	,	PUNCT
aiua-11533	29	171	chile	chile	NOUN
aiua-11533	29	172	;	;	PUNCT
aiua-11533	29	173	5	5	NUM
aiua-11533	29	174	department	department	NOUN
aiua-11533	29	175	of	of	ADP
aiua-11533	29	176	radiation	radiation	NOUN
aiua-11533	29	177	oncology	oncology	NOUN
aiua-11533	29	178	,	,	PUNCT
aiua-11533	29	179	mayo	mayo	NOUN
aiua-11533	29	180	clinic	clinic	PROPN
aiua-11533	29	181	arizona	arizona	PROPN
aiua-11533	29	182	,	,	PUNCT
aiua-11533	29	183	phoenix	phoenix	PROPN
aiua-11533	29	184	,	,	PUNCT
aiua-11533	29	185	usa	usa	PROPN
aiua-11533	29	186	;	;	PUNCT
aiua-11533	29	187	6	6	NUM
aiua-11533	29	188	department	department	NOUN
aiua-11533	29	189	of	of	ADP
aiua-11533	29	190	radiation	radiation	NOUN
aiua-11533	29	191	oncology	oncology	NOUN
aiua-11533	29	192	,	,	PUNCT
aiua-11533	29	193	institute	institute	NOUN
aiua-11533	29	194	bergonie	bergonie	PROPN
aiua-11533	29	195	,	,	PUNCT
aiua-11533	29	196	bordeaux	bordeaux	NOUN
aiua-11533	29	197	,	,	PUNCT
aiua-11533	29	198	france	france	PROPN
aiua-11533	29	199	;	;	PUNCT
aiua-11533	29	200	7	7	NUM
aiua-11533	29	201	department	department	NOUN
aiua-11533	29	202	of	of	ADP
aiua-11533	29	203	radiation	radiation	NOUN
aiua-11533	29	204	oncology	oncology	NOUN
aiua-11533	29	205	,	,	PUNCT
aiua-11533	29	206	geneva	geneva	PROPN
aiua-11533	29	207	university	university	PROPN
aiua-11533	29	208	hospital	hospital	NOUN
aiua-11533	29	209	,	,	PUNCT
aiua-11533	29	210	geneva	geneva	PROPN
aiua-11533	29	211	,	,	PUNCT
aiua-11533	29	212	switzerland	switzerland	PROPN
aiua-11533	29	213	;	;	PUNCT
aiua-11533	29	214	8	8	NUM
aiua-11533	29	215	department	department	NOUN
aiua-11533	29	216	of	of	ADP
aiua-11533	29	217	radiation	radiation	NOUN
aiua-11533	29	218	therapy	therapy	NOUN
aiua-11533	29	219	,	,	PUNCT
aiua-11533	29	220	centre	centre	PROPN
aiua-11533	29	221	francoise	francoise	PROPN
aiua-11533	29	222	baclese	baclese	PROPN
aiua-11533	29	223	,	,	PUNCT
aiua-11533	29	224	caen	caen	PROPN
aiua-11533	29	225	,	,	PUNCT
aiua-11533	29	226	france	france	PROPN
aiua-11533	29	227	;	;	PUNCT
aiua-11533	29	228	9	9	NUM
aiua-11533	29	229	facultad	facultad	PROPN
aiua-11533	29	230	de	de	PROPN
aiua-11533	29	231	medicina	medicina	PROPN
aiua-11533	29	232	,	,	PUNCT
aiua-11533	29	233	universidad	universidad	PROPN
aiua-11533	29	234	diego	diego	PROPN
aiua-11533	29	235	portales	portales	PROPN
aiua-11533	29	236	,	,	PUNCT
aiua-11533	29	237	santiago	santiago	PROPN
aiua-11533	29	238	,	,	PUNCT
aiua-11533	29	239	chile	chile	NOUN
aiua-11533	29	240	;	;	PUNCT
aiua-11533	29	241	10	10	NUM
aiua-11533	29	242	department	department	NOUN
aiua-11533	29	243	of	of	ADP
aiua-11533	29	244	urology	urology	NOUN
aiua-11533	29	245	,	,	PUNCT
aiua-11533	29	246	la	la	PROPN
aiua-11533	29	247	croix	croix	PROPN
aiua-11533	29	248	du	du	PROPN
aiua-11533	29	249	sud	sud	PROPN
aiua-11533	29	250	hospital	hospital	PROPN
aiua-11533	29	251	,	,	PUNCT
aiua-11533	29	252	toulouse	toulouse	NOUN
aiua-11533	29	253	,	,	PUNCT
aiua-11533	29	254	france	france	PROPN
aiua-11533	29	255	;	;	PUNCT
aiua-11533	29	256	11	11	NUM
aiua-11533	29	257	department	department	NOUN
aiua-11533	29	258	of	of	ADP
aiua-11533	29	259	radiation	radiation	NOUN
aiua-11533	29	260	oncology	oncology	NOUN
aiua-11533	29	261	,	,	PUNCT
aiua-11533	29	262	george	george	PROPN
aiua-11533	29	263	washington	washington	PROPN
aiua-11533	29	264	university	university	PROPN
aiua-11533	29	265	hospital	hospital	NOUN
aiua-11533	29	266	,	,	PUNCT
aiua-11533	29	267	washington	washington	PROPN
aiua-11533	29	268	dc	dc	PROPN
aiua-11533	29	269	,	,	PUNCT
aiua-11533	29	270	usa	usa	PROPN
aiua-11533	29	271	.	.	PROPN
aiua-11533	29	272	doi	doi	PROPN
aiua-11533	29	273	:	:	PUNCT
aiua-11533	29	274	10.4081	10.4081	NUM
aiua-11533	29	275	/	/	SYM
aiua-11533	29	276	aiua.2023.11533	aiua.2023.11533	NOUN
aiua-11533	29	277	summary	summary	NOUN
aiua-11533	29	278	archivio	archivio	NOUN
aiua-11533	29	279	italiano	italiano	X
aiua-11533	29	280	di	di	X
aiua-11533	29	281	urologia	urologia	PROPN
aiua-11533	29	282	e	e	PROPN
aiua-11533	29	283	andrologia	andrologia	NOUN
aiua-11533	29	284	2023	2023	NUM
aiua-11533	29	285	;	;	PUNCT
aiua-11533	29	286	95(3):11533	95(3):11533	NUM
aiua-11533	29	287	p.	p.	NOUN
aiua-11533	29	288	bettoli	bettoli	PROPN
aiua-11533	29	289	,	,	PUNCT
aiua-11533	29	290	z.	z.	PROPN
aiua-11533	29	291	liu	liu	PROPN
aiua-11533	29	292	,	,	PUNCT
aiua-11533	29	293	n.	n.	PROPN
aiua-11533	29	294	jara	jara	PROPN
aiua-11533	29	295	,	,	PUNCT
aiua-11533	29	296	et	et	PROPN
aiua-11533	29	297	al	al	PROPN
aiua-11533	29	298	.	.	PROPN
aiua-11533	29	299	2	2	NUM
aiua-11533	29	300	ing	ing	NOUN
aiua-11533	29	301	for	for	ADP
aiua-11533	29	302	tumor	tumor	NOUN
aiua-11533	29	303	stage	stage	NOUN
aiua-11533	29	304	,	,	PUNCT
aiua-11533	29	305	overall	overall	ADJ
aiua-11533	29	306	survival	survival	NOUN
aiua-11533	29	307	(	(	PUNCT
aiua-11533	29	308	os	os	NOUN
aiua-11533	29	309	)	)	PUNCT
aiua-11533	29	310	rates	rate	NOUN
aiua-11533	29	311	for	for	ADP
aiua-11533	29	312	sub	sub	NOUN
aiua-11533	29	313	vs	vs	ADP
aiua-11533	29	314	high	high	ADJ
aiua-11533	29	315	-	-	PUNCT
aiua-11533	29	316	grade	grade	NOUN
aiua-11533	29	317	,	,	PUNCT
aiua-11533	29	318	pure	pure	ADJ
aiua-11533	29	319	uc	uc	NOUN
aiua-11533	29	320	are	be	AUX
aiua-11533	29	321	54	54	NUM
aiua-11533	29	322	%	%	NOUN
aiua-11533	29	323	vs	vs	ADP
aiua-11533	29	324	77	77	NUM
aiua-11533	29	325	%	%	NOUN
aiua-11533	29	326	at	at	ADP
aiua-11533	29	327	1	1	NUM
aiua-11533	29	328	year	year	NOUN
aiua-11533	29	329	and	and	CCONJ
aiua-11533	29	330	37	37	NUM
aiua-11533	29	331	%	%	NOUN
aiua-11533	29	332	vs	vs	ADP
aiua-11533	29	333	47	47	NUM
aiua-11533	29	334	%	%	NOUN
aiua-11533	29	335	at	at	ADP
aiua-11533	29	336	5	5	NUM
aiua-11533	29	337	years	year	NOUN
aiua-11533	29	338	,	,	PUNCT
aiua-11533	29	339	respectively	respectively	ADV
aiua-11533	29	340	(	(	PUNCT
aiua-11533	29	341	4	4	NUM
aiua-11533	29	342	,	,	PUNCT
aiua-11533	29	343	7	7	NUM
aiua-11533	29	344	)	)	PUNCT
aiua-11533	29	345	.	.	PUNCT
aiua-11533	30	1	published	publish	VERB
aiua-11533	30	2	data	datum	NOUN
aiua-11533	30	3	on	on	ADP
aiua-11533	30	4	sub	sub	NOUN
aiua-11533	30	5	only	only	ADV
aiua-11533	30	6	consist	consist	VERB
aiua-11533	30	7	of	of	ADP
aiua-11533	30	8	case	case	NOUN
aiua-11533	30	9	reports	report	NOUN
aiua-11533	30	10	and	and	CCONJ
aiua-11533	30	11	limited	limited	ADJ
aiua-11533	30	12	case	case	NOUN
aiua-11533	30	13	series	series	NOUN
aiua-11533	30	14	.	.	PUNCT
aiua-11533	31	1	not	not	PART
aiua-11533	31	2	much	much	ADV
aiua-11533	31	3	is	be	AUX
aiua-11533	31	4	understood	understand	VERB
aiua-11533	31	5	of	of	ADP
aiua-11533	31	6	sub	sub	NOUN
aiua-11533	31	7	biology	biology	NOUN
aiua-11533	31	8	and	and	CCONJ
aiua-11533	31	9	behavior	behavior	NOUN
aiua-11533	31	10	and	and	CCONJ
aiua-11533	31	11	its	its	PRON
aiua-11533	31	12	rarity	rarity	NOUN
aiua-11533	31	13	does	do	AUX
aiua-11533	31	14	not	not	PART
aiua-11533	31	15	permit	permit	VERB
aiua-11533	31	16	to	to	PART
aiua-11533	31	17	design	design	VERB
aiua-11533	31	18	specific	specific	ADJ
aiua-11533	31	19	treatment	treatment	NOUN
aiua-11533	31	20	guidelines	guideline	NOUN
aiua-11533	31	21	.	.	PUNCT
aiua-11533	32	1	thus	thus	ADV
aiua-11533	32	2	,	,	PUNCT
aiua-11533	32	3	we	we	PRON
aiua-11533	32	4	intend	intend	VERB
aiua-11533	32	5	to	to	PART
aiua-11533	32	6	summarize	summarize	VERB
aiua-11533	32	7	the	the	DET
aiua-11533	32	8	current	current	ADJ
aiua-11533	32	9	multi	multi	ADJ
aiua-11533	32	10	-	-	ADJ
aiua-11533	32	11	institutional	institutional	ADJ
aiua-11533	32	12	knowledge	knowledge	NOUN
aiua-11533	32	13	of	of	ADP
aiua-11533	32	14	sub	sub	NOUN
aiua-11533	32	15	and	and	CCONJ
aiua-11533	32	16	present	present	VERB
aiua-11533	32	17	an	an	DET
aiua-11533	32	18	overview	overview	NOUN
aiua-11533	32	19	of	of	ADP
aiua-11533	32	20	the	the	DET
aiua-11533	32	21	epidemiology	epidemiology	NOUN
aiua-11533	32	22	,	,	PUNCT
aiua-11533	32	23	clinical	clinical	ADJ
aiua-11533	32	24	features	feature	NOUN
aiua-11533	32	25	,	,	PUNCT
aiua-11533	32	26	and	and	CCONJ
aiua-11533	32	27	management	management	NOUN
aiua-11533	32	28	of	of	ADP
aiua-11533	32	29	this	this	DET
aiua-11533	32	30	uncommon	uncommon	ADJ
aiua-11533	32	31	type	type	NOUN
aiua-11533	32	32	of	of	ADP
aiua-11533	32	33	bca	bca	PROPN
aiua-11533	32	34	that	that	PRON
aiua-11533	32	35	can	can	AUX
aiua-11533	32	36	help	help	VERB
aiua-11533	32	37	clinicians	clinician	NOUN
aiua-11533	32	38	to	to	PART
aiua-11533	32	39	better	well	ADV
aiua-11533	32	40	tailor	tailor	VERB
aiua-11533	32	41	clinical	clinical	ADJ
aiua-11533	32	42	decisions	decision	NOUN
aiua-11533	32	43	on	on	ADP
aiua-11533	32	44	this	this	DET
aiua-11533	32	45	rare	rare	ADJ
aiua-11533	32	46	disease	disease	NOUN
aiua-11533	32	47	.	.	PUNCT
aiua-11533	33	1	methods	method	NOUN
aiua-11533	33	2	data	datum	NOUN
aiua-11533	33	3	on	on	ADP
aiua-11533	33	4	sub	sub	NOUN
aiua-11533	33	5	from	from	ADP
aiua-11533	33	6	january	january	PROPN
aiua-11533	33	7	1994	1994	NUM
aiua-11533	33	8	to	to	ADP
aiua-11533	33	9	september	september	PROPN
aiua-11533	33	10	2021	2021	NUM
aiua-11533	33	11	from	from	ADP
aiua-11533	33	12	7	7	NUM
aiua-11533	33	13	institutions	institution	NOUN
aiua-11533	33	14	were	be	AUX
aiua-11533	33	15	retrospectively	retrospectively	ADV
aiua-11533	33	16	collected	collect	VERB
aiua-11533	33	17	.	.	PUNCT
aiua-11533	34	1	international	international	ADJ
aiua-11533	34	2	review	review	PROPN
aiua-11533	34	3	board	board	PROPN
aiua-11533	34	4	(	(	PUNCT
aiua-11533	34	5	irb	irb	PROPN
aiua-11533	34	6	)	)	PUNCT
aiua-11533	34	7	approval	approval	NOUN
aiua-11533	34	8	based	base	VERB
aiua-11533	34	9	on	on	ADP
aiua-11533	34	10	each	each	DET
aiua-11533	34	11	country	country	NOUN
aiua-11533	34	12	/	/	SYM
aiua-11533	34	13	institution	institution	NOUN
aiua-11533	34	14	was	be	AUX
aiua-11533	34	15	obtained	obtain	VERB
aiua-11533	34	16	for	for	ADP
aiua-11533	34	17	retrospective	retrospective	ADJ
aiua-11533	34	18	review	review	NOUN
aiua-11533	34	19	of	of	ADP
aiua-11533	34	20	data	datum	NOUN
aiua-11533	34	21	.	.	PUNCT
aiua-11533	35	1	we	we	PRON
aiua-11533	35	2	only	only	ADV
aiua-11533	35	3	collected	collect	VERB
aiua-11533	35	4	data	datum	NOUN
aiua-11533	35	5	from	from	ADP
aiua-11533	35	6	localized	localized	ADJ
aiua-11533	35	7	primary	primary	ADJ
aiua-11533	35	8	bladder	bladder	NOUN
aiua-11533	35	9	tumors	tumor	NOUN
aiua-11533	35	10	with	with	ADP
aiua-11533	35	11	soft	soft	ADJ
aiua-11533	35	12	tissue	tissue	NOUN
aiua-11533	35	13	tumor	tumor	NOUN
aiua-11533	35	14	histology	histology	NOUN
aiua-11533	35	15	,	,	PUNCT
aiua-11533	35	16	including	include	VERB
aiua-11533	35	17	sc	sc	PROPN
aiua-11533	35	18	,	,	PUNCT
aiua-11533	35	19	cs	cs	PROPN
aiua-11533	35	20	and	and	CCONJ
aiua-11533	35	21	ts	ts	NOUN
aiua-11533	35	22	.	.	PUNCT
aiua-11533	36	1	the	the	DET
aiua-11533	36	2	data	datum	NOUN
aiua-11533	36	3	obtained	obtain	VERB
aiua-11533	36	4	included	include	VERB
aiua-11533	36	5	age	age	NOUN
aiua-11533	36	6	,	,	PUNCT
aiua-11533	36	7	gender	gender	NOUN
aiua-11533	36	8	,	,	PUNCT
aiua-11533	36	9	country	country	NOUN
aiua-11533	36	10	and	and	CCONJ
aiua-11533	36	11	institution	institution	NOUN
aiua-11533	36	12	,	,	PUNCT
aiua-11533	36	13	symptoms	symptom	NOUN
aiua-11533	36	14	at	at	ADP
aiua-11533	36	15	the	the	DET
aiua-11533	36	16	time	time	NOUN
aiua-11533	36	17	of	of	ADP
aiua-11533	36	18	diagnosis	diagnosis	NOUN
aiua-11533	36	19	,	,	PUNCT
aiua-11533	36	20	risk	risk	NOUN
aiua-11533	36	21	factors	factor	NOUN
aiua-11533	36	22	(	(	PUNCT
aiua-11533	36	23	smoking	smoking	NOUN
aiua-11533	36	24	and	and	CCONJ
aiua-11533	36	25	rt	rt	PROPN
aiua-11533	36	26	exposure	exposure	NOUN
aiua-11533	36	27	)	)	PUNCT
aiua-11533	36	28	,	,	PUNCT
aiua-11533	36	29	tumor	tumor	NOUN
aiua-11533	36	30	size	size	NOUN
aiua-11533	36	31	,	,	PUNCT
aiua-11533	36	32	tumor	tumor	NOUN
aiua-11533	36	33	location	location	NOUN
aiua-11533	36	34	,	,	PUNCT
aiua-11533	36	35	margins	margin	NOUN
aiua-11533	36	36	and	and	CCONJ
aiua-11533	36	37	nodal	nodal	ADJ
aiua-11533	36	38	status	status	NOUN
aiua-11533	36	39	.	.	PUNCT
aiua-11533	37	1	sarcoma	sarcoma	NOUN
aiua-11533	37	2	subtype	subtype	NOUN
aiua-11533	37	3	,	,	PUNCT
aiua-11533	37	4	grade	grade	NOUN
aiua-11533	37	5	and	and	CCONJ
aiua-11533	37	6	specific	specific	ADJ
aiua-11533	37	7	immuno	immuno	ADJ
aiua-11533	37	8	-	-	ADJ
aiua-11533	37	9	histochemical	histochemical	ADJ
aiua-11533	37	10	markers	marker	NOUN
aiua-11533	37	11	of	of	ADP
aiua-11533	37	12	these	these	DET
aiua-11533	37	13	tumors	tumor	NOUN
aiua-11533	37	14	were	be	AUX
aiua-11533	37	15	noted	note	VERB
aiua-11533	37	16	.	.	PUNCT
aiua-11533	38	1	staging	stage	VERB
aiua-11533	38	2	at	at	ADP
aiua-11533	38	3	the	the	DET
aiua-11533	38	4	time	time	NOUN
aiua-11533	38	5	of	of	ADP
aiua-11533	38	6	pathological	pathological	ADJ
aiua-11533	38	7	diagnosis	diagnosis	NOUN
aiua-11533	38	8	was	be	AUX
aiua-11533	38	9	based	base	VERB
aiua-11533	38	10	on	on	ADP
aiua-11533	38	11	the	the	DET
aiua-11533	38	12	tnm	tnm	PROPN
aiua-11533	38	13	(	(	PUNCT
aiua-11533	38	14	tumor	tumor	NOUN
aiua-11533	38	15	,	,	PUNCT
aiua-11533	38	16	lymph	lymph	NOUN
aiua-11533	38	17	node	node	NOUN
aiua-11533	38	18	,	,	PUNCT
aiua-11533	38	19	metastasis	metastasis	NOUN
aiua-11533	38	20	)	)	PUNCT
aiua-11533	38	21	classification	classification	NOUN
aiua-11533	38	22	for	for	ADP
aiua-11533	38	23	genitourinary	genitourinary	ADJ
aiua-11533	38	24	tumors	tumor	NOUN
aiua-11533	38	25	.	.	PUNCT
aiua-11533	39	1	treatment	treatment	NOUN
aiua-11533	39	2	modalities	modality	NOUN
aiua-11533	39	3	analyzed	analyze	VERB
aiua-11533	39	4	included	include	VERB
aiua-11533	39	5	cystectomy	cystectomy	NOUN
aiua-11533	39	6	(	(	PUNCT
aiua-11533	39	7	radical	radical	ADJ
aiua-11533	39	8	,	,	PUNCT
aiua-11533	39	9	partial	partial	ADJ
aiua-11533	39	10	,	,	PUNCT
aiua-11533	39	11	other	other	ADJ
aiua-11533	39	12	)	)	PUNCT
aiua-11533	39	13	,	,	PUNCT
aiua-11533	39	14	rt	rt	PROPN
aiua-11533	39	15	(	(	PUNCT
aiua-11533	39	16	definitive	definitive	ADJ
aiua-11533	39	17	,	,	PUNCT
aiua-11533	39	18	adjuvant	adjuvant	ADJ
aiua-11533	39	19	,	,	PUNCT
aiua-11533	39	20	neo	neo	NOUN
aiua-11533	39	21	-	-	PUNCT
aiua-11533	39	22	adjuvant	adjuvant	ADJ
aiua-11533	39	23	or	or	CCONJ
aiua-11533	39	24	palliative	palliative	NOUN
aiua-11533	39	25	)	)	PUNCT
aiua-11533	39	26	and	and	CCONJ
aiua-11533	39	27	chemotherapy	chemotherapy	NOUN
aiua-11533	39	28	(	(	PUNCT
aiua-11533	39	29	neo	neo	NOUN
aiua-11533	39	30	-	-	NOUN
aiua-11533	39	31	adjuvant	adjuvant	ADJ
aiua-11533	39	32	,	,	PUNCT
aiua-11533	39	33	adjuvant	adjuvant	NOUN
aiua-11533	39	34	,	,	PUNCT
aiua-11533	39	35	radio	radio	NOUN
aiua-11533	39	36	-	-	PUNCT
aiua-11533	39	37	sensitizer	sensitizer	NOUN
aiua-11533	39	38	or	or	CCONJ
aiua-11533	39	39	palliative	palliative	NOUN
aiua-11533	39	40	)	)	PUNCT
aiua-11533	39	41	.	.	PUNCT
aiua-11533	40	1	overall	overall	ADJ
aiua-11533	40	2	survival	survival	NOUN
aiua-11533	40	3	(	(	PUNCT
aiua-11533	40	4	os	os	NOUN
aiua-11533	40	5	)	)	PUNCT
aiua-11533	40	6	,	,	PUNCT
aiua-11533	40	7	cancer	cancer	NOUN
aiua-11533	40	8	-	-	PUNCT
aiua-11533	40	9	specific	specific	ADJ
aiua-11533	40	10	survival	survival	NOUN
aiua-11533	40	11	(	(	PUNCT
aiua-11533	40	12	css	css	PROPN
aiua-11533	40	13	)	)	PUNCT
aiua-11533	40	14	,	,	PUNCT
aiua-11533	40	15	disease	disease	NOUN
aiua-11533	40	16	-	-	PUNCT
aiua-11533	40	17	free	free	ADJ
aiua-11533	40	18	survival	survival	NOUN
aiua-11533	40	19	(	(	PUNCT
aiua-11533	40	20	dfs	dfs	PROPN
aiua-11533	40	21	)	)	PUNCT
aiua-11533	40	22	,	,	PUNCT
aiua-11533	40	23	distant	distant	ADJ
aiua-11533	40	24	metastases	metastasis	NOUN
aiua-11533	40	25	(	(	PUNCT
aiua-11533	40	26	dm	dm	NOUN
aiua-11533	40	27	)	)	PUNCT
aiua-11533	40	28	and	and	CCONJ
aiua-11533	40	29	local	local	ADJ
aiua-11533	40	30	control	control	NOUN
aiua-11533	40	31	(	(	PUNCT
aiua-11533	40	32	lc	lc	NOUN
aiua-11533	40	33	)	)	PUNCT
aiua-11533	40	34	were	be	AUX
aiua-11533	40	35	calculated	calculate	VERB
aiua-11533	40	36	from	from	ADP
aiua-11533	40	37	diagnosis	diagnosis	NOUN
aiua-11533	40	38	to	to	ADP
aiua-11533	40	39	the	the	DET
aiua-11533	40	40	date	date	NOUN
aiua-11533	40	41	of	of	ADP
aiua-11533	40	42	any	any	DET
aiua-11533	40	43	specific	specific	ADJ
aiua-11533	40	44	event	event	NOUN
aiua-11533	40	45	or	or	CCONJ
aiua-11533	40	46	the	the	DET
aiua-11533	40	47	date	date	NOUN
aiua-11533	40	48	of	of	ADP
aiua-11533	40	49	last	last	ADJ
aiua-11533	40	50	follow	follow	NOUN
aiua-11533	40	51	-	-	PUNCT
aiua-11533	40	52	up	up	NOUN
aiua-11533	40	53	in	in	ADP
aiua-11533	40	54	case	case	NOUN
aiua-11533	40	55	an	an	DET
aiua-11533	40	56	event	event	NOUN
aiua-11533	40	57	did	do	AUX
aiua-11533	40	58	not	not	PART
aiua-11533	40	59	occur	occur	VERB
aiua-11533	40	60	.	.	PUNCT
aiua-11533	41	1	probabilities	probability	NOUN
aiua-11533	41	2	for	for	ADP
aiua-11533	41	3	os	os	NOUN
aiua-11533	41	4	,	,	PUNCT
aiua-11533	41	5	css	css	PROPN
aiua-11533	41	6	and	and	CCONJ
aiua-11533	41	7	dfs	dfs	PROPN
aiua-11533	41	8	were	be	AUX
aiua-11533	41	9	determined	determine	VERB
aiua-11533	41	10	by	by	ADP
aiua-11533	41	11	kaplan	kaplan	PROPN
aiua-11533	41	12	-	-	PUNCT
aiua-11533	41	13	meier	meier	PROPN
aiua-11533	41	14	estimates	estimate	NOUN
aiua-11533	41	15	.	.	PUNCT
aiua-11533	42	1	local	local	ADJ
aiua-11533	42	2	recurrence	recurrence	NOUN
aiua-11533	42	3	(	(	PUNCT
aiua-11533	42	4	lr	lr	NOUN
aiua-11533	42	5	)	)	PUNCT
aiua-11533	42	6	and	and	CCONJ
aiua-11533	42	7	dm	dm	PROPN
aiua-11533	42	8	were	be	AUX
aiua-11533	42	9	estimated	estimate	VERB
aiua-11533	42	10	using	use	VERB
aiua-11533	42	11	cumulative	cumulative	ADJ
aiua-11533	42	12	incidence	incidence	NOUN
aiua-11533	42	13	function	function	NOUN
aiua-11533	42	14	considering	consider	VERB
aiua-11533	42	15	death	death	NOUN
aiua-11533	42	16	as	as	ADP
aiua-11533	42	17	a	a	DET
aiua-11533	42	18	competing	compete	VERB
aiua-11533	42	19	risk	risk	NOUN
aiua-11533	42	20	.	.	PUNCT
aiua-11533	43	1	selective	selective	ADJ
aiua-11533	43	2	comparisons	comparison	NOUN
aiua-11533	43	3	of	of	ADP
aiua-11533	43	4	survival	survival	NOUN
aiua-11533	43	5	curves	curve	NOUN
aiua-11533	43	6	were	be	AUX
aiua-11533	43	7	calculated	calculate	VERB
aiua-11533	43	8	by	by	ADP
aiua-11533	43	9	the	the	DET
aiua-11533	43	10	log	log	NOUN
aiua-11533	43	11	-	-	PUNCT
aiua-11533	43	12	rank	rank	NOUN
aiua-11533	43	13	test	test	NOUN
aiua-11533	43	14	.	.	PUNCT
aiua-11533	44	1	multivariate	multivariate	NOUN
aiua-11533	44	2	models	model	NOUN
aiua-11533	44	3	were	be	AUX
aiua-11533	44	4	not	not	PART
aiua-11533	44	5	used	use	VERB
aiua-11533	44	6	because	because	SCONJ
aiua-11533	44	7	of	of	ADP
aiua-11533	44	8	the	the	DET
aiua-11533	44	9	small	small	ADJ
aiua-11533	44	10	number	number	NOUN
aiua-11533	44	11	of	of	ADP
aiua-11533	44	12	patients	patient	NOUN
aiua-11533	44	13	and	and	CCONJ
aiua-11533	44	14	events	event	NOUN
aiua-11533	44	15	.	.	PUNCT
aiua-11533	45	1	for	for	ADP
aiua-11533	45	2	statistical	statistical	ADJ
aiua-11533	45	3	analyses	analysis	NOUN
aiua-11533	45	4	the	the	DET
aiua-11533	45	5	software	software	NOUN
aiua-11533	45	6	program	program	NOUN
aiua-11533	45	7	stata	stata	NOUN
aiua-11533	45	8	(	(	PUNCT
aiua-11533	45	9	version	version	NOUN
aiua-11533	45	10	13	13	NUM
aiua-11533	45	11	;	;	PUNCT
aiua-11533	45	12	college	college	NOUN
aiua-11533	45	13	station	station	NOUN
aiua-11533	45	14	,	,	PUNCT
aiua-11533	45	15	texas	texas	PROPN
aiua-11533	45	16	,	,	PUNCT
aiua-11533	45	17	usa	usa	PROPN
aiua-11533	45	18	)	)	PUNCT
aiua-11533	45	19	was	be	AUX
aiua-11533	45	20	used	use	VERB
aiua-11533	45	21	.	.	PUNCT
aiua-11533	46	1	results	result	VERB
aiua-11533	46	2	fifty	fifty	NUM
aiua-11533	46	3	-	-	PUNCT
aiua-11533	46	4	three	three	NUM
aiua-11533	46	5	patients	patient	NOUN
aiua-11533	46	6	were	be	AUX
aiua-11533	46	7	evaluated	evaluate	VERB
aiua-11533	46	8	,	,	PUNCT
aiua-11533	46	9	38	38	NUM
aiua-11533	46	10	men	man	NOUN
aiua-11533	46	11	(	(	PUNCT
aiua-11533	46	12	72	72	NUM
aiua-11533	46	13	%	%	NOUN
aiua-11533	46	14	)	)	PUNCT
aiua-11533	46	15	and	and	CCONJ
aiua-11533	46	16	15	15	NUM
aiua-11533	46	17	women	woman	NOUN
aiua-11533	46	18	(	(	PUNCT
aiua-11533	46	19	28	28	NUM
aiua-11533	46	20	%	%	NOUN
aiua-11533	46	21	)	)	PUNCT
aiua-11533	46	22	,	,	PUNCT
aiua-11533	46	23	who	who	PRON
aiua-11533	46	24	had	have	VERB
aiua-11533	46	25	a	a	DET
aiua-11533	46	26	median	median	ADJ
aiua-11533	46	27	age	age	NOUN
aiua-11533	46	28	at	at	ADP
aiua-11533	46	29	presentation	presentation	NOUN
aiua-11533	46	30	of	of	ADP
aiua-11533	46	31	69	69	NUM
aiua-11533	46	32	years	year	NOUN
aiua-11533	46	33	(	(	PUNCT
aiua-11533	46	34	range	range	NOUN
aiua-11533	46	35	16	16	NUM
aiua-11533	46	36	-	-	SYM
aiua-11533	46	37	89	89	NUM
aiua-11533	46	38	years	year	NOUN
aiua-11533	46	39	)	)	PUNCT
aiua-11533	46	40	.	.	PUNCT
aiua-11533	47	1	twenty	twenty	NUM
aiua-11533	47	2	-	-	PUNCT
aiua-11533	47	3	six	six	NUM
aiua-11533	47	4	percent	percent	NOUN
aiua-11533	47	5	of	of	ADP
aiua-11533	47	6	patients	patient	NOUN
aiua-11533	47	7	had	have	VERB
aiua-11533	47	8	a	a	DET
aiua-11533	47	9	prior	prior	ADJ
aiua-11533	47	10	history	history	NOUN
aiua-11533	47	11	of	of	ADP
aiua-11533	47	12	pelvic	pelvic	PROPN
aiua-11533	47	13	rt	rt	PROPN
aiua-11533	47	14	;	;	PUNCT
aiua-11533	47	15	contrary	contrary	ADV
aiua-11533	47	16	to	to	ADP
aiua-11533	47	17	patients	patient	NOUN
aiua-11533	47	18	with	with	ADP
aiua-11533	47	19	transitional	transitional	ADJ
aiua-11533	47	20	cell	cell	NOUN
aiua-11533	47	21	carcinoma	carcinoma	NOUN
aiua-11533	47	22	,	,	PUNCT
aiua-11533	47	23	only	only	ADV
aiua-11533	47	24	37	37	NUM
aiua-11533	47	25	%	%	NOUN
aiua-11533	47	26	of	of	ADP
aiua-11533	47	27	patients	patient	NOUN
aiua-11533	47	28	had	have	VERB
aiua-11533	47	29	a	a	DET
aiua-11533	47	30	history	history	NOUN
aiua-11533	47	31	of	of	ADP
aiua-11533	47	32	tobacco	tobacco	NOUN
aiua-11533	47	33	use	use	NOUN
aiua-11533	47	34	.	.	PUNCT
aiua-11533	48	1	symptoms	symptom	NOUN
aiua-11533	48	2	at	at	ADP
aiua-11533	48	3	diagnosis	diagnosis	NOUN
aiua-11533	48	4	were	be	AUX
aiua-11533	48	5	mainly	mainly	ADV
aiua-11533	48	6	hematuria	hematuria	NOUN
aiua-11533	48	7	(	(	PUNCT
aiua-11533	48	8	52	52	NUM
aiua-11533	48	9	%	%	NOUN
aiua-11533	48	10	)	)	PUNCT
aiua-11533	48	11	,	,	PUNCT
aiua-11533	48	12	pelvic	pelvic	ADJ
aiua-11533	48	13	pain	pain	NOUN
aiua-11533	48	14	(	(	PUNCT
aiua-11533	48	15	27	27	NUM
aiua-11533	48	16	%	%	NOUN
aiua-11533	48	17	)	)	PUNCT
aiua-11533	48	18	,	,	PUNCT
aiua-11533	48	19	and	and	CCONJ
aiua-11533	48	20	both	both	PRON
aiua-11533	48	21	hematuria	hematuria	NOUN
aiua-11533	48	22	and	and	CCONJ
aiua-11533	48	23	pelvic	pelvic	ADJ
aiua-11533	48	24	pain	pain	NOUN
aiua-11533	48	25	(	(	PUNCT
aiua-11533	48	26	10	10	NUM
aiua-11533	48	27	%	%	NOUN
aiua-11533	48	28	)	)	PUNCT
aiua-11533	48	29	.	.	PUNCT
aiua-11533	49	1	median	median	ADJ
aiua-11533	49	2	tumor	tumor	NOUN
aiua-11533	49	3	size	size	NOUN
aiua-11533	49	4	was	be	AUX
aiua-11533	49	5	4.5	4.5	NUM
aiua-11533	49	6	cm	cm	NOUN
aiua-11533	49	7	(	(	PUNCT
aiua-11533	49	8	range	range	NOUN
aiua-11533	49	9	1.5	1.5	NUM
aiua-11533	49	10	-	-	SYM
aiua-11533	49	11	9.5	9.5	NUM
aiua-11533	49	12	cm	cm	NOUN
aiua-11533	49	13	)	)	PUNCT
aiua-11533	49	14	.	.	PUNCT
aiua-11533	50	1	extravesical	extravesical	ADJ
aiua-11533	50	2	spread	spread	NOUN
aiua-11533	50	3	(	(	PUNCT
aiua-11533	50	4	t3	t3	PROPN
aiua-11533	50	5	/	/	SYM
aiua-11533	50	6	t4	t4	PROPN
aiua-11533	50	7	)	)	PUNCT
aiua-11533	50	8	was	be	AUX
aiua-11533	50	9	the	the	DET
aiua-11533	50	10	most	most	ADV
aiua-11533	50	11	common	common	ADJ
aiua-11533	50	12	presentation	presentation	NOUN
aiua-11533	50	13	of	of	ADP
aiua-11533	50	14	the	the	DET
aiua-11533	50	15	primary	primary	ADJ
aiua-11533	50	16	tumor	tumor	NOUN
aiua-11533	50	17	in	in	ADP
aiua-11533	50	18	59	59	NUM
aiua-11533	50	19	%	%	NOUN
aiua-11533	50	20	of	of	ADP
aiua-11533	50	21	cases	case	NOUN
aiua-11533	50	22	.	.	PUNCT
aiua-11533	51	1	nodal	nodal	NOUN
aiua-11533	51	2	metastases	metastasis	NOUN
aiua-11533	51	3	were	be	AUX
aiua-11533	51	4	identified	identify	VERB
aiua-11533	51	5	in	in	ADP
aiua-11533	51	6	35	35	NUM
aiua-11533	51	7	%	%	NOUN
aiua-11533	51	8	of	of	ADP
aiua-11533	51	9	patients	patient	NOUN
aiua-11533	51	10	.	.	PUNCT
aiua-11533	52	1	ajcc	ajcc	PROPN
aiua-11533	52	2	8th	8th	PROPN
aiua-11533	52	3	edition	edition	PROPN
aiua-11533	52	4	stage	stage	PROPN
aiua-11533	52	5	ii	ii	PROPN
aiua-11533	52	6	,	,	PUNCT
aiua-11533	52	7	iii	iii	PROPN
aiua-11533	52	8	and	and	CCONJ
aiua-11533	52	9	iv	iv	NUM
aiua-11533	52	10	at	at	ADP
aiua-11533	52	11	diagnosis	diagnosis	NOUN
aiua-11533	52	12	were	be	AUX
aiua-11533	52	13	21	21	NUM
aiua-11533	52	14	%	%	NOUN
aiua-11533	52	15	,	,	PUNCT
aiua-11533	52	16	63	63	NUM
aiua-11533	52	17	%	%	NOUN
aiua-11533	52	18	and	and	CCONJ
aiua-11533	52	19	16	16	NUM
aiua-11533	52	20	%	%	NOUN
aiua-11533	52	21	,	,	PUNCT
aiua-11533	52	22	respectively	respectively	ADV
aiua-11533	52	23	.	.	PUNCT
aiua-11533	53	1	the	the	DET
aiua-11533	53	2	majority	majority	NOUN
aiua-11533	53	3	of	of	ADP
aiua-11533	53	4	tumors	tumor	NOUN
aiua-11533	53	5	presented	present	VERB
aiua-11533	53	6	with	with	ADP
aiua-11533	53	7	high	high	ADJ
aiua-11533	53	8	grade	grade	NOUN
aiua-11533	53	9	histology	histology	NOUN
aiua-11533	53	10	(	(	PUNCT
aiua-11533	53	11	88	88	NUM
aiua-11533	53	12	%	%	NOUN
aiua-11533	53	13	)	)	PUNCT
aiua-11533	53	14	.	.	PUNCT
aiua-11533	54	1	distribution	distribution	NOUN
aiua-11533	54	2	of	of	ADP
aiua-11533	54	3	ts	t	NOUN
aiua-11533	54	4	and	and	CCONJ
aiua-11533	54	5	mbt	mbt	PROPN
aiua-11533	54	6	were	be	AUX
aiua-11533	54	7	43	43	NUM
aiua-11533	54	8	%	%	NOUN
aiua-11533	54	9	and	and	CCONJ
aiua-11533	54	10	57	57	NUM
aiua-11533	54	11	%	%	NOUN
aiua-11533	54	12	,	,	PUNCT
aiua-11533	54	13	respectively	respectively	ADV
aiua-11533	54	14	.	.	PUNCT
aiua-11533	55	1	leiomyosarcoma	leiomyosarcoma	PROPN
aiua-11533	55	2	was	be	AUX
aiua-11533	55	3	the	the	DET
aiua-11533	55	4	most	most	ADV
aiua-11533	55	5	common	common	ADJ
aiua-11533	55	6	histology	histology	NOUN
aiua-11533	55	7	in	in	ADP
aiua-11533	55	8	the	the	DET
aiua-11533	55	9	ts	ts	PROPN
aiua-11533	55	10	group	group	NOUN
aiua-11533	55	11	(	(	PUNCT
aiua-11533	55	12	63	63	NUM
aiua-11533	55	13	%	%	NOUN
aiua-11533	55	14	)	)	PUNCT
aiua-11533	55	15	,	,	PUNCT
aiua-11533	55	16	followed	follow	VERB
aiua-11533	55	17	by	by	ADP
aiua-11533	55	18	angiosarcoma	angiosarcoma	PROPN
aiua-11533	55	19	(	(	PUNCT
aiua-11533	55	20	13	13	NUM
aiua-11533	55	21	%	%	NOUN
aiua-11533	55	22	)	)	PUNCT
aiua-11533	55	23	,	,	PUNCT
aiua-11533	55	24	pleomorphic	pleomorphic	ADJ
aiua-11533	55	25	undifferentiated	undifferentiated	ADJ
aiua-11533	55	26	sarcoma	sarcoma	NOUN
aiua-11533	55	27	(	(	PUNCT
aiua-11533	55	28	10	10	NUM
aiua-11533	55	29	%	%	NOUN
aiua-11533	55	30	)	)	PUNCT
aiua-11533	55	31	,	,	PUNCT
aiua-11533	55	32	rhabdomyosarcoma	rhabdomyosarcoma	NOUN
aiua-11533	55	33	(	(	PUNCT
aiua-11533	55	34	7	7	NUM
aiua-11533	55	35	%	%	NOUN
aiua-11533	55	36	)	)	PUNCT
aiua-11533	55	37	,	,	PUNCT
aiua-11533	55	38	chondrosarcoma	chondrosarcoma	NOUN
aiua-11533	55	39	of	of	ADP
aiua-11533	55	40	soft	soft	ADJ
aiua-11533	55	41	tissue	tissue	NOUN
aiua-11533	55	42	(	(	PUNCT
aiua-11533	55	43	3	3	NUM
aiua-11533	55	44	%	%	NOUN
aiua-11533	55	45	)	)	PUNCT
aiua-11533	55	46	and	and	CCONJ
aiua-11533	55	47	leiomyoma	leiomyoma	NOUN
aiua-11533	55	48	(	(	PUNCT
aiua-11533	55	49	3	3	NUM
aiua-11533	55	50	%	%	NOUN
aiua-11533	55	51	)	)	PUNCT
aiua-11533	55	52	.	.	PUNCT
aiua-11533	56	1	table	table	NOUN
aiua-11533	56	2	1	1	NUM
aiua-11533	56	3	presents	present	NOUN
aiua-11533	56	4	patient	patient	ADJ
aiua-11533	56	5	and	and	CCONJ
aiua-11533	56	6	tumor	tumor	NOUN
aiua-11533	56	7	characteristics	characteristic	NOUN
aiua-11533	56	8	.	.	PUNCT
aiua-11533	57	1	seventy	seventy	NUM
aiua-11533	57	2	-	-	PUNCT
aiua-11533	57	3	three	three	NUM
aiua-11533	57	4	percent	percent	NOUN
aiua-11533	57	5	of	of	ADP
aiua-11533	57	6	patients	patient	NOUN
aiua-11533	57	7	underwent	undergo	VERB
aiua-11533	57	8	radical	radical	ADJ
aiua-11533	57	9	or	or	CCONJ
aiua-11533	57	10	partial	partial	ADJ
aiua-11533	57	11	cystectomy	cystectomy	NOUN
aiua-11533	57	12	.	.	PUNCT
aiua-11533	58	1	specifically	specifically	ADV
aiua-11533	58	2	,	,	PUNCT
aiua-11533	58	3	treatment	treatment	NOUN
aiua-11533	58	4	modalities	modality	NOUN
aiua-11533	58	5	included	include	VERB
aiua-11533	58	6	surgery	surgery	NOUN
aiua-11533	58	7	alone	alone	ADV
aiua-11533	58	8	(	(	PUNCT
aiua-11533	58	9	45	45	NUM
aiua-11533	58	10	%	%	NOUN
aiua-11533	58	11	)	)	PUNCT
aiua-11533	58	12	,	,	PUNCT
aiua-11533	58	13	surgery	surgery	NOUN
aiua-11533	58	14	preceded	precede	VERB
aiua-11533	58	15	or	or	CCONJ
aiua-11533	58	16	followed	follow	VERB
aiua-11533	58	17	by	by	ADP
aiua-11533	58	18	either	either	DET
aiua-11533	58	19	chemotherapy	chemotherapy	NOUN
aiua-11533	58	20	(	(	PUNCT
aiua-11533	58	21	17	17	NUM
aiua-11533	58	22	%	%	NOUN
aiua-11533	58	23	)	)	PUNCT
aiua-11533	58	24	or	or	CCONJ
aiua-11533	58	25	radiotherapy	radiotherapy	NOUN
aiua-11533	58	26	(	(	PUNCT
aiua-11533	58	27	11	11	NUM
aiua-11533	58	28	%	%	NOUN
aiua-11533	58	29	)	)	PUNCT
aiua-11533	58	30	,	,	PUNCT
aiua-11533	58	31	definitive	definitive	ADJ
aiua-11533	58	32	radiotherapy	radiotherapy	NOUN
aiua-11533	58	33	with	with	ADP
aiua-11533	58	34	concurrent	concurrent	ADJ
aiua-11533	58	35	chemotherapy	chemotherapy	NOUN
aiua-11533	58	36	(	(	PUNCT
aiua-11533	58	37	4	4	NUM
aiua-11533	58	38	%	%	NOUN
aiua-11533	58	39	)	)	PUNCT
aiua-11533	58	40	,	,	PUNCT
aiua-11533	58	41	neo	neo	NOUN
aiua-11533	58	42	-	-	ADJ
aiua-11533	58	43	adjuvant	adjuvant	ADJ
aiua-11533	58	44	chemotherapy	chemotherapy	NOUN
aiua-11533	58	45	plus	plus	CCONJ
aiua-11533	58	46	surgery	surgery	NOUN
aiua-11533	58	47	plus	plus	CCONJ
aiua-11533	58	48	adjuvant	adjuvant	ADJ
aiua-11533	58	49	radiotherapy	radiotherapy	NOUN
aiua-11533	58	50	(	(	PUNCT
aiua-11533	58	51	2	2	NUM
aiua-11533	58	52	%	%	NOUN
aiua-11533	58	53	)	)	PUNCT
aiua-11533	58	54	and	and	CCONJ
aiua-11533	58	55	palliative	palliative	ADJ
aiua-11533	58	56	treatment	treatment	NOUN
aiua-11533	58	57	(	(	PUNCT
aiua-11533	58	58	21	21	NUM
aiua-11533	58	59	%	%	NOUN
aiua-11533	58	60	)	)	PUNCT
aiua-11533	58	61	.	.	PUNCT
aiua-11533	59	1	treatment	treatment	NOUN
aiua-11533	59	2	modalities	modality	NOUN
aiua-11533	59	3	are	be	AUX
aiua-11533	59	4	outlined	outline	VERB
aiua-11533	59	5	in	in	ADP
aiua-11533	59	6	table	table	NOUN
aiua-11533	59	7	2	2	NUM
aiua-11533	59	8	.	.	PUNCT
aiua-11533	59	9	table	table	NOUN
aiua-11533	59	10	1	1	NUM
aiua-11533	59	11	.	.	PUNCT
aiua-11533	59	12	patient	patient	ADJ
aiua-11533	59	13	and	and	CCONJ
aiua-11533	59	14	tumor	tumor	NOUN
aiua-11533	59	15	characteristics	characteristic	NOUN
aiua-11533	59	16	.	.	PUNCT
aiua-11533	60	1	patients	patient	NOUN
aiua-11533	60	2	characteristics	characteristic	VERB
aiua-11533	60	3	n	n	PROPN
aiua-11533	60	4	(	(	PUNCT
aiua-11533	60	5	%	%	INTJ
aiua-11533	60	6	)	)	PUNCT
aiua-11533	60	7	age	age	NOUN
aiua-11533	60	8	mean	mean	VERB
aiua-11533	60	9	69	69	NUM
aiua-11533	60	10	gender	gender	NOUN
aiua-11533	60	11	male	male	NOUN
aiua-11533	60	12	38	38	NUM
aiua-11533	60	13	(	(	PUNCT
aiua-11533	60	14	72	72	NUM
aiua-11533	60	15	)	)	PUNCT
aiua-11533	60	16	female	female	NOUN
aiua-11533	60	17	15	15	NUM
aiua-11533	60	18	(	(	PUNCT
aiua-11533	60	19	28	28	NUM
aiua-11533	60	20	)	)	PUNCT
aiua-11533	60	21	prior	prior	ADJ
aiua-11533	60	22	history	history	NOUN
aiua-11533	60	23	of	of	ADP
aiua-11533	60	24	rt	rt	PROPN
aiua-11533	60	25	14	14	NUM
aiua-11533	60	26	(	(	PUNCT
aiua-11533	60	27	26	26	NUM
aiua-11533	60	28	)	)	PUNCT
aiua-11533	60	29	tobacco	tobacco	NOUN
aiua-11533	60	30	exposure	exposure	NOUN
aiua-11533	60	31	20	20	NUM
aiua-11533	60	32	(	(	PUNCT
aiua-11533	60	33	37	37	NUM
aiua-11533	60	34	)	)	PUNCT
aiua-11533	60	35	symptoms	symptom	NOUN
aiua-11533	60	36	hematuria	hematuria	VERB
aiua-11533	60	37	28	28	NUM
aiua-11533	60	38	(	(	PUNCT
aiua-11533	60	39	52	52	NUM
aiua-11533	60	40	)	)	PUNCT
aiua-11533	60	41	pelvic	pelvic	ADJ
aiua-11533	60	42	pain	pain	NOUN
aiua-11533	60	43	14	14	NUM
aiua-11533	60	44	(	(	PUNCT
aiua-11533	60	45	27	27	NUM
aiua-11533	60	46	)	)	PUNCT
aiua-11533	60	47	both	both	PRON
aiua-11533	60	48	5	5	NUM
aiua-11533	60	49	(	(	PUNCT
aiua-11533	60	50	10	10	NUM
aiua-11533	60	51	)	)	PUNCT
aiua-11533	60	52	other	other	ADJ
aiua-11533	60	53	6	6	NUM
aiua-11533	60	54	(	(	PUNCT
aiua-11533	60	55	11	11	NUM
aiua-11533	60	56	)	)	PUNCT
aiua-11533	60	57	tumor	tumor	NOUN
aiua-11533	60	58	size	size	NOUN
aiua-11533	60	59	(	(	PUNCT
aiua-11533	60	60	median	median	NOUN
aiua-11533	60	61	)	)	PUNCT
aiua-11533	60	62	4.5	4.5	NUM
aiua-11533	60	63	cm	cm	NOUN
aiua-11533	60	64	(	(	PUNCT
aiua-11533	60	65	1.5	1.5	NUM
aiua-11533	60	66	-9.5	-9.5	NOUN
aiua-11533	60	67	)	)	PUNCT
aiua-11533	60	68	t	t	NOUN
aiua-11533	60	69	stage	stage	NOUN
aiua-11533	60	70	t1	t1	PROPN
aiua-11533	60	71	/	/	SYM
aiua-11533	60	72	t2	t2	PROPN
aiua-11533	60	73	22	22	NUM
aiua-11533	60	74	(	(	PUNCT
aiua-11533	60	75	41	41	NUM
aiua-11533	60	76	)	)	PUNCT
aiua-11533	60	77	t3	t3	PROPN
aiua-11533	60	78	/	/	SYM
aiua-11533	60	79	t4	t4	PROPN
aiua-11533	60	80	31	31	NUM
aiua-11533	60	81	(	(	PUNCT
aiua-11533	60	82	59	59	NUM
aiua-11533	60	83	)	)	PUNCT
aiua-11533	60	84	nodal	nodal	NOUN
aiua-11533	60	85	metastases	metastasis	NOUN
aiua-11533	60	86	19	19	NUM
aiua-11533	60	87	(	(	PUNCT
aiua-11533	60	88	35	35	NUM
aiua-11533	60	89	)	)	PUNCT
aiua-11533	60	90	ajcc	ajcc	PROPN
aiua-11533	60	91	ii	ii	PROPN
aiua-11533	60	92	11	11	NUM
aiua-11533	60	93	(	(	PUNCT
aiua-11533	60	94	21	21	NUM
aiua-11533	60	95	)	)	PUNCT
aiua-11533	60	96	iii	iii	X
aiua-11533	60	97	33	33	NUM
aiua-11533	60	98	(	(	PUNCT
aiua-11533	60	99	63	63	NUM
aiua-11533	60	100	)	)	PUNCT
aiua-11533	60	101	iv	iv	NUM
aiua-11533	60	102	9	9	NUM
aiua-11533	60	103	(	(	PUNCT
aiua-11533	60	104	16	16	NUM
aiua-11533	60	105	)	)	PUNCT
aiua-11533	60	106	malignant	malignant	ADJ
aiua-11533	60	107	biphasic	biphasic	ADJ
aiua-11533	60	108	tumors	tumor	NOUN
aiua-11533	60	109	(	(	PUNCT
aiua-11533	60	110	mbt	mbt	PROPN
aiua-11533	60	111	)	)	PUNCT
aiua-11533	60	112	23	23	NUM
aiua-11533	60	113	(	(	PUNCT
aiua-11533	60	114	43	43	NUM
aiua-11533	60	115	)	)	PUNCT
aiua-11533	60	116	true	true	ADJ
aiua-11533	60	117	sarcoma	sarcoma	NOUN
aiua-11533	60	118	(	(	PUNCT
aiua-11533	60	119	ts	ts	NOUN
aiua-11533	60	120	)	)	PUNCT
aiua-11533	60	121	31	31	NUM
aiua-11533	60	122	(	(	PUNCT
aiua-11533	60	123	57	57	NUM
aiua-11533	60	124	)	)	PUNCT
aiua-11533	60	125	leiomyosarcoma	leiomyosarcoma	NOUN
aiua-11533	60	126	19	19	NUM
aiua-11533	60	127	(	(	PUNCT
aiua-11533	60	128	61	61	NUM
aiua-11533	60	129	)	)	PUNCT
aiua-11533	60	130	angiosarcoma	angiosarcoma	NOUN
aiua-11533	60	131	7	7	NUM
aiua-11533	60	132	(	(	PUNCT
aiua-11533	60	133	22	22	NUM
aiua-11533	60	134	)	)	PUNCT
aiua-11533	60	135	pleomorphic	pleomorphic	ADJ
aiua-11533	60	136	undifferentiated	undifferentiated	ADJ
aiua-11533	60	137	sarcoma	sarcoma	NOUN
aiua-11533	60	138	2	2	NUM
aiua-11533	60	139	(	(	PUNCT
aiua-11533	60	140	7	7	NUM
aiua-11533	60	141	)	)	PUNCT
aiua-11533	60	142	rhabdomyosarcoma	rhabdomyosarcoma	NOUN
aiua-11533	60	143	2	2	NUM
aiua-11533	60	144	(	(	PUNCT
aiua-11533	60	145	7	7	NUM
aiua-11533	60	146	)	)	PUNCT
aiua-11533	60	147	chondrosarcoma	chondrosarcoma	NOUN
aiua-11533	60	148	1	1	NUM
aiua-11533	60	149	(	(	PUNCT
aiua-11533	60	150	3	3	NUM
aiua-11533	60	151	)	)	PUNCT
aiua-11533	60	152	table	table	NOUN
aiua-11533	60	153	2	2	NUM
aiua-11533	60	154	.	.	PUNCT
aiua-11533	60	155	treatment	treatment	NOUN
aiua-11533	60	156	modalities	modality	NOUN
aiua-11533	60	157	.	.	PUNCT
aiua-11533	61	1	treatment	treatment	NOUN
aiua-11533	61	2	modalities	modality	NOUN
aiua-11533	61	3	n	n	CCONJ
aiua-11533	61	4	(	(	PUNCT
aiua-11533	61	5	%	%	NOUN
aiua-11533	61	6	)	)	PUNCT
aiua-11533	61	7	surgery	surgery	NOUN
aiua-11533	61	8	alone	alone	ADJ
aiua-11533	61	9	24	24	NUM
aiua-11533	61	10	(	(	PUNCT
aiua-11533	61	11	45	45	NUM
aiua-11533	61	12	)	)	PUNCT
aiua-11533	61	13	surgery	surgery	NOUN
aiua-11533	61	14	plus	plus	CCONJ
aiua-11533	61	15	neo	neo	NOUN
aiua-11533	61	16	-	-	PUNCT
aiua-11533	61	17	adjuvant	adjuvant	ADJ
aiua-11533	61	18	or	or	CCONJ
aiua-11533	61	19	adjuvant	adjuvant	ADJ
aiua-11533	61	20	chemotherapy	chemotherapy	NOUN
aiua-11533	61	21	9	9	NUM
aiua-11533	61	22	(	(	PUNCT
aiua-11533	61	23	17	17	NUM
aiua-11533	61	24	)	)	PUNCT
aiua-11533	61	25	surgery	surgery	NOUN
aiua-11533	61	26	plus	plus	CCONJ
aiua-11533	61	27	neo	neo	NOUN
aiua-11533	61	28	-	-	PUNCT
aiua-11533	61	29	adjuvant	adjuvant	ADJ
aiua-11533	61	30	or	or	CCONJ
aiua-11533	61	31	adjuvant	adjuvant	ADJ
aiua-11533	61	32	radiotherapy	radiotherapy	NOUN
aiua-11533	61	33	6	6	NUM
aiua-11533	61	34	(	(	PUNCT
aiua-11533	61	35	11	11	NUM
aiua-11533	61	36	)	)	PUNCT
aiua-11533	61	37	definitive	definitive	ADJ
aiua-11533	61	38	radiotherapy	radiotherapy	NOUN
aiua-11533	61	39	with	with	ADP
aiua-11533	61	40	concurrent	concurrent	ADJ
aiua-11533	61	41	chemotherapy	chemotherapy	NOUN
aiua-11533	61	42	2	2	NUM
aiua-11533	61	43	(	(	PUNCT
aiua-11533	61	44	4	4	NUM
aiua-11533	61	45	)	)	PUNCT
aiua-11533	61	46	neo	neo	NOUN
aiua-11533	61	47	-	-	PUNCT
aiua-11533	61	48	adjuvant	adjuvant	ADJ
aiua-11533	61	49	chemotherapy	chemotherapy	NOUN
aiua-11533	61	50	plus	plus	CCONJ
aiua-11533	61	51	surgery	surgery	NOUN
aiua-11533	61	52	plus	plus	CCONJ
aiua-11533	61	53	adjuvant	adjuvant	ADJ
aiua-11533	61	54	radiotherapy	radiotherapy	NOUN
aiua-11533	61	55	1	1	NUM
aiua-11533	61	56	(	(	PUNCT
aiua-11533	61	57	2	2	NUM
aiua-11533	61	58	)	)	PUNCT
aiua-11533	61	59	palliative	palliative	ADJ
aiua-11533	61	60	11	11	NUM
aiua-11533	61	61	(	(	PUNCT
aiua-11533	61	62	21	21	NUM
aiua-11533	61	63	)	)	PUNCT
aiua-11533	61	64	archivio	archivio	NOUN
aiua-11533	61	65	italiano	italiano	X
aiua-11533	61	66	di	di	X
aiua-11533	61	67	urologia	urologia	PROPN
aiua-11533	61	68	e	e	PROPN
aiua-11533	61	69	andrologia	andrologia	NOUN
aiua-11533	61	70	2023	2023	NUM
aiua-11533	61	71	;	;	PUNCT
aiua-11533	61	72	95(3):11533	95(3):11533	NUM
aiua-11533	61	73	3	3	NUM
aiua-11533	61	74	primary	primary	ADJ
aiua-11533	61	75	bladder	bladder	NOUN
aiua-11533	61	76	sarcoma	sarcoma	NOUN
aiua-11533	61	77	median	median	PROPN
aiua-11533	61	78	follow	follow	NOUN
aiua-11533	61	79	-	-	PUNCT
aiua-11533	61	80	up	up	NOUN
aiua-11533	61	81	was	be	AUX
aiua-11533	61	82	18	18	NUM
aiua-11533	61	83	months	month	NOUN
aiua-11533	61	84	(	(	PUNCT
aiua-11533	61	85	range	range	NOUN
aiua-11533	61	86	1	1	NUM
aiua-11533	61	87	-	-	SYM
aiua-11533	61	88	263	263	NUM
aiua-11533	61	89	months	month	NOUN
aiua-11533	61	90	)	)	PUNCT
aiua-11533	61	91	.	.	PUNCT
aiua-11533	62	1	local	local	ADJ
aiua-11533	62	2	recurrence	recurrence	NOUN
aiua-11533	62	3	(	(	PUNCT
aiua-11533	62	4	lr	lr	NOUN
aiua-11533	62	5	)	)	PUNCT
aiua-11533	62	6	occurred	occur	VERB
aiua-11533	62	7	in	in	ADP
aiua-11533	62	8	49	49	NUM
aiua-11533	62	9	%	%	NOUN
aiua-11533	62	10	of	of	ADP
aiua-11533	62	11	patients	patient	NOUN
aiua-11533	62	12	and	and	CCONJ
aiua-11533	62	13	distant	distant	ADJ
aiua-11533	62	14	metastases	metastasis	NOUN
aiua-11533	62	15	(	(	PUNCT
aiua-11533	62	16	dm	dm	NOUN
aiua-11533	62	17	)	)	PUNCT
aiua-11533	62	18	were	be	AUX
aiua-11533	62	19	present	present	ADJ
aiua-11533	62	20	in	in	ADP
aiua-11533	62	21	37	37	NUM
aiua-11533	62	22	%	%	NOUN
aiua-11533	62	23	.	.	PUNCT
aiua-11533	63	1	five	five	NUM
aiua-11533	63	2	-	-	PUNCT
aiua-11533	63	3	year	year	NOUN
aiua-11533	63	4	os	os	NOUN
aiua-11533	63	5	and	and	CCONJ
aiua-11533	63	6	pfs	pfs	PROPN
aiua-11533	63	7	were	be	AUX
aiua-11533	63	8	66.5	66.5	NUM
aiua-11533	63	9	%	%	NOUN
aiua-11533	63	10	and	and	CCONJ
aiua-11533	63	11	37.6	37.6	NUM
aiua-11533	63	12	%	%	NOUN
aiua-11533	63	13	,	,	PUNCT
aiua-11533	63	14	respectively	respectively	ADV
aiua-11533	63	15	.	.	PUNCT
aiua-11533	64	1	kaplanmeier	kaplanmei	ADJ
aiua-11533	64	2	curves	curve	NOUN
aiua-11533	64	3	for	for	ADP
aiua-11533	64	4	os	os	NOUN
aiua-11533	64	5	and	and	CCONJ
aiua-11533	64	6	pfs	pfs	PROPN
aiua-11533	64	7	and	and	CCONJ
aiua-11533	64	8	the	the	DET
aiua-11533	64	9	cumulative	cumulative	ADJ
aiua-11533	64	10	incidence	incidence	NOUN
aiua-11533	64	11	for	for	ADP
aiua-11533	64	12	lr	lr	NOUN
aiua-11533	64	13	and	and	CCONJ
aiua-11533	64	14	dm	dm	PROPN
aiua-11533	64	15	are	be	AUX
aiua-11533	64	16	shown	show	VERB
aiua-11533	64	17	in	in	ADP
aiua-11533	64	18	figures	figure	NOUN
aiua-11533	64	19	1	1	NUM
aiua-11533	64	20	,	,	PUNCT
aiua-11533	64	21	2	2	NUM
aiua-11533	64	22	,	,	PUNCT
aiua-11533	64	23	3	3	NUM
aiua-11533	64	24	and	and	CCONJ
aiua-11533	64	25	4	4	NUM
aiua-11533	64	26	respectively	respectively	ADV
aiua-11533	64	27	.	.	PUNCT
aiua-11533	65	1	when	when	SCONJ
aiua-11533	65	2	outcomes	outcome	NOUN
aiua-11533	65	3	in	in	ADP
aiua-11533	65	4	subgroups	subgroup	NOUN
aiua-11533	65	5	were	be	AUX
aiua-11533	65	6	examined	examine	VERB
aiua-11533	65	7	,	,	PUNCT
aiua-11533	65	8	a	a	DET
aiua-11533	65	9	more	more	ADV
aiua-11533	65	10	advanced	advanced	ADJ
aiua-11533	65	11	tumor	tumor	NOUN
aiua-11533	65	12	stage	stage	NOUN
aiua-11533	65	13	(	(	PUNCT
aiua-11533	65	14	t2	t2	NOUN
aiua-11533	65	15	vs	vs	ADP
aiua-11533	65	16	t3	t3	PROPN
aiua-11533	65	17	/	/	SYM
aiua-11533	65	18	t4	t4	PROPN
aiua-11533	65	19	)	)	PUNCT
aiua-11533	65	20	correlated	correlate	VERB
aiua-11533	65	21	to	to	ADP
aiua-11533	65	22	shorter	short	ADJ
aiua-11533	65	23	pfs	pfs	PROPN
aiua-11533	65	24	(	(	PUNCT
aiua-11533	65	25	median	median	PROPN
aiua-11533	65	26	pfs	pfs	PROPN
aiua-11533	65	27	for	for	ADP
aiua-11533	65	28	t2	t2	NOUN
aiua-11533	65	29	-	-	PUNCT
aiua-11533	65	30	category	category	NOUN
aiua-11533	65	31	was	be	AUX
aiua-11533	65	32	not	not	PART
aiua-11533	65	33	reached	reach	VERB
aiua-11533	65	34	and	and	CCONJ
aiua-11533	65	35	for	for	ADP
aiua-11533	65	36	t3	t3	PROPN
aiua-11533	65	37	/	/	SYM
aiua-11533	65	38	t4	t4	PROPN
aiua-11533	65	39	was	be	AUX
aiua-11533	65	40	8.4	8.4	NUM
aiua-11533	65	41	months	month	NOUN
aiua-11533	65	42	;	;	PUNCT
aiua-11533	65	43	p	p	PROPN
aiua-11533	65	44	=	=	NOUN
aiua-11533	65	45	0.059	0.059	NUM
aiua-11533	65	46	)	)	PUNCT
aiua-11533	65	47	.	.	PUNCT
aiua-11533	66	1	prior	prior	ADJ
aiua-11533	66	2	history	history	NOUN
aiua-11533	66	3	of	of	ADP
aiua-11533	66	4	pelvic	pelvic	ADJ
aiua-11533	66	5	radiotherapy	radiotherapy	NOUN
aiua-11533	66	6	also	also	ADV
aiua-11533	66	7	related	relate	VERB
aiua-11533	66	8	to	to	ADP
aiua-11533	66	9	lower	low	ADJ
aiua-11533	66	10	pfs	pfs	PROPN
aiua-11533	66	11	(	(	PUNCT
aiua-11533	66	12	7	7	NUM
aiua-11533	66	13	vs	vs	ADP
aiua-11533	66	14	31	31	NUM
aiua-11533	66	15	months	month	NOUN
aiua-11533	66	16	,	,	PUNCT
aiua-11533	66	17	p	p	PROPN
aiua-11533	66	18	=	=	PROPN
aiua-11533	66	19	0.0018	0.0018	NUM
aiua-11533	66	20	)	)	PUNCT
aiua-11533	66	21	and	and	CCONJ
aiua-11533	66	22	os	os	INTJ
aiua-11533	66	23	(	(	PUNCT
aiua-11533	66	24	9	9	NUM
aiua-11533	66	25	vs	vs	ADP
aiua-11533	66	26	43	43	NUM
aiua-11533	66	27	months	month	NOUN
aiua-11533	66	28	,	,	PUNCT
aiua-11533	66	29	p	p	NOUN
aiua-11533	66	30	=	=	PROPN
aiua-11533	66	31	0.0007	0.0007	NUM
aiua-11533	66	32	)	)	PUNCT
aiua-11533	66	33	.	.	PUNCT
aiua-11533	67	1	we	we	PRON
aiua-11533	67	2	found	find	VERB
aiua-11533	67	3	no	no	DET
aiua-11533	67	4	statistically	statistically	ADV
aiua-11533	67	5	significant	significant	ADJ
aiua-11533	67	6	differences	difference	NOUN
aiua-11533	67	7	in	in	ADP
aiua-11533	67	8	pfs	pfs	PROPN
aiua-11533	67	9	between	between	ADP
aiua-11533	67	10	treatment	treatment	NOUN
aiua-11533	67	11	modalities	modality	NOUN
aiua-11533	67	12	or	or	CCONJ
aiua-11533	67	13	between	between	ADP
aiua-11533	67	14	the	the	DET
aiua-11533	67	15	presence	presence	NOUN
aiua-11533	67	16	vs	vs	ADP
aiua-11533	67	17	absence	absence	NOUN
aiua-11533	67	18	of	of	ADP
aiua-11533	67	19	epithelial	epithelial	ADJ
aiua-11533	67	20	components	component	NOUN
aiua-11533	67	21	(	(	PUNCT
aiua-11533	67	22	ts	ts	NOUN
aiua-11533	67	23	and	and	CCONJ
aiua-11533	67	24	mbt	mbt	NOUN
aiua-11533	67	25	)	)	PUNCT
aiua-11533	67	26	.	.	PUNCT
aiua-11533	68	1	discussion	discussion	NOUN
aiua-11533	68	2	although	although	SCONJ
aiua-11533	68	3	the	the	DET
aiua-11533	68	4	occurrence	occurrence	NOUN
aiua-11533	68	5	of	of	ADP
aiua-11533	68	6	rare	rare	ADJ
aiua-11533	68	7	cancers	cancer	NOUN
aiua-11533	68	8	in	in	ADP
aiua-11533	68	9	the	the	DET
aiua-11533	68	10	general	general	ADJ
aiua-11533	68	11	public	public	NOUN
aiua-11533	68	12	is	be	AUX
aiua-11533	68	13	a	a	DET
aiua-11533	68	14	serious	serious	ADJ
aiua-11533	68	15	health	health	NOUN
aiua-11533	68	16	issue	issue	NOUN
aiua-11533	68	17	as	as	ADP
aiua-11533	68	18	a	a	DET
aiua-11533	68	19	whole	whole	NOUN
aiua-11533	68	20	,	,	PUNCT
aiua-11533	68	21	acquiring	acquire	VERB
aiua-11533	68	22	statistically	statistically	ADV
aiua-11533	68	23	-	-	PUNCT
aiua-11533	68	24	reliable	reliable	ADJ
aiua-11533	68	25	clinical	clinical	ADJ
aiua-11533	68	26	trial	trial	NOUN
aiua-11533	68	27	data	datum	NOUN
aiua-11533	68	28	is	be	AUX
aiua-11533	68	29	difficult	difficult	ADJ
aiua-11533	68	30	due	due	ADP
aiua-11533	68	31	to	to	ADP
aiua-11533	68	32	the	the	DET
aiua-11533	68	33	low	low	ADJ
aiua-11533	68	34	number	number	NOUN
aiua-11533	68	35	of	of	ADP
aiua-11533	68	36	patients	patient	NOUN
aiua-11533	68	37	with	with	ADP
aiua-11533	68	38	an	an	DET
aiua-11533	68	39	individual	individual	ADJ
aiua-11533	68	40	rare	rare	ADJ
aiua-11533	68	41	cancer	cancer	NOUN
aiua-11533	68	42	type	type	NOUN
aiua-11533	68	43	within	within	ADP
aiua-11533	68	44	specific	specific	ADJ
aiua-11533	68	45	areas	area	NOUN
aiua-11533	68	46	(	(	PUNCT
aiua-11533	68	47	8)	8)	NUM
aiua-11533	68	48	.	.	PUNCT
aiua-11533	69	1	since	since	SCONJ
aiua-11533	69	2	most	most	ADJ
aiua-11533	69	3	available	available	ADJ
aiua-11533	69	4	literature	literature	NOUN
aiua-11533	69	5	on	on	ADP
aiua-11533	69	6	rare	rare	ADJ
aiua-11533	69	7	cancers	cancer	NOUN
aiua-11533	69	8	is	be	AUX
aiua-11533	69	9	published	publish	VERB
aiua-11533	69	10	as	as	ADP
aiua-11533	69	11	single	single	ADJ
aiua-11533	69	12	-	-	PUNCT
aiua-11533	69	13	institution	institution	NOUN
aiua-11533	69	14	case	case	NOUN
aiua-11533	69	15	reports	report	VERB
aiua-11533	69	16	,	,	PUNCT
aiua-11533	69	17	it	it	PRON
aiua-11533	69	18	is	be	AUX
aiua-11533	69	19	arduous	arduous	ADJ
aiua-11533	69	20	to	to	PART
aiua-11533	69	21	draw	draw	VERB
aiua-11533	69	22	prognostic	prognostic	ADJ
aiua-11533	69	23	implications	implication	NOUN
aiua-11533	69	24	from	from	ADP
aiua-11533	69	25	these	these	DET
aiua-11533	69	26	data	datum	NOUN
aiua-11533	69	27	;	;	PUNCT
aiua-11533	69	28	furthermore	furthermore	ADV
aiua-11533	69	29	the	the	DET
aiua-11533	69	30	impact	impact	NOUN
aiua-11533	69	31	of	of	ADP
aiua-11533	69	32	local	local	ADJ
aiua-11533	69	33	practices	practice	NOUN
aiua-11533	69	34	on	on	ADP
aiua-11533	69	35	treatment	treatment	NOUN
aiua-11533	69	36	outcomes	outcome	NOUN
aiua-11533	69	37	is	be	AUX
aiua-11533	69	38	amplified	amplify	VERB
aiua-11533	69	39	when	when	SCONJ
aiua-11533	69	40	dealing	deal	VERB
aiua-11533	69	41	with	with	ADP
aiua-11533	69	42	rare	rare	ADJ
aiua-11533	69	43	diseases	disease	NOUN
aiua-11533	69	44	.	.	PUNCT
aiua-11533	70	1	patients	patient	NOUN
aiua-11533	70	2	with	with	ADP
aiua-11533	70	3	rare	rare	ADJ
aiua-11533	70	4	neoplasm	neoplasm	NOUN
aiua-11533	70	5	show	show	VERB
aiua-11533	70	6	significantly	significantly	ADV
aiua-11533	70	7	poorer	poor	ADJ
aiua-11533	70	8	results	result	NOUN
aiua-11533	70	9	than	than	ADP
aiua-11533	70	10	patients	patient	NOUN
aiua-11533	70	11	with	with	ADP
aiua-11533	70	12	more	more	ADJ
aiua-11533	70	13	common	common	ADJ
aiua-11533	70	14	malignancies	malignancy	NOUN
aiua-11533	70	15	;	;	PUNCT
aiua-11533	70	16	mean	mean	ADJ
aiua-11533	70	17	5	5	NUM
aiua-11533	70	18	-	-	PUNCT
aiua-11533	70	19	year	year	NOUN
aiua-11533	70	20	survival	survival	NOUN
aiua-11533	70	21	for	for	ADP
aiua-11533	70	22	the	the	DET
aiua-11533	70	23	former	former	ADJ
aiua-11533	70	24	is	be	AUX
aiua-11533	70	25	up	up	ADV
aiua-11533	70	26	to	to	PART
aiua-11533	70	27	20	20	NUM
aiua-11533	70	28	%	%	NOUN
aiua-11533	70	29	lower	low	ADJ
aiua-11533	70	30	than	than	ADP
aiua-11533	70	31	for	for	ADP
aiua-11533	70	32	the	the	DET
aiua-11533	70	33	latter	latter	ADJ
aiua-11533	70	34	(	(	PUNCT
aiua-11533	70	35	9	9	NUM
aiua-11533	70	36	)	)	PUNCT
aiua-11533	70	37	.	.	PUNCT
aiua-11533	71	1	this	this	PRON
aiua-11533	71	2	is	be	AUX
aiua-11533	71	3	the	the	DET
aiua-11533	71	4	case	case	NOUN
aiua-11533	71	5	with	with	ADP
aiua-11533	71	6	primary	primary	ADJ
aiua-11533	71	7	sub	sub	NOUN
aiua-11533	71	8	,	,	PUNCT
aiua-11533	71	9	a	a	DET
aiua-11533	71	10	disease	disease	NOUN
aiua-11533	71	11	comprising	comprise	VERB
aiua-11533	71	12	less	less	ADJ
aiua-11533	71	13	than	than	ADP
aiua-11533	71	14	1	1	NUM
aiua-11533	71	15	%	%	NOUN
aiua-11533	71	16	of	of	ADP
aiua-11533	71	17	all	all	DET
aiua-11533	71	18	bca	bca	PROPN
aiua-11533	71	19	,	,	PUNCT
aiua-11533	71	20	which	which	PRON
aiua-11533	71	21	poses	pose	VERB
aiua-11533	71	22	a	a	DET
aiua-11533	71	23	challenge	challenge	NOUN
aiua-11533	71	24	in	in	ADP
aiua-11533	71	25	the	the	DET
aiua-11533	71	26	treatment	treatment	NOUN
aiua-11533	71	27	of	of	ADP
aiua-11533	71	28	this	this	DET
aiua-11533	71	29	uncommon	uncommon	ADJ
aiua-11533	71	30	histological	histological	ADJ
aiua-11533	71	31	variant	variant	NOUN
aiua-11533	71	32	.	.	PUNCT
aiua-11533	72	1	poor	poor	ADJ
aiua-11533	72	2	outcomes	outcome	NOUN
aiua-11533	72	3	have	have	AUX
aiua-11533	72	4	been	be	AUX
aiua-11533	72	5	reported	report	VERB
aiua-11533	72	6	in	in	ADP
aiua-11533	72	7	patients	patient	NOUN
aiua-11533	72	8	with	with	ADP
aiua-11533	72	9	sub	sub	NOUN
aiua-11533	72	10	,	,	PUNCT
aiua-11533	72	11	whatever	whatever	PRON
aiua-11533	72	12	the	the	DET
aiua-11533	72	13	treatment	treatment	NOUN
aiua-11533	72	14	used	use	VERB
aiua-11533	72	15	.	.	PUNCT
aiua-11533	73	1	the	the	DET
aiua-11533	73	2	five	five	NUM
aiua-11533	73	3	-	-	PUNCT
aiua-11533	73	4	year	year	NOUN
aiua-11533	73	5	overall	overall	ADJ
aiua-11533	73	6	survival	survival	NOUN
aiua-11533	73	7	(	(	PUNCT
aiua-11533	73	8	os	os	NOUN
aiua-11533	73	9	)	)	PUNCT
aiua-11533	73	10	rate	rate	NOUN
aiua-11533	73	11	of	of	ADP
aiua-11533	73	12	the	the	DET
aiua-11533	73	13	present	present	ADJ
aiua-11533	73	14	cohort	cohort	NOUN
aiua-11533	73	15	is	be	AUX
aiua-11533	73	16	66.5	66.5	NUM
aiua-11533	73	17	%	%	NOUN
aiua-11533	73	18	,	,	PUNCT
aiua-11533	73	19	which	which	PRON
aiua-11533	73	20	exceeds	exceed	VERB
aiua-11533	73	21	the	the	DET
aiua-11533	73	22	findings	finding	NOUN
aiua-11533	73	23	of	of	ADP
aiua-11533	73	24	previous	previous	ADJ
aiua-11533	73	25	studies	study	NOUN
aiua-11533	73	26	where	where	SCONJ
aiua-11533	73	27	survival	survival	NOUN
aiua-11533	73	28	rates	rate	NOUN
aiua-11533	73	29	at	at	ADP
aiua-11533	73	30	five	five	NUM
aiua-11533	73	31	years	year	NOUN
aiua-11533	73	32	were	be	AUX
aiua-11533	73	33	consistently	consistently	ADV
aiua-11533	73	34	below	below	ADP
aiua-11533	73	35	50	50	NUM
aiua-11533	73	36	%	%	NOUN
aiua-11533	73	37	(	(	PUNCT
aiua-11533	73	38	4	4	NUM
aiua-11533	73	39	,	,	PUNCT
aiua-11533	73	40	10	10	NUM
aiua-11533	73	41	,	,	PUNCT
aiua-11533	73	42	11	11	NUM
aiua-11533	73	43	)	)	PUNCT
aiua-11533	73	44	.	.	PUNCT
aiua-11533	74	1	this	this	DET
aiua-11533	74	2	difference	difference	NOUN
aiua-11533	74	3	in	in	ADP
aiua-11533	74	4	outcomes	outcome	NOUN
aiua-11533	74	5	can	can	AUX
aiua-11533	74	6	be	be	AUX
aiua-11533	74	7	attributed	attribute	VERB
aiua-11533	74	8	,	,	PUNCT
aiua-11533	74	9	at	at	ADP
aiua-11533	74	10	least	least	ADJ
aiua-11533	74	11	partially	partially	ADV
aiua-11533	74	12	,	,	PUNCT
aiua-11533	74	13	to	to	ADP
aiua-11533	74	14	two	two	NUM
aiua-11533	74	15	key	key	ADJ
aiua-11533	74	16	factors	factor	NOUN
aiua-11533	74	17	within	within	ADP
aiua-11533	74	18	the	the	DET
aiua-11533	74	19	study	study	NOUN
aiua-11533	74	20	.	.	PUNCT
aiua-11533	75	1	firstly	firstly	ADV
aiua-11533	75	2	,	,	PUNCT
aiua-11533	75	3	this	this	DET
aiua-11533	75	4	cohort	cohort	NOUN
aiua-11533	75	5	predominantly	predominantly	ADV
aiua-11533	75	6	consisted	consist	VERB
aiua-11533	75	7	of	of	ADP
aiua-11533	75	8	a	a	DET
aiua-11533	75	9	younger	young	ADJ
aiua-11533	75	10	population	population	NOUN
aiua-11533	75	11	,	,	PUNCT
aiua-11533	75	12	with	with	ADP
aiua-11533	75	13	a	a	DET
aiua-11533	75	14	median	median	ADJ
aiua-11533	75	15	age	age	NOUN
aiua-11533	75	16	at	at	ADP
aiua-11533	75	17	presentation	presentation	NOUN
aiua-11533	75	18	of	of	ADP
aiua-11533	75	19	69	69	NUM
aiua-11533	75	20	years	year	NOUN
aiua-11533	75	21	,	,	PUNCT
aiua-11533	75	22	which	which	PRON
aiua-11533	75	23	is	be	AUX
aiua-11533	75	24	lower	low	ADJ
aiua-11533	75	25	than	than	ADP
aiua-11533	75	26	other	other	ADJ
aiua-11533	75	27	reports	report	NOUN
aiua-11533	75	28	(	(	PUNCT
aiua-11533	75	29	4	4	NUM
aiua-11533	75	30	)	)	PUNCT
aiua-11533	75	31	.	.	PUNCT
aiua-11533	76	1	younger	young	ADJ
aiua-11533	76	2	patients	patient	NOUN
aiua-11533	76	3	have	have	AUX
aiua-11533	76	4	generally	generally	ADV
aiua-11533	76	5	been	be	AUX
aiua-11533	76	6	associated	associate	VERB
aiua-11533	76	7	with	with	ADP
aiua-11533	76	8	better	well	ADJ
aiua-11533	76	9	treatment	treatment	NOUN
aiua-11533	76	10	tolerance	tolerance	NOUN
aiua-11533	76	11	,	,	PUNCT
aiua-11533	76	12	higher	high	ADJ
aiua-11533	76	13	overall	overall	ADJ
aiua-11533	76	14	fitness	fitness	NOUN
aiua-11533	76	15	levels	level	NOUN
aiua-11533	76	16	,	,	PUNCT
aiua-11533	76	17	and	and	CCONJ
aiua-11533	76	18	potentially	potentially	ADV
aiua-11533	76	19	more	more	ADV
aiua-11533	76	20	favorable	favorable	ADJ
aiua-11533	76	21	disease	disease	NOUN
aiua-11533	76	22	characteristics	characteristic	NOUN
aiua-11533	76	23	,	,	PUNCT
aiua-11533	76	24	all	all	PRON
aiua-11533	76	25	of	of	ADP
aiua-11533	76	26	which	which	PRON
aiua-11533	76	27	could	could	AUX
aiua-11533	76	28	contribute	contribute	VERB
aiua-11533	76	29	to	to	ADP
aiua-11533	76	30	improved	improved	ADJ
aiua-11533	76	31	survival	survival	NOUN
aiua-11533	76	32	rates	rate	NOUN
aiua-11533	76	33	.	.	PUNCT
aiua-11533	77	1	secondly	secondly	ADV
aiua-11533	77	2	,	,	PUNCT
aiua-11533	77	3	the	the	DET
aiua-11533	77	4	analysis	analysis	NOUN
aiua-11533	77	5	encompassed	encompass	VERB
aiua-11533	77	6	both	both	CCONJ
aiua-11533	77	7	malignant	malignant	ADJ
aiua-11533	77	8	biphasic	biphasic	ADJ
aiua-11533	77	9	tumors	tumor	NOUN
aiua-11533	77	10	(	(	PUNCT
aiua-11533	77	11	cs	cs	PROPN
aiua-11533	77	12	and	and	CCONJ
aiua-11533	77	13	sc	sc	PROPN
aiua-11533	77	14	)	)	PUNCT
aiua-11533	77	15	and	and	CCONJ
aiua-11533	77	16	true	true	ADJ
aiua-11533	77	17	heterologous	heterologous	ADJ
aiua-11533	77	18	sarcomas	sarcoma	NOUN
aiua-11533	77	19	(	(	PUNCT
aiua-11533	77	20	ts	ts	NOUN
aiua-11533	77	21	)	)	PUNCT
aiua-11533	77	22	.	.	PUNCT
aiua-11533	78	1	by	by	ADP
aiua-11533	78	2	including	include	VERB
aiua-11533	78	3	both	both	DET
aiua-11533	78	4	types	type	NOUN
aiua-11533	78	5	of	of	ADP
aiua-11533	78	6	tumors	tumor	NOUN
aiua-11533	78	7	,	,	PUNCT
aiua-11533	78	8	we	we	PRON
aiua-11533	78	9	accounted	account	VERB
aiua-11533	78	10	for	for	ADP
aiua-11533	78	11	the	the	DET
aiua-11533	78	12	inherent	inherent	ADJ
aiua-11533	78	13	biological	biological	ADJ
aiua-11533	78	14	diverfigure	diverfigure	NOUN
aiua-11533	78	15	1	1	NUM
aiua-11533	78	16	.	.	PUNCT
aiua-11533	79	1	os	os	ADJ
aiua-11533	79	2	5	5	NUM
aiua-11533	79	3	-	-	PUNCT
aiua-11533	79	4	year	year	NOUN
aiua-11533	79	5	rate	rate	NOUN
aiua-11533	79	6	66.5	66.5	NUM
aiua-11533	79	7	%	%	NOUN
aiua-11533	79	8	(	(	PUNCT
aiua-11533	79	9	53.3	53.3	NUM
aiua-11533	79	10	-	-	NUM
aiua-11533	79	11	83	83	NUM
aiua-11533	79	12	)	)	PUNCT
aiua-11533	79	13	figure	figure	NOUN
aiua-11533	79	14	2	2	NUM
aiua-11533	79	15	.	.	NUM
aiua-11533	79	16	pfs	pfs	PROPN
aiua-11533	79	17	5	5	NUM
aiua-11533	79	18	-	-	PUNCT
aiua-11533	79	19	year	year	NOUN
aiua-11533	79	20	rate	rate	NOUN
aiua-11533	79	21	:	:	PUNCT
aiua-11533	79	22	37.6	37.6	NUM
aiua-11533	79	23	%	%	NOUN
aiua-11533	79	24	(	(	PUNCT
aiua-11533	79	25	25.8	25.8	NUM
aiua-11533	79	26	-	-	NUM
aiua-11533	79	27	54.7	54.7	NUM
aiua-11533	79	28	)	)	PUNCT
aiua-11533	79	29	.	.	PUNCT
aiua-11533	80	1	figure	figure	VERB
aiua-11533	80	2	3	3	NUM
aiua-11533	80	3	.	.	PUNCT
aiua-11533	80	4	lr	lr	PROPN
aiua-11533	80	5	5	5	NUM
aiua-11533	80	6	-	-	PUNCT
aiua-11533	80	7	year	year	NOUN
aiua-11533	80	8	rate	rate	NOUN
aiua-11533	80	9	:	:	PUNCT
aiua-11533	80	10	49	49	NUM
aiua-11533	80	11	%	%	NOUN
aiua-11533	80	12	(	(	PUNCT
aiua-11533	80	13	34	34	NUM
aiua-11533	80	14	-	-	SYM
aiua-11533	80	15	64	64	NUM
aiua-11533	80	16	)	)	PUNCT
aiua-11533	80	17	.	.	PUNCT
aiua-11533	81	1	figure	figure	VERB
aiua-11533	81	2	4	4	NUM
aiua-11533	81	3	.	.	PUNCT
aiua-11533	82	1	dm	dm	PROPN
aiua-11533	82	2	5	5	NUM
aiua-11533	82	3	-	-	PUNCT
aiua-11533	82	4	year	year	NOUN
aiua-11533	82	5	rate	rate	NOUN
aiua-11533	82	6	:	:	PUNCT
aiua-11533	82	7	36.9	36.9	NUM
aiua-11533	82	8	%	%	NOUN
aiua-11533	82	9	(	(	PUNCT
aiua-11533	82	10	21.4	21.4	NUM
aiua-11533	82	11	-	-	SYM
aiua-11533	82	12	52.4	52.4	NUM
aiua-11533	82	13	)	)	PUNCT
aiua-11533	82	14	.	.	PUNCT
aiua-11533	83	1	archivio	archivio	NOUN
aiua-11533	83	2	italiano	italiano	PROPN
aiua-11533	83	3	di	di	X
aiua-11533	83	4	urologia	urologia	PROPN
aiua-11533	83	5	e	e	PROPN
aiua-11533	83	6	andrologia	andrologia	NOUN
aiua-11533	83	7	2023	2023	NUM
aiua-11533	83	8	;	;	PUNCT
aiua-11533	83	9	95(3):11533	95(3):11533	NUM
aiua-11533	83	10	p.	p.	NOUN
aiua-11533	83	11	bettoli	bettoli	PROPN
aiua-11533	83	12	,	,	PUNCT
aiua-11533	83	13	z.	z.	PROPN
aiua-11533	83	14	liu	liu	PROPN
aiua-11533	83	15	,	,	PUNCT
aiua-11533	83	16	n.	n.	PROPN
aiua-11533	83	17	jara	jara	PROPN
aiua-11533	83	18	,	,	PUNCT
aiua-11533	83	19	et	et	PROPN
aiua-11533	83	20	al	al	PROPN
aiua-11533	83	21	.	.	PROPN
aiua-11533	83	22	4	4	NUM
aiua-11533	83	23	sity	sity	NOUN
aiua-11533	83	24	,	,	PUNCT
aiua-11533	83	25	variable	variable	ADJ
aiua-11533	83	26	clinical	clinical	ADJ
aiua-11533	83	27	behavior	behavior	NOUN
aiua-11533	83	28	of	of	ADP
aiua-11533	83	29	both	both	DET
aiua-11533	83	30	entities	entity	NOUN
aiua-11533	83	31	and	and	CCONJ
aiua-11533	83	32	perhaps	perhaps	ADV
aiua-11533	83	33	different	different	ADJ
aiua-11533	83	34	outcomes	outcome	NOUN
aiua-11533	83	35	.	.	PUNCT
aiua-11533	84	1	twenty	twenty	NUM
aiua-11533	84	2	-	-	PUNCT
aiua-11533	84	3	six	six	NUM
aiua-11533	84	4	percent	percent	NOUN
aiua-11533	84	5	of	of	ADP
aiua-11533	84	6	the	the	DET
aiua-11533	84	7	patients	patient	NOUN
aiua-11533	84	8	of	of	ADP
aiua-11533	84	9	the	the	DET
aiua-11533	84	10	cohort	cohort	NOUN
aiua-11533	84	11	have	have	VERB
aiua-11533	84	12	a	a	DET
aiua-11533	84	13	previous	previous	ADJ
aiua-11533	84	14	history	history	NOUN
aiua-11533	84	15	of	of	ADP
aiua-11533	84	16	pelvic	pelvic	ADJ
aiua-11533	84	17	radiation	radiation	NOUN
aiua-11533	84	18	therapy	therapy	NOUN
aiua-11533	84	19	(	(	PUNCT
aiua-11533	84	20	rt	rt	PROPN
aiua-11533	84	21	)	)	PUNCT
aiua-11533	84	22	,	,	PUNCT
aiua-11533	84	23	observing	observe	VERB
aiua-11533	84	24	inferior	inferior	ADJ
aiua-11533	84	25	outcomes	outcome	NOUN
aiua-11533	84	26	in	in	ADP
aiua-11533	84	27	this	this	DET
aiua-11533	84	28	subgroup	subgroup	NOUN
aiua-11533	84	29	compared	compare	VERB
aiua-11533	84	30	to	to	ADP
aiua-11533	84	31	those	those	PRON
aiua-11533	84	32	without	without	ADP
aiua-11533	84	33	prior	prior	ADJ
aiua-11533	84	34	rt	rt	PROPN
aiua-11533	84	35	(	(	PUNCT
aiua-11533	84	36	median	median	PROPN
aiua-11533	84	37	os	os	NOUN
aiua-11533	84	38	of	of	ADP
aiua-11533	84	39	9	9	NUM
aiua-11533	84	40	vs.	vs.	ADP
aiua-11533	84	41	43	43	NUM
aiua-11533	84	42	months	month	NOUN
aiua-11533	84	43	,	,	PUNCT
aiua-11533	84	44	p	p	NOUN
aiua-11533	84	45	=	=	PROPN
aiua-11533	84	46	0.0007	0.0007	NUM
aiua-11533	84	47	)	)	PUNCT
aiua-11533	84	48	.	.	PUNCT
aiua-11533	85	1	is	be	AUX
aiua-11533	85	2	well	well	ADV
aiua-11533	85	3	known	know	VERB
aiua-11533	85	4	that	that	SCONJ
aiua-11533	85	5	radiation	radiation	NOUN
aiua-11533	85	6	-	-	PUNCT
aiua-11533	85	7	induced	induce	VERB
aiua-11533	85	8	sarcomas	sarcoma	NOUN
aiua-11533	85	9	pose	pose	VERB
aiua-11533	85	10	treatment	treatment	NOUN
aiua-11533	85	11	challenges	challenge	NOUN
aiua-11533	85	12	as	as	SCONJ
aiua-11533	85	13	they	they	PRON
aiua-11533	85	14	arise	arise	VERB
aiua-11533	85	15	in	in	ADP
aiua-11533	85	16	areas	area	NOUN
aiua-11533	85	17	with	with	ADP
aiua-11533	85	18	complications	complication	NOUN
aiua-11533	85	19	from	from	ADP
aiua-11533	85	20	previous	previous	ADJ
aiua-11533	85	21	treatments	treatment	NOUN
aiua-11533	85	22	,	,	PUNCT
aiua-11533	85	23	making	make	VERB
aiua-11533	85	24	surgical	surgical	ADJ
aiua-11533	85	25	removal	removal	NOUN
aiua-11533	85	26	difficult	difficult	ADJ
aiua-11533	85	27	.	.	PUNCT
aiua-11533	86	1	retrospective	retrospective	ADJ
aiua-11533	86	2	analyses	analysis	NOUN
aiua-11533	86	3	have	have	AUX
aiua-11533	86	4	shown	show	VERB
aiua-11533	86	5	poor	poor	ADJ
aiua-11533	86	6	prognosis	prognosis	NOUN
aiua-11533	86	7	in	in	ADP
aiua-11533	86	8	these	these	DET
aiua-11533	86	9	patients	patient	NOUN
aiua-11533	86	10	compared	compare	VERB
aiua-11533	86	11	to	to	ADP
aiua-11533	86	12	sporadic	sporadic	ADJ
aiua-11533	86	13	soft	soft	ADJ
aiua-11533	86	14	-	-	PUNCT
aiua-11533	86	15	tissue	tissue	NOUN
aiua-11533	86	16	sarcomas	sarcomas	NOUN
aiua-11533	86	17	,	,	PUNCT
aiua-11533	86	18	with	with	ADP
aiua-11533	86	19	5	5	NUM
aiua-11533	86	20	-	-	PUNCT
aiua-11533	86	21	year	year	NOUN
aiua-11533	86	22	os	os	NOUN
aiua-11533	86	23	rates	rate	NOUN
aiua-11533	86	24	ranging	range	VERB
aiua-11533	86	25	between	between	ADP
aiua-11533	86	26	32	32	NUM
aiua-11533	86	27	%	%	NOUN
aiua-11533	86	28	and	and	CCONJ
aiua-11533	86	29	45	45	NUM
aiua-11533	86	30	%	%	NOUN
aiua-11533	86	31	(	(	PUNCT
aiua-11533	86	32	12	12	NUM
aiua-11533	86	33	)	)	PUNCT
aiua-11533	86	34	which	which	PRON
aiua-11533	86	35	are	be	AUX
aiua-11533	86	36	in	in	ADP
aiua-11533	86	37	line	line	NOUN
aiua-11533	86	38	with	with	ADP
aiua-11533	86	39	the	the	DET
aiua-11533	86	40	findings	finding	NOUN
aiua-11533	86	41	of	of	ADP
aiua-11533	86	42	this	this	DET
aiua-11533	86	43	study	study	NOUN
aiua-11533	86	44	.	.	PUNCT
aiua-11533	87	1	continuing	continue	VERB
aiua-11533	87	2	with	with	ADP
aiua-11533	87	3	subgroup	subgroup	NOUN
aiua-11533	87	4	analyses	analysis	NOUN
aiua-11533	87	5	,	,	PUNCT
aiua-11533	87	6	patients	patient	NOUN
aiua-11533	87	7	with	with	ADP
aiua-11533	87	8	extravesical	extravesical	ADJ
aiua-11533	87	9	spread	spread	NOUN
aiua-11533	87	10	(	(	PUNCT
aiua-11533	87	11	t3	t3	PROPN
aiua-11533	87	12	/	/	SYM
aiua-11533	87	13	t4	t4	PROPN
aiua-11533	87	14	)	)	PUNCT
aiua-11533	87	15	exhibit	exhibit	VERB
aiua-11533	87	16	notable	notable	ADJ
aiua-11533	87	17	decreases	decrease	NOUN
aiua-11533	87	18	in	in	ADP
aiua-11533	87	19	progression	progression	NOUN
aiua-11533	87	20	-	-	PUNCT
aiua-11533	87	21	free	free	ADJ
aiua-11533	87	22	survival	survival	NOUN
aiua-11533	87	23	(	(	PUNCT
aiua-11533	87	24	pfs	pfs	PROPN
aiua-11533	87	25	)	)	PUNCT
aiua-11533	87	26	compare	compare	VERB
aiua-11533	87	27	to	to	ADP
aiua-11533	87	28	those	those	PRON
aiua-11533	87	29	with	with	ADP
aiua-11533	87	30	less	less	ADV
aiua-11533	87	31	advanced	advanced	ADJ
aiua-11533	87	32	tumors	tumor	NOUN
aiua-11533	87	33	(	(	PUNCT
aiua-11533	87	34	median	median	PROPN
aiua-11533	87	35	pfs	pfs	PROPN
aiua-11533	87	36	for	for	ADP
aiua-11533	87	37	t2	t2	NOUN
aiua-11533	87	38	-	-	PUNCT
aiua-11533	87	39	category	category	NOUN
aiua-11533	87	40	was	be	AUX
aiua-11533	87	41	not	not	PART
aiua-11533	87	42	reached	reach	VERB
aiua-11533	87	43	and	and	CCONJ
aiua-11533	87	44	for	for	ADP
aiua-11533	87	45	t3	t3	PROPN
aiua-11533	87	46	/	/	SYM
aiua-11533	87	47	t4	t4	PROPN
aiua-11533	87	48	was	be	AUX
aiua-11533	87	49	8.4	8.4	NUM
aiua-11533	87	50	months	month	NOUN
aiua-11533	87	51	)	)	PUNCT
aiua-11533	87	52	.	.	PUNCT
aiua-11533	88	1	the	the	DET
aiua-11533	88	2	reduced	reduce	VERB
aiua-11533	88	3	pfs	pfs	PROPN
aiua-11533	88	4	observed	observe	VERB
aiua-11533	88	5	in	in	ADP
aiua-11533	88	6	this	this	DET
aiua-11533	88	7	particular	particular	ADJ
aiua-11533	88	8	subgroup	subgroup	NOUN
aiua-11533	88	9	of	of	ADP
aiua-11533	88	10	patients	patient	NOUN
aiua-11533	88	11	(	(	PUNCT
aiua-11533	88	12	t3	t3	PROPN
aiua-11533	88	13	/	/	SYM
aiua-11533	88	14	t4	t4	PROPN
aiua-11533	88	15	)	)	PUNCT
aiua-11533	88	16	can	can	AUX
aiua-11533	88	17	be	be	AUX
aiua-11533	88	18	attributed	attribute	VERB
aiua-11533	88	19	to	to	ADP
aiua-11533	88	20	the	the	DET
aiua-11533	88	21	higher	high	ADJ
aiua-11533	88	22	likelihood	likelihood	NOUN
aiua-11533	88	23	of	of	ADP
aiua-11533	88	24	developing	develop	VERB
aiua-11533	88	25	distant	distant	ADJ
aiua-11533	88	26	metastases	metastasis	NOUN
aiua-11533	88	27	,	,	PUNCT
aiua-11533	88	28	but	but	CCONJ
aiua-11533	88	29	also	also	ADV
aiua-11533	88	30	because	because	SCONJ
aiua-11533	88	31	of	of	ADP
aiua-11533	88	32	the	the	DET
aiua-11533	88	33	complex	complex	ADJ
aiua-11533	88	34	relationship	relationship	NOUN
aiua-11533	88	35	between	between	ADP
aiua-11533	88	36	advanced	advanced	ADJ
aiua-11533	88	37	tumor	tumor	NOUN
aiua-11533	88	38	stage	stage	NOUN
aiua-11533	88	39	and	and	CCONJ
aiua-11533	88	40	critical	critical	ADJ
aiua-11533	88	41	anatomical	anatomical	ADJ
aiua-11533	88	42	structures	structure	NOUN
aiua-11533	88	43	,	,	PUNCT
aiua-11533	88	44	resulting	result	VERB
aiua-11533	88	45	in	in	ADP
aiua-11533	88	46	a	a	DET
aiua-11533	88	47	potentially	potentially	ADV
aiua-11533	88	48	decreased	decrease	VERB
aiua-11533	88	49	effectiveness	effectiveness	NOUN
aiua-11533	88	50	of	of	ADP
aiua-11533	88	51	local	local	ADJ
aiua-11533	88	52	treatment	treatment	NOUN
aiua-11533	88	53	.	.	PUNCT
aiua-11533	89	1	data	datum	NOUN
aiua-11533	89	2	from	from	ADP
aiua-11533	89	3	pelvic	pelvic	ADJ
aiua-11533	89	4	sarcomas	sarcoma	NOUN
aiua-11533	89	5	exemplify	exemplify	VERB
aiua-11533	89	6	this	this	DET
aiua-11533	89	7	last	last	ADJ
aiua-11533	89	8	phenomenon	phenomenon	NOUN
aiua-11533	89	9	,	,	PUNCT
aiua-11533	89	10	with	with	ADP
aiua-11533	89	11	successful	successful	ADJ
aiua-11533	89	12	attainment	attainment	NOUN
aiua-11533	89	13	of	of	ADP
aiua-11533	89	14	a	a	DET
aiua-11533	89	15	microscopically	microscopically	ADV
aiua-11533	89	16	margin	margin	NOUN
aiua-11533	89	17	-	-	PUNCT
aiua-11533	89	18	negative	negative	ADJ
aiua-11533	89	19	resection	resection	NOUN
aiua-11533	89	20	(	(	PUNCT
aiua-11533	89	21	r0	r0	NOUN
aiua-11533	89	22	)	)	PUNCT
aiua-11533	89	23	surgery	surgery	NOUN
aiua-11533	89	24	achieved	achieve	VERB
aiua-11533	89	25	only	only	ADV
aiua-11533	89	26	in	in	ADP
aiua-11533	89	27	70	70	NUM
aiua-11533	89	28	%	%	NOUN
aiua-11533	89	29	of	of	ADP
aiua-11533	89	30	cases	case	NOUN
aiua-11533	89	31	(	(	PUNCT
aiua-11533	89	32	13	13	NUM
aiua-11533	89	33	)	)	PUNCT
aiua-11533	89	34	.	.	PUNCT
aiua-11533	90	1	contrary	contrary	ADJ
aiua-11533	90	2	to	to	ADP
aiua-11533	90	3	uc	uc	PROPN
aiua-11533	90	4	,	,	PUNCT
aiua-11533	90	5	where	where	SCONJ
aiua-11533	90	6	distant	distant	ADJ
aiua-11533	90	7	recurrence	recurrence	NOUN
aiua-11533	90	8	is	be	AUX
aiua-11533	90	9	the	the	DET
aiua-11533	90	10	primary	primary	ADJ
aiua-11533	90	11	pattern	pattern	NOUN
aiua-11533	90	12	,	,	PUNCT
aiua-11533	90	13	this	this	DET
aiua-11533	90	14	study	study	NOUN
aiua-11533	90	15	reveals	reveal	VERB
aiua-11533	90	16	that	that	SCONJ
aiua-11533	90	17	rates	rate	NOUN
aiua-11533	90	18	of	of	ADP
aiua-11533	90	19	local	local	ADJ
aiua-11533	90	20	and	and	CCONJ
aiua-11533	90	21	distant	distant	ADJ
aiua-11533	90	22	recurrences	recurrence	NOUN
aiua-11533	90	23	observed	observe	VERB
aiua-11533	90	24	were	be	AUX
aiua-11533	90	25	49	49	NUM
aiua-11533	90	26	%	%	NOUN
aiua-11533	90	27	and	and	CCONJ
aiua-11533	90	28	37	37	NUM
aiua-11533	90	29	%	%	NOUN
aiua-11533	90	30	,	,	PUNCT
aiua-11533	90	31	respectively	respectively	ADV
aiua-11533	90	32	.	.	PUNCT
aiua-11533	91	1	these	these	DET
aiua-11533	91	2	findings	finding	NOUN
aiua-11533	91	3	hold	hold	VERB
aiua-11533	91	4	significant	significant	ADJ
aiua-11533	91	5	implications	implication	NOUN
aiua-11533	91	6	,	,	PUNCT
aiua-11533	91	7	particularly	particularly	ADV
aiua-11533	91	8	considering	consider	VERB
aiua-11533	91	9	that	that	SCONJ
aiua-11533	91	10	approximately	approximately	ADV
aiua-11533	91	11	60	60	NUM
aiua-11533	91	12	%	%	NOUN
aiua-11533	91	13	of	of	ADP
aiua-11533	91	14	patients	patient	NOUN
aiua-11533	91	15	in	in	ADP
aiua-11533	91	16	this	this	DET
aiua-11533	91	17	cohort	cohort	NOUN
aiua-11533	91	18	exhibit	exhibit	VERB
aiua-11533	91	19	extra	extra	ADJ
aiua-11533	91	20	-	-	ADJ
aiua-11533	91	21	vesical	vesical	ADJ
aiua-11533	91	22	spread	spread	NOUN
aiua-11533	91	23	(	(	PUNCT
aiua-11533	91	24	t3	t3	PROPN
aiua-11533	91	25	/	/	SYM
aiua-11533	91	26	t4	t4	PROPN
aiua-11533	91	27	)	)	PUNCT
aiua-11533	91	28	.	.	PUNCT
aiua-11533	92	1	the	the	DET
aiua-11533	92	2	high	high	ADJ
aiua-11533	92	3	rates	rate	NOUN
aiua-11533	92	4	of	of	ADP
aiua-11533	92	5	local	local	ADJ
aiua-11533	92	6	failures	failure	NOUN
aiua-11533	92	7	observed	observe	VERB
aiua-11533	92	8	emphasize	emphasize	VERB
aiua-11533	92	9	the	the	DET
aiua-11533	92	10	critical	critical	ADJ
aiua-11533	92	11	need	need	NOUN
aiua-11533	92	12	for	for	ADP
aiua-11533	92	13	optimizing	optimize	VERB
aiua-11533	92	14	local	local	ADJ
aiua-11533	92	15	therapies	therapy	NOUN
aiua-11533	92	16	,	,	PUNCT
aiua-11533	92	17	particularly	particularly	ADV
aiua-11533	92	18	within	within	ADP
aiua-11533	92	19	the	the	DET
aiua-11533	92	20	latter	latter	ADJ
aiua-11533	92	21	sub	sub	NOUN
aiua-11533	92	22	-	-	NOUN
aiua-11533	92	23	group	group	NOUN
aiua-11533	92	24	.	.	PUNCT
aiua-11533	93	1	typically	typically	ADV
aiua-11533	93	2	,	,	PUNCT
aiua-11533	93	3	the	the	DET
aiua-11533	93	4	treatment	treatment	NOUN
aiua-11533	93	5	approach	approach	NOUN
aiua-11533	93	6	for	for	ADP
aiua-11533	93	7	sub	sub	NOUN
aiua-11533	93	8	has	have	AUX
aiua-11533	93	9	been	be	AUX
aiua-11533	93	10	extrapolated	extrapolate	VERB
aiua-11533	93	11	from	from	ADP
aiua-11533	93	12	the	the	DET
aiua-11533	93	13	management	management	NOUN
aiua-11533	93	14	of	of	ADP
aiua-11533	93	15	uc	uc	PROPN
aiua-11533	93	16	of	of	ADP
aiua-11533	93	17	the	the	DET
aiua-11533	93	18	bladder	bladder	NOUN
aiua-11533	93	19	,	,	PUNCT
aiua-11533	93	20	where	where	SCONJ
aiua-11533	93	21	cystectomy	cystectomy	NOUN
aiua-11533	93	22	and	and	CCONJ
aiua-11533	93	23	chemotherapy	chemotherapy	NOUN
aiua-11533	93	24	are	be	AUX
aiua-11533	93	25	considered	consider	VERB
aiua-11533	93	26	fundamental	fundamental	ADJ
aiua-11533	93	27	in	in	ADP
aiua-11533	93	28	a	a	DET
aiua-11533	93	29	multimodality	multimodality	NOUN
aiua-11533	93	30	approach	approach	NOUN
aiua-11533	93	31	(	(	PUNCT
aiua-11533	93	32	5	5	NUM
aiua-11533	93	33	,	,	PUNCT
aiua-11533	93	34	6	6	NUM
aiua-11533	93	35	)	)	PUNCT
aiua-11533	93	36	.	.	PUNCT
aiua-11533	94	1	retroperitoneal	retroperitoneal	ADJ
aiua-11533	94	2	sarcomas	sarcoma	NOUN
aiua-11533	94	3	(	(	PUNCT
aiua-11533	94	4	rps	rps	NOUN
aiua-11533	94	5	)	)	PUNCT
aiua-11533	94	6	exhibit	exhibit	VERB
aiua-11533	94	7	a	a	DET
aiua-11533	94	8	behavioral	behavioral	ADJ
aiua-11533	94	9	pattern	pattern	NOUN
aiua-11533	94	10	that	that	PRON
aiua-11533	94	11	aligns	align	VERB
aiua-11533	94	12	more	more	ADV
aiua-11533	94	13	closely	closely	ADV
aiua-11533	94	14	with	with	ADP
aiua-11533	94	15	the	the	DET
aiua-11533	94	16	presents	present	NOUN
aiua-11533	94	17	findings	finding	NOUN
aiua-11533	94	18	,	,	PUNCT
aiua-11533	94	19	showing	show	VERB
aiua-11533	94	20	a	a	DET
aiua-11533	94	21	higher	high	ADJ
aiua-11533	94	22	incidence	incidence	NOUN
aiua-11533	94	23	of	of	ADP
aiua-11533	94	24	local	local	ADJ
aiua-11533	94	25	recurrence	recurrence	NOUN
aiua-11533	94	26	,	,	PUNCT
aiua-11533	94	27	which	which	PRON
aiua-11533	94	28	remains	remain	VERB
aiua-11533	94	29	the	the	DET
aiua-11533	94	30	primary	primary	ADJ
aiua-11533	94	31	cause	cause	NOUN
aiua-11533	94	32	of	of	ADP
aiua-11533	94	33	mortality	mortality	NOUN
aiua-11533	94	34	(	(	PUNCT
aiua-11533	94	35	14	14	NUM
aiua-11533	94	36	)	)	PUNCT
aiua-11533	94	37	.	.	PUNCT
aiua-11533	95	1	within	within	ADP
aiua-11533	95	2	this	this	DET
aiua-11533	95	3	context	context	NOUN
aiua-11533	95	4	,	,	PUNCT
aiua-11533	95	5	local	local	ADJ
aiua-11533	95	6	recurrence	recurrence	NOUN
aiua-11533	95	7	and	and	CCONJ
aiua-11533	95	8	metastatic	metastatic	ADJ
aiua-11533	95	9	disease	disease	NOUN
aiua-11533	95	10	occur	occur	VERB
aiua-11533	95	11	in	in	ADP
aiua-11533	95	12	approximately	approximately	ADV
aiua-11533	95	13	50	50	NUM
aiua-11533	95	14	-	-	SYM
aiua-11533	95	15	60	60	NUM
aiua-11533	95	16	%	%	NOUN
aiua-11533	95	17	and	and	CCONJ
aiua-11533	95	18	20	20	NUM
aiua-11533	95	19	%	%	NOUN
aiua-11533	95	20	of	of	ADP
aiua-11533	95	21	cases	case	NOUN
aiua-11533	95	22	,	,	PUNCT
aiua-11533	95	23	respectively	respectively	ADV
aiua-11533	95	24	(	(	PUNCT
aiua-11533	95	25	15	15	NUM
aiua-11533	95	26	)	)	PUNCT
aiua-11533	95	27	,	,	PUNCT
aiua-11533	95	28	mirroring	mirror	VERB
aiua-11533	95	29	the	the	DET
aiua-11533	95	30	failure	failure	NOUN
aiua-11533	95	31	pattern	pattern	NOUN
aiua-11533	95	32	observed	observe	VERB
aiua-11533	95	33	in	in	ADP
aiua-11533	95	34	this	this	DET
aiua-11533	95	35	study	study	NOUN
aiua-11533	95	36	.	.	PUNCT
aiua-11533	96	1	the	the	DET
aiua-11533	96	2	importance	importance	NOUN
aiua-11533	96	3	of	of	ADP
aiua-11533	96	4	local	local	ADJ
aiua-11533	96	5	control	control	NOUN
aiua-11533	96	6	drives	drive	VERB
aiua-11533	96	7	management	management	NOUN
aiua-11533	96	8	of	of	ADP
aiua-11533	96	9	rps	rps	PROPN
aiua-11533	96	10	,	,	PUNCT
aiua-11533	96	11	with	with	ADP
aiua-11533	96	12	surgery	surgery	NOUN
aiua-11533	96	13	been	be	VERB
aiua-11533	96	14	the	the	DET
aiua-11533	96	15	mainstay	mainstay	NOUN
aiua-11533	96	16	of	of	ADP
aiua-11533	96	17	curative	curative	ADJ
aiua-11533	96	18	intent	intent	NOUN
aiua-11533	96	19	therapy	therapy	NOUN
aiua-11533	96	20	(	(	PUNCT
aiua-11533	96	21	16	16	NUM
aiua-11533	96	22	)	)	PUNCT
aiua-11533	96	23	.	.	PUNCT
aiua-11533	97	1	complete	complete	ADJ
aiua-11533	97	2	gross	gross	ADJ
aiua-11533	97	3	resection	resection	NOUN
aiua-11533	97	4	(	(	PUNCT
aiua-11533	97	5	r0	r0	NOUN
aiua-11533	97	6	or	or	CCONJ
aiua-11533	97	7	r1	r1	PROPN
aiua-11533	97	8	)	)	PUNCT
aiua-11533	97	9	has	have	AUX
aiua-11533	97	10	been	be	AUX
aiua-11533	97	11	associated	associate	VERB
aiua-11533	97	12	with	with	ADP
aiua-11533	97	13	improved	improved	ADJ
aiua-11533	97	14	disease	disease	NOUN
aiua-11533	97	15	-	-	PUNCT
aiua-11533	97	16	free	free	ADJ
aiua-11533	97	17	survival	survival	NOUN
aiua-11533	97	18	(	(	PUNCT
aiua-11533	97	19	17	17	NUM
aiua-11533	97	20	)	)	PUNCT
aiua-11533	97	21	.	.	PUNCT
aiua-11533	98	1	however	however	ADV
aiua-11533	98	2	,	,	PUNCT
aiua-11533	98	3	even	even	ADV
aiua-11533	98	4	with	with	ADP
aiua-11533	98	5	a	a	DET
aiua-11533	98	6	histologically	histologically	ADV
aiua-11533	98	7	negative	negative	ADJ
aiua-11533	98	8	margin	margin	NOUN
aiua-11533	98	9	(	(	PUNCT
aiua-11533	98	10	r0	r0	NOUN
aiua-11533	98	11	)	)	PUNCT
aiua-11533	98	12	,	,	PUNCT
aiua-11533	98	13	local	local	ADJ
aiua-11533	98	14	recurrence	recurrence	NOUN
aiua-11533	98	15	can	can	AUX
aiua-11533	98	16	still	still	ADV
aiua-11533	98	17	occur	occur	VERB
aiua-11533	98	18	(	(	PUNCT
aiua-11533	98	19	18	18	NUM
aiua-11533	98	20	)	)	PUNCT
aiua-11533	98	21	.	.	PUNCT
aiua-11533	99	1	considering	consider	VERB
aiua-11533	99	2	the	the	DET
aiua-11533	99	3	high	high	ADJ
aiua-11533	99	4	incidence	incidence	NOUN
aiua-11533	99	5	of	of	ADP
aiua-11533	99	6	local	local	ADJ
aiua-11533	99	7	recurrences	recurrence	NOUN
aiua-11533	99	8	following	follow	VERB
aiua-11533	99	9	surgery	surgery	NOUN
aiua-11533	99	10	,	,	PUNCT
aiua-11533	99	11	neoadjuvant	neoadjuvant	ADJ
aiua-11533	99	12	radiotherapy	radiotherapy	NOUN
aiua-11533	99	13	has	have	AUX
aiua-11533	99	14	emerged	emerge	VERB
aiua-11533	99	15	as	as	ADP
aiua-11533	99	16	an	an	DET
aiua-11533	99	17	attractive	attractive	ADJ
aiua-11533	99	18	yet	yet	CCONJ
aiua-11533	99	19	controversial	controversial	ADJ
aiua-11533	99	20	option	option	NOUN
aiua-11533	99	21	for	for	ADP
aiua-11533	99	22	rps	rps	PROPN
aiua-11533	99	23	(	(	PUNCT
aiua-11533	99	24	19	19	NUM
aiua-11533	99	25	,	,	PUNCT
aiua-11533	99	26	20	20	NUM
aiua-11533	99	27	)	)	PUNCT
aiua-11533	99	28	.	.	PUNCT
aiua-11533	100	1	despite	despite	SCONJ
aiua-11533	100	2	the	the	DET
aiua-11533	100	3	retrospective	retrospective	ADJ
aiua-11533	100	4	nature	nature	NOUN
aiua-11533	100	5	of	of	ADP
aiua-11533	100	6	this	this	DET
aiua-11533	100	7	study	study	NOUN
aiua-11533	100	8	,	,	PUNCT
aiua-11533	100	9	and	and	CCONJ
aiua-11533	100	10	therefore	therefore	ADV
aiua-11533	100	11	hampered	hamper	VERB
aiua-11533	100	12	by	by	ADP
aiua-11533	100	13	its	its	PRON
aiua-11533	100	14	intrinsic	intrinsic	ADJ
aiua-11533	100	15	biases	bias	NOUN
aiua-11533	100	16	,	,	PUNCT
aiua-11533	100	17	the	the	DET
aiua-11533	100	18	high	high	ADJ
aiua-11533	100	19	local	local	ADJ
aiua-11533	100	20	failure	failure	NOUN
aiua-11533	100	21	rates	rate	NOUN
aiua-11533	100	22	seen	see	VERB
aiua-11533	100	23	in	in	ADP
aiua-11533	100	24	this	this	DET
aiua-11533	100	25	cohort	cohort	NOUN
aiua-11533	100	26	prompts	prompt	VERB
aiua-11533	100	27	the	the	DET
aiua-11533	100	28	hypothesis	hypothesis	NOUN
aiua-11533	100	29	that	that	DET
aiua-11533	100	30	neoadjuvant	neoadjuvant	ADJ
aiua-11533	100	31	radiotherapy	radiotherapy	NOUN
aiua-11533	100	32	as	as	ADP
aiua-11533	100	33	part	part	NOUN
aiua-11533	100	34	of	of	ADP
aiua-11533	100	35	a	a	DET
aiua-11533	100	36	multi	multi	ADJ
aiua-11533	100	37	-	-	ADJ
aiua-11533	100	38	disciplinary	disciplinary	ADJ
aiua-11533	100	39	approach	approach	NOUN
aiua-11533	100	40	for	for	ADP
aiua-11533	100	41	sub	sub	NOUN
aiua-11533	100	42	may	may	AUX
aiua-11533	100	43	play	play	VERB
aiua-11533	100	44	an	an	DET
aiua-11533	100	45	important	important	ADJ
aiua-11533	100	46	role	role	NOUN
aiua-11533	100	47	in	in	ADP
aiua-11533	100	48	reducing	reduce	VERB
aiua-11533	100	49	loco	loco	PROPN
aiua-11533	100	50	-	-	PUNCT
aiua-11533	100	51	regional	regional	ADJ
aiua-11533	100	52	failure	failure	NOUN
aiua-11533	100	53	rate	rate	NOUN
aiua-11533	100	54	and	and	CCONJ
aiua-11533	100	55	improving	improve	VERB
aiua-11533	100	56	,	,	PUNCT
aiua-11533	100	57	at	at	ADP
aiua-11533	100	58	least	least	ADJ
aiua-11533	100	59	to	to	ADP
aiua-11533	100	60	some	some	DET
aiua-11533	100	61	extent	extent	NOUN
aiua-11533	100	62	,	,	PUNCT
aiua-11533	100	63	the	the	DET
aiua-11533	100	64	survival	survival	NOUN
aiua-11533	100	65	of	of	ADP
aiua-11533	100	66	this	this	DET
aiua-11533	100	67	patients	patient	NOUN
aiua-11533	100	68	,	,	PUNCT
aiua-11533	100	69	especially	especially	ADV
aiua-11533	100	70	in	in	ADP
aiua-11533	100	71	higher	high	ADJ
aiua-11533	100	72	tumor	tumor	NOUN
aiua-11533	100	73	stages	stage	NOUN
aiua-11533	100	74	(	(	PUNCT
aiua-11533	100	75	t3	t3	PROPN
aiua-11533	100	76	/	/	SYM
aiua-11533	100	77	t4	t4	PROPN
aiua-11533	100	78	)	)	PUNCT
aiua-11533	100	79	where	where	SCONJ
aiua-11533	100	80	r0	r0	NOUN
aiua-11533	100	81	surgery	surgery	NOUN
aiua-11533	100	82	with	with	ADP
aiua-11533	100	83	wide	wide	ADJ
aiua-11533	100	84	margins	margin	NOUN
aiua-11533	100	85	is	be	AUX
aiua-11533	100	86	more	more	ADV
aiua-11533	100	87	difficult	difficult	ADJ
aiua-11533	100	88	to	to	PART
aiua-11533	100	89	obtain	obtain	VERB
aiua-11533	100	90	and	and	CCONJ
aiua-11533	100	91	were	be	AUX
aiua-11533	100	92	poorer	poor	ADJ
aiua-11533	100	93	outcomes	outcome	NOUN
aiua-11533	100	94	we	we	PRON
aiua-11533	100	95	have	have	AUX
aiua-11533	100	96	observed	observe	VERB
aiua-11533	100	97	.	.	PUNCT
aiua-11533	101	1	although	although	SCONJ
aiua-11533	101	2	the	the	DET
aiua-11533	101	3	existing	exist	VERB
aiua-11533	101	4	evidence	evidence	NOUN
aiua-11533	101	5	is	be	AUX
aiua-11533	101	6	limited	limit	VERB
aiua-11533	101	7	,	,	PUNCT
aiua-11533	101	8	our	our	PRON
aiua-11533	101	9	retrospective	retrospective	ADJ
aiua-11533	101	10	data	datum	NOUN
aiua-11533	101	11	can	can	AUX
aiua-11533	101	12	provide	provide	VERB
aiua-11533	101	13	valuable	valuable	ADJ
aiua-11533	101	14	insights	insight	NOUN
aiua-11533	101	15	into	into	ADP
aiua-11533	101	16	this	this	DET
aiua-11533	101	17	uncommon	uncommon	ADJ
aiua-11533	101	18	neoplasm	neoplasm	NOUN
aiua-11533	101	19	,	,	PUNCT
aiua-11533	101	20	enabling	enable	VERB
aiua-11533	101	21	clinicians	clinician	NOUN
aiua-11533	101	22	to	to	PART
aiua-11533	101	23	make	make	VERB
aiua-11533	101	24	more	more	ADV
aiua-11533	101	25	informed	informed	ADJ
aiua-11533	101	26	clinical	clinical	ADJ
aiua-11533	101	27	decisions	decision	NOUN
aiua-11533	101	28	tailored	tailor	VERB
aiua-11533	101	29	to	to	ADP
aiua-11533	101	30	this	this	DET
aiua-11533	101	31	rare	rare	ADJ
aiua-11533	101	32	disease	disease	NOUN
aiua-11533	101	33	.	.	PUNCT
aiua-11533	102	1	conclusions	conclusion	NOUN
aiua-11533	102	2	primary	primary	ADJ
aiua-11533	102	3	sub	sub	NOUN
aiua-11533	102	4	is	be	AUX
aiua-11533	102	5	a	a	DET
aiua-11533	102	6	heterogeneous	heterogeneous	ADJ
aiua-11533	102	7	disease	disease	NOUN
aiua-11533	102	8	group	group	NOUN
aiua-11533	102	9	,	,	PUNCT
aiua-11533	102	10	commonly	commonly	ADV
aiua-11533	102	11	presenting	present	VERB
aiua-11533	102	12	at	at	ADP
aiua-11533	102	13	advanced	advanced	ADJ
aiua-11533	102	14	stages	stage	NOUN
aiua-11533	102	15	and	and	CCONJ
aiua-11533	102	16	exhibiting	exhibit	VERB
aiua-11533	102	17	aggressive	aggressive	ADJ
aiua-11533	102	18	disease	disease	NOUN
aiua-11533	102	19	evolution	evolution	NOUN
aiua-11533	102	20	.	.	PUNCT
aiua-11533	103	1	in	in	ADP
aiua-11533	103	2	contrast	contrast	NOUN
aiua-11533	103	3	to	to	ADP
aiua-11533	103	4	uc	uc	PROPN
aiua-11533	103	5	,	,	PUNCT
aiua-11533	103	6	the	the	DET
aiua-11533	103	7	primary	primary	ADJ
aiua-11533	103	8	pattern	pattern	NOUN
aiua-11533	103	9	of	of	ADP
aiua-11533	103	10	recurrence	recurrence	NOUN
aiua-11533	103	11	of	of	ADP
aiua-11533	103	12	sub	sub	NOUN
aiua-11533	103	13	is	be	AUX
aiua-11533	103	14	local	local	ADJ
aiua-11533	103	15	,	,	PUNCT
aiua-11533	103	16	suggesting	suggest	VERB
aiua-11533	103	17	the	the	DET
aiua-11533	103	18	need	need	NOUN
aiua-11533	103	19	for	for	ADP
aiua-11533	103	20	multimodal	multimodal	NOUN
aiua-11533	103	21	approaches	approach	NOUN
aiua-11533	103	22	.	.	PUNCT
aiua-11533	104	1	continuous	continuous	ADJ
aiua-11533	104	2	international	international	ADJ
aiua-11533	104	3	collaborative	collaborative	ADJ
aiua-11533	104	4	efforts	effort	NOUN
aiua-11533	104	5	seem	seem	VERB
aiua-11533	104	6	warranted	warrant	VERB
aiua-11533	104	7	to	to	PART
aiua-11533	104	8	provide	provide	VERB
aiua-11533	104	9	guidance	guidance	NOUN
aiua-11533	104	10	on	on	ADP
aiua-11533	104	11	how	how	SCONJ
aiua-11533	104	12	to	to	PART
aiua-11533	104	13	best	good	ADJ
aiua-11533	104	14	tailor	tailor	NOUN
aiua-11533	104	15	treatments	treatment	NOUN
aiua-11533	104	16	based	base	VERB
aiua-11533	104	17	on	on	ADP
aiua-11533	104	18	sub	sub	ADJ
aiua-11533	104	19	-	-	ADJ
aiua-11533	104	20	specific	specific	ADJ
aiua-11533	104	21	indices	index	NOUN
aiua-11533	104	22	.	.	PUNCT
aiua-11533	105	1	references	reference	NOUN
aiua-11533	105	2	1	1	NUM
aiua-11533	105	3	.	.	PUNCT
aiua-11533	106	1	lopez	lopez	PROPN
aiua-11533	106	2	-	-	PUNCT
aiua-11533	106	3	beltran	beltran	PROPN
aiua-11533	106	4	a	a	PROPN
aiua-11533	106	5	,	,	PUNCT
aiua-11533	106	6	pacelli	pacelli	PROPN
aiua-11533	106	7	a	a	PROPN
aiua-11533	106	8	,	,	PUNCT
aiua-11533	106	9	rothenberg	rothenberg	PROPN
aiua-11533	106	10	hj	hj	PROPN
aiua-11533	106	11	.	.	PROPN
aiua-11533	106	12	carcinosarcoma	carcinosarcoma	PROPN
aiua-11533	106	13	and	and	CCONJ
aiua-11533	106	14	sarcomatoid	sarcomatoid	ADJ
aiua-11533	106	15	carcinoma	carcinoma	NOUN
aiua-11533	106	16	of	of	ADP
aiua-11533	106	17	the	the	DET
aiua-11533	106	18	bladder	bladder	NOUN
aiua-11533	106	19	:	:	PUNCT
aiua-11533	106	20	clinicopathological	clinicopathological	ADJ
aiua-11533	106	21	study	study	NOUN
aiua-11533	106	22	of	of	ADP
aiua-11533	106	23	41	41	NUM
aiua-11533	106	24	cases	case	NOUN
aiua-11533	106	25	.	.	PUNCT
aiua-11533	107	1	j	j	PROPN
aiua-11533	107	2	urol	urol	PROPN
aiua-11533	107	3	.	.	PUNCT
aiua-11533	108	1	1998	1998	NUM
aiua-11533	108	2	;	;	PUNCT
aiua-11533	108	3	159:1497	159:1497	NUM
aiua-11533	108	4	-	-	SYM
aiua-11533	108	5	1503	1503	NUM
aiua-11533	108	6	.	.	PUNCT
aiua-11533	109	1	2	2	X
aiua-11533	109	2	.	.	X
aiua-11533	109	3	mukhopadhyay	mukhopadhyay	PROPN
aiua-11533	109	4	s	s	PROPN
aiua-11533	109	5	,	,	PUNCT
aiua-11533	109	6	shrimpton	shrimpton	PROPN
aiua-11533	109	7	ae	ae	PROPN
aiua-11533	109	8	,	,	PUNCT
aiua-11533	109	9	jones	jones	PROPN
aiua-11533	109	10	la	la	PROPN
aiua-11533	109	11	.	.	PROPN
aiua-11533	110	1	carcinosarcoma	carcinosarcoma	NOUN
aiua-11533	110	2	of	of	ADP
aiua-11533	110	3	the	the	DET
aiua-11533	110	4	urinary	urinary	ADJ
aiua-11533	110	5	bladder	bladder	NOUN
aiua-11533	110	6	following	follow	VERB
aiua-11533	110	7	cyclophosphamide	cyclophosphamide	NOUN
aiua-11533	110	8	therapy	therapy	NOUN
aiua-11533	110	9	:	:	PUNCT
aiua-11533	110	10	evidence	evidence	NOUN
aiua-11533	110	11	for	for	ADP
aiua-11533	110	12	monoclonal	monoclonal	NOUN
aiua-11533	110	13	origin	origin	NOUN
aiua-11533	110	14	and	and	CCONJ
aiua-11533	110	15	chromosome	chromosome	NOUN
aiua-11533	110	16	9p	9p	NUM
aiua-11533	110	17	allelic	allelic	ADJ
aiua-11533	110	18	loss	loss	NOUN
aiua-11533	110	19	.	.	PUNCT
aiua-11533	111	1	arch	arch	ADJ
aiua-11533	111	2	pathol	pathol	NOUN
aiua-11533	111	3	lab	lab	NOUN
aiua-11533	111	4	med	me	VERB
aiua-11533	111	5	.	.	PUNCT
aiua-11533	111	6	2004	2004	NUM
aiua-11533	111	7	;	;	PUNCT
aiua-11533	111	8	128	128	NUM
aiua-11533	111	9	:	:	PUNCT
aiua-11533	111	10	e8	e8	NOUN
aiua-11533	111	11	-	-	PUNCT
aiua-11533	111	12	e11	e11	NOUN
aiua-11533	111	13	.	.	PUNCT
aiua-11533	112	1	3	3	X
aiua-11533	112	2	.	.	X
aiua-11533	112	3	wick	wick	PROPN
aiua-11533	112	4	mr	mr	PROPN
aiua-11533	112	5	,	,	PUNCT
aiua-11533	112	6	swanson	swanson	PROPN
aiua-11533	112	7	pe	pe	PROPN
aiua-11533	112	8	.	.	PUNCT
aiua-11533	112	9	carcinosarcomas	carcinosarcomas	PROPN
aiua-11533	112	10	:	:	PUNCT
aiua-11533	112	11	current	current	ADJ
aiua-11533	112	12	perspectives	perspective	NOUN
aiua-11533	112	13	and	and	CCONJ
aiua-11533	112	14	an	an	DET
aiua-11533	112	15	historical	historical	ADJ
aiua-11533	112	16	review	review	NOUN
aiua-11533	112	17	of	of	ADP
aiua-11533	112	18	nosological	nosological	ADJ
aiua-11533	112	19	concepts	concept	NOUN
aiua-11533	112	20	.	.	PUNCT
aiua-11533	113	1	semin	semin	PROPN
aiua-11533	113	2	diagn	diagn	PROPN
aiua-11533	113	3	pathol	pathol	PROPN
aiua-11533	113	4	.	.	PUNCT
aiua-11533	114	1	1993	1993	NUM
aiua-11533	114	2	;	;	PUNCT
aiua-11533	114	3	10:118	10:118	NUM
aiua-11533	114	4	.	.	PUNCT
aiua-11533	115	1	4	4	NUM
aiua-11533	115	2	.	.	X
aiua-11533	115	3	wright	wright	PROPN
aiua-11533	115	4	jl	jl	PROPN
aiua-11533	115	5	,	,	PUNCT
aiua-11533	115	6	black	black	ADJ
aiua-11533	115	7	pc	pc	NOUN
aiua-11533	115	8	,	,	PUNCT
aiua-11533	115	9	brown	brown	PROPN
aiua-11533	115	10	ga	ga	PROPN
aiua-11533	115	11	,	,	PUNCT
aiua-11533	115	12	et	et	PROPN
aiua-11533	115	13	al	al	PROPN
aiua-11533	115	14	.	.	PROPN
aiua-11533	115	15	differences	difference	NOUN
aiua-11533	115	16	in	in	ADP
aiua-11533	115	17	survival	survival	NOUN
aiua-11533	115	18	among	among	ADP
aiua-11533	115	19	patients	patient	NOUN
aiua-11533	115	20	with	with	ADP
aiua-11533	115	21	sarcomatoid	sarcomatoid	NOUN
aiua-11533	115	22	carcinoma	carcinoma	NOUN
aiua-11533	115	23	,	,	PUNCT
aiua-11533	115	24	carcinosarcoma	carcinosarcoma	ADJ
aiua-11533	115	25	,	,	PUNCT
aiua-11533	115	26	and	and	CCONJ
aiua-11533	115	27	urothelial	urothelial	ADJ
aiua-11533	115	28	carcinoma	carcinoma	NOUN
aiua-11533	115	29	of	of	ADP
aiua-11533	115	30	the	the	DET
aiua-11533	115	31	bladder	bladder	NOUN
aiua-11533	115	32	.	.	PUNCT
aiua-11533	116	1	j	j	PROPN
aiua-11533	116	2	urol	urol	PROPN
aiua-11533	116	3	.	.	PUNCT
aiua-11533	117	1	2007	2007	NUM
aiua-11533	117	2	;	;	PUNCT
aiua-11533	117	3	178:2302	178:2302	NUM
aiua-11533	117	4	-	-	SYM
aiua-11533	117	5	2307	2307	NUM
aiua-11533	117	6	.	.	PUNCT
aiua-11533	118	1	5	5	X
aiua-11533	118	2	.	.	X
aiua-11533	118	3	eau	eau	PROPN
aiua-11533	118	4	(	(	PUNCT
aiua-11533	118	5	european	european	PROPN
aiua-11533	118	6	association	association	PROPN
aiua-11533	118	7	of	of	ADP
aiua-11533	118	8	urology	urology	NOUN
aiua-11533	118	9	)	)	PUNCT
aiua-11533	118	10	.	.	PUNCT
aiua-11533	119	1	guidelines	guideline	NOUN
aiua-11533	119	2	on	on	ADP
aiua-11533	119	3	muscleinvasive	muscleinvasive	ADJ
aiua-11533	119	4	and	and	CCONJ
aiua-11533	119	5	metastatic	metastatic	ADJ
aiua-11533	119	6	bladder	bladder	NOUN
aiua-11533	119	7	cancer	cancer	NOUN
aiua-11533	119	8	.	.	PUNCT
aiua-11533	120	1	2021	2021	NUM
aiua-11533	120	2	edition	edition	NOUN
aiua-11533	120	3	.	.	PUNCT
aiua-11533	121	1	available	available	ADJ
aiua-11533	121	2	at	at	ADP
aiua-11533	121	3	:	:	PUNCT
aiua-11533	121	4	https://uroweb.org/guideline/bladder-cancer-muscle-invasive-andmetastatic/.	https://uroweb.org/guideline/bladder-cancer-muscle-invasive-andmetastatic/.	PROPN
aiua-11533	121	5	6	6	NUM
aiua-11533	121	6	.	.	PUNCT
aiua-11533	121	7	nccn	nccn	PROPN
aiua-11533	121	8	(	(	PUNCT
aiua-11533	121	9	national	national	ADJ
aiua-11533	121	10	comprehensive	comprehensive	ADJ
aiua-11533	121	11	cancer	cancer	NOUN
aiua-11533	121	12	network	network	NOUN
aiua-11533	121	13	)	)	PUNCT
aiua-11533	121	14	.	.	PUNCT
aiua-11533	122	1	bladder	bladder	NOUN
aiua-11533	122	2	cancer	cancer	NOUN
aiua-11533	122	3	.	.	PUNCT
aiua-11533	123	1	nccn	nccn	ADJ
aiua-11533	123	2	clinical	clinical	ADJ
aiua-11533	123	3	practice	practice	NOUN
aiua-11533	123	4	guidelines	guideline	NOUN
aiua-11533	123	5	in	in	ADP
aiua-11533	123	6	oncology	oncology	NOUN
aiua-11533	123	7	.	.	PUNCT
aiua-11533	124	1	available	available	ADJ
aiua-11533	124	2	at	at	ADP
aiua-11533	124	3	:	:	PUNCT
aiua-11533	124	4	https://www.nccn.org/professionals/physician_gls/default.aspx#bladder	https://www.nccn.org/professionals/physician_gls/default.aspx#bladder	PROPN
aiua-11533	124	5	.	.	PROPN
aiua-11533	124	6	7	7	NUM
aiua-11533	124	7	.	.	X
aiua-11533	124	8	lobo	lobo	PROPN
aiua-11533	124	9	n	n	CCONJ
aiua-11533	124	10	,	,	PUNCT
aiua-11533	124	11	et	et	PROPN
aiua-11533	124	12	al	al	PROPN
aiua-11533	124	13	.	.	PUNCT
aiua-11533	125	1	what	what	PRON
aiua-11533	125	2	is	be	AUX
aiua-11533	125	3	the	the	DET
aiua-11533	125	4	significance	significance	NOUN
aiua-11533	125	5	of	of	ADP
aiua-11533	125	6	variant	variant	ADJ
aiua-11533	125	7	histology	histology	NOUN
aiua-11533	125	8	in	in	ADP
aiua-11533	125	9	urothelial	urothelial	ADJ
aiua-11533	125	10	carcinoma	carcinoma	NOUN
aiua-11533	125	11	?	?	PUNCT
aiua-11533	126	1	eur	eur	PROPN
aiua-11533	126	2	urol	urol	ADJ
aiua-11533	126	3	focus	focus	NOUN
aiua-11533	126	4	.	.	PUNCT
aiua-11533	127	1	2020	2020	NUM
aiua-11533	127	2	jul	jul	PROPN
aiua-11533	127	3	15	15	NUM
aiua-11533	127	4	;	;	PUNCT
aiua-11533	127	5	6:653	6:653	NUM
aiua-11533	127	6	-	-	SYM
aiua-11533	127	7	663	663	NUM
aiua-11533	127	8	.	.	PUNCT
aiua-11533	128	1	8	8	X
aiua-11533	128	2	.	.	X
aiua-11533	128	3	blay	blay	PROPN
aiua-11533	128	4	jy	jy	PROPN
aiua-11533	128	5	,	,	PUNCT
aiua-11533	128	6	coindre	coindre	PROPN
aiua-11533	128	7	jm	jm	PROPN
aiua-11533	128	8	,	,	PUNCT
aiua-11533	128	9	ducimetière	ducimetière	PROPN
aiua-11533	128	10	f	f	PROPN
aiua-11533	128	11	,	,	PUNCT
aiua-11533	128	12	ray	ray	NOUN
aiua-11533	128	13	-	-	PUNCT
aiua-11533	128	14	coquard	coquard	NOUN
aiua-11533	128	15	i.	i.	NOUN
aiua-11533	128	16	rare	rare	ADJ
aiua-11533	128	17	cancers	cancer	NOUN
aiua-11533	128	18	:	:	PUNCT
aiua-11533	128	19	the	the	DET
aiua-11533	128	20	value	value	NOUN
aiua-11533	128	21	of	of	ADP
aiua-11533	128	22	research	research	NOUN
aiua-11533	128	23	collaborations	collaboration	NOUN
aiua-11533	128	24	and	and	CCONJ
aiua-11533	128	25	consortia	consortium	NOUN
aiua-11533	128	26	in	in	ADP
aiua-11533	128	27	rare	rare	ADJ
aiua-11533	128	28	cancers	cancer	NOUN
aiua-11533	128	29	.	.	PUNCT
aiua-11533	129	1	lancet	lancet	PROPN
aiua-11533	129	2	oncol	oncol	PROPN
aiua-11533	129	3	.	.	PUNCT
aiua-11533	130	1	2016	2016	NUM
aiua-11533	130	2	;	;	PUNCT
aiua-11533	130	3	17	17	NUM
aiua-11533	130	4	:	:	PUNCT
aiua-11533	130	5	e62	e62	NOUN
aiua-11533	130	6	.	.	PUNCT
aiua-11533	131	1	9	9	X
aiua-11533	131	2	.	.	X
aiua-11533	131	3	desantis	desantis	PROPN
aiua-11533	131	4	ce	ce	PROPN
aiua-11533	131	5	,	,	PUNCT
aiua-11533	131	6	kramer	kramer	PROPN
aiua-11533	131	7	jl	jl	PROPN
aiua-11533	131	8	,	,	PUNCT
aiua-11533	131	9	jemal	jemal	ADJ
aiua-11533	131	10	a.	a.	NOUN
aiua-11533	131	11	the	the	DET
aiua-11533	131	12	burden	burden	NOUN
aiua-11533	131	13	of	of	ADP
aiua-11533	131	14	rare	rare	ADJ
aiua-11533	131	15	cancers	cancer	NOUN
aiua-11533	131	16	in	in	ADP
aiua-11533	131	17	the	the	DET
aiua-11533	131	18	united	united	PROPN
aiua-11533	131	19	states	states	PROPN
aiua-11533	131	20	.	.	PUNCT
aiua-11533	132	1	ca	can	AUX
aiua-11533	132	2	cancer	cancer	PROPN
aiua-11533	132	3	j	j	PROPN
aiua-11533	132	4	clin	clin	PROPN
aiua-11533	132	5	.	.	PROPN
aiua-11533	133	1	2017	2017	NUM
aiua-11533	133	2	;	;	PUNCT
aiua-11533	133	3	67:261	67:261	NUM
aiua-11533	133	4	-	-	SYM
aiua-11533	133	5	72	72	NUM
aiua-11533	133	6	.	.	PUNCT
aiua-11533	134	1	10	10	NUM
aiua-11533	134	2	.	.	PUNCT
aiua-11533	135	1	zieschang	zieschang	PROPN
aiua-11533	135	2	h	h	PROPN
aiua-11533	135	3	,	,	PUNCT
aiua-11533	135	4	koch	koch	PROPN
aiua-11533	135	5	r	r	PROPN
aiua-11533	135	6	,	,	PUNCT
aiua-11533	135	7	wirth	wirth	PROPN
aiua-11533	135	8	m	m	PROPN
aiua-11533	135	9	,	,	PUNCT
aiua-11533	135	10	froehner	froehner	ADJ
aiua-11533	135	11	m.	m.	NOUN
aiua-11533	135	12	leiomyosarcoma	leiomyosarcoma	NOUN
aiua-11533	135	13	of	of	ADP
aiua-11533	135	14	the	the	DET
aiua-11533	135	15	urinary	urinary	ADJ
aiua-11533	135	16	bladder	bladder	NOUN
aiua-11533	135	17	in	in	ADP
aiua-11533	135	18	adult	adult	NOUN
aiua-11533	135	19	patients	patient	NOUN
aiua-11533	135	20	:	:	PUNCT
aiua-11533	135	21	a	a	DET
aiua-11533	135	22	systematic	systematic	ADJ
aiua-11533	135	23	review	review	NOUN
aiua-11533	135	24	of	of	ADP
aiua-11533	135	25	the	the	DET
aiua-11533	135	26	literature	literature	NOUN
aiua-11533	135	27	and	and	CCONJ
aiua-11533	135	28	meta	meta	ADJ
aiua-11533	135	29	-	-	PUNCT
aiua-11533	135	30	analysis	analysis	NOUN
aiua-11533	135	31	.	.	PUNCT
aiua-11533	136	1	urolint	urolint	INTJ
aiua-11533	136	2	.	.	PUNCT
aiua-11533	137	1	2019	2019	NUM
aiua-11533	137	2	;	;	PUNCT
aiua-11533	138	1	102:96	102:96	X
aiua-11533	138	2	-	-	SYM
aiua-11533	138	3	101	101	NUM
aiua-11533	138	4	.	.	PUNCT
aiua-11533	138	5	11	11	NUM
aiua-11533	138	6	.	.	PUNCT
aiua-11533	138	7	li	li	PROPN
aiua-11533	138	8	s.	s.	PROPN
aiua-11533	138	9	development	development	PROPN
aiua-11533	138	10	and	and	CCONJ
aiua-11533	138	11	validation	validation	NOUN
aiua-11533	138	12	of	of	ADP
aiua-11533	138	13	a	a	DET
aiua-11533	138	14	prognostic	prognostic	ADJ
aiua-11533	138	15	nomogram	nomogram	NOUN
aiua-11533	138	16	for	for	ADP
aiua-11533	138	17	predicting	predict	VERB
aiua-11533	138	18	overall	overall	ADJ
aiua-11533	138	19	survival	survival	NOUN
aiua-11533	138	20	in	in	ADP
aiua-11533	138	21	patients	patient	NOUN
aiua-11533	138	22	with	with	ADP
aiua-11533	138	23	primary	primary	ADJ
aiua-11533	138	24	bladder	bladder	NOUN
aiua-11533	138	25	sarcoma	sarcoma	NOUN
aiua-11533	138	26	:	:	PUNCT
aiua-11533	138	27	a	a	DET
aiua-11533	138	28	seer	seer	NOUN
aiua-11533	138	29	-	-	PUNCT
aiua-11533	138	30	based	base	VERB
aiua-11533	138	31	retrospective	retrospective	ADJ
aiua-11533	138	32	study	study	NOUN
aiua-11533	138	33	.	.	PUNCT
aiua-11533	139	1	bmc	bmc	PROPN
aiua-11533	139	2	urol	urol	PROPN
aiua-11533	139	3	.	.	PUNCT
aiua-11533	139	4	2021	2021	NUM
aiua-11533	139	5	;	;	PUNCT
aiua-11533	139	6	21:162	21:162	NUM
aiua-11533	139	7	.	.	PROPN
aiua-11533	140	1	12	12	NUM
aiua-11533	140	2	.	.	PUNCT
aiua-11533	141	1	callesen	callesen	PROPN
aiua-11533	141	2	lb	lb	PROPN
aiua-11533	141	3	,	,	PUNCT
aiua-11533	141	4	et	et	PROPN
aiua-11533	141	5	al	al	PROPN
aiua-11533	141	6	.	.	PUNCT
aiua-11533	141	7	radiation	radiation	NOUN
aiua-11533	141	8	-	-	PUNCT
aiua-11533	141	9	induced	induce	VERB
aiua-11533	141	10	sarcoma	sarcoma	NOUN
aiua-11533	141	11	:	:	PUNCT
aiua-11533	141	12	a	a	DET
aiua-11533	141	13	retrospective	retrospective	ADJ
aiua-11533	141	14	population	population	NOUN
aiua-11533	141	15	-	-	PUNCT
aiua-11533	141	16	based	base	VERB
aiua-11533	141	17	study	study	NOUN
aiua-11533	141	18	over	over	ADP
aiua-11533	141	19	34	34	NUM
aiua-11533	141	20	years	year	NOUN
aiua-11533	141	21	in	in	ADP
aiua-11533	141	22	a	a	DET
aiua-11533	141	23	single	single	ADJ
aiua-11533	141	24	institution	institution	NOUN
aiua-11533	141	25	.	.	PUNCT
aiua-11533	142	1	clin	clin	PROPN
aiua-11533	142	2	oncol	oncol	PROPN
aiua-11533	142	3	.	.	PUNCT
aiua-11533	143	1	2021	2021	NUM
aiua-11533	143	2	;	;	PUNCT
aiua-11533	143	3	33	33	NUM
aiua-11533	143	4	:	:	PUNCT
aiua-11533	143	5	e232	e232	PROPN
aiua-11533	143	6	-	-	PUNCT
aiua-11533	143	7	e238	e238	PROPN
aiua-11533	143	8	.	.	PROPN
aiua-11533	143	9	13	13	NUM
aiua-11533	143	10	.	.	PUNCT
aiua-11533	144	1	lee	lee	PROPN
aiua-11533	144	2	js	js	PROPN
aiua-11533	144	3	.	.	PUNCT
aiua-11533	144	4	management	management	NOUN
aiua-11533	144	5	of	of	ADP
aiua-11533	144	6	pelvic	pelvic	ADJ
aiua-11533	144	7	sarcoma	sarcoma	NOUN
aiua-11533	144	8	.	.	PUNCT
aiua-11533	145	1	eur	eur	PROPN
aiua-11533	145	2	j	j	PROPN
aiua-11533	145	3	surg	surg	PROPN
aiua-11533	145	4	oncol	oncol	PROPN
aiua-11533	145	5	.	.	PUNCT
aiua-11533	146	1	2022	2022	NUM
aiua-11533	146	2	;	;	PUNCT
aiua-11533	146	3	48:2299	48:2299	NUM
aiua-11533	146	4	-	-	SYM
aiua-11533	146	5	2307	2307	NUM
aiua-11533	146	6	.	.	PUNCT
aiua-11533	147	1	archivio	archivio	NOUN
aiua-11533	147	2	italiano	italiano	PROPN
aiua-11533	147	3	di	di	PROPN
aiua-11533	147	4	urologia	urologia	PROPN
aiua-11533	147	5	e	e	PROPN
aiua-11533	147	6	andrologia	andrologia	NOUN
aiua-11533	147	7	2023	2023	NUM
aiua-11533	147	8	;	;	PUNCT
aiua-11533	147	9	95(3):11533	95(3):11533	NUM
aiua-11533	147	10	5	5	NUM
aiua-11533	147	11	primary	primary	ADJ
aiua-11533	147	12	bladder	bladder	NOUN
aiua-11533	147	13	sarcoma	sarcoma	NOUN
aiua-11533	147	14	14	14	NUM
aiua-11533	147	15	.	.	PUNCT
aiua-11533	148	1	brennan	brennan	PROPN
aiua-11533	148	2	mf	mf	PROPN
aiua-11533	148	3	,	,	PUNCT
aiua-11533	148	4	antonescu	antonescu	PROPN
aiua-11533	148	5	cr	cr	PROPN
aiua-11533	148	6	,	,	PUNCT
aiua-11533	148	7	moraco	moraco	PROPN
aiua-11533	148	8	n	n	CCONJ
aiua-11533	148	9	,	,	PUNCT
aiua-11533	148	10	singer	singer	NOUN
aiua-11533	148	11	s.	s.	PROPN
aiua-11533	148	12	lessons	lessons	PROPN
aiua-11533	148	13	learned	learn	VERB
aiua-11533	148	14	from	from	ADP
aiua-11533	148	15	the	the	DET
aiua-11533	148	16	study	study	NOUN
aiua-11533	148	17	of	of	ADP
aiua-11533	148	18	10,000	10,000	NUM
aiua-11533	148	19	patients	patient	NOUN
aiua-11533	148	20	with	with	ADP
aiua-11533	148	21	soft	soft	ADJ
aiua-11533	148	22	tissue	tissue	NOUN
aiua-11533	148	23	sarcoma	sarcoma	NOUN
aiua-11533	148	24	.	.	PUNCT
aiua-11533	149	1	ann	ann	PROPN
aiua-11533	149	2	surg	surg	PROPN
aiua-11533	149	3	.	.	PUNCT
aiua-11533	150	1	2014	2014	NUM
aiua-11533	150	2	;	;	PUNCT
aiua-11533	150	3	260:416	260:416	NUM
aiua-11533	150	4	-	-	PUNCT
aiua-11533	150	5	21	21	NUM
aiua-11533	150	6	.	.	PUNCT
aiua-11533	151	1	15	15	NUM
aiua-11533	151	2	.	.	PUNCT
aiua-11533	152	1	chouliaras	chouliaras	PROPN
aiua-11533	152	2	k	k	PROPN
aiua-11533	152	3	,	,	PUNCT
aiua-11533	152	4	senehi	senehi	NOUN
aiua-11533	152	5	r	r	NOUN
aiua-11533	152	6	,	,	PUNCT
aiua-11533	152	7	ethun	ethun	PROPN
aiua-11533	152	8	cg	cg	PROPN
aiua-11533	152	9	,	,	PUNCT
aiua-11533	152	10	et	et	PROPN
aiua-11533	152	11	al	al	PROPN
aiua-11533	152	12	.	.	PROPN
aiua-11533	153	1	recurrence	recurrence	NOUN
aiua-11533	153	2	patterns	pattern	NOUN
aiua-11533	153	3	after	after	ADP
aiua-11533	153	4	resection	resection	NOUN
aiua-11533	153	5	of	of	ADP
aiua-11533	153	6	retroperitoneal	retroperitoneal	ADJ
aiua-11533	153	7	sarcomas	sarcomas	NOUN
aiua-11533	153	8	:	:	PUNCT
aiua-11533	153	9	an	an	DET
aiua-11533	153	10	eight	eight	NUM
aiua-11533	153	11	-	-	PUNCT
aiua-11533	153	12	institution	institution	NOUN
aiua-11533	153	13	study	study	NOUN
aiua-11533	153	14	from	from	ADP
aiua-11533	153	15	the	the	DET
aiua-11533	153	16	us	us	PROPN
aiua-11533	153	17	sarcoma	sarcoma	NOUN
aiua-11533	153	18	collaborative	collaborative	PROPN
aiua-11533	153	19	.	.	PUNCT
aiua-11533	154	1	j	j	PROPN
aiua-11533	154	2	surg	surg	PROPN
aiua-11533	154	3	oncol	oncol	PROPN
aiua-11533	154	4	.	.	PUNCT
aiua-11533	155	1	2019	2019	NUM
aiua-11533	155	2	;	;	PUNCT
aiua-11533	155	3	120:340	120:340	NUM
aiua-11533	155	4	-	-	SYM
aiua-11533	155	5	7	7	NUM
aiua-11533	155	6	.	.	NOUN
aiua-11533	155	7	16	16	NUM
aiua-11533	155	8	.	.	PUNCT
aiua-11533	156	1	trans	trans	ADJ
aiua-11533	156	2	-	-	PROPN
aiua-11533	156	3	atlantic	atlantic	ADJ
aiua-11533	156	4	rpswg	rpswg	NOUN
aiua-11533	156	5	.	.	PUNCT
aiua-11533	157	1	management	management	NOUN
aiua-11533	157	2	of	of	ADP
aiua-11533	157	3	primary	primary	ADJ
aiua-11533	157	4	retroperitoneal	retroperitoneal	ADJ
aiua-11533	157	5	sarcoma	sarcoma	NOUN
aiua-11533	157	6	(	(	PUNCT
aiua-11533	157	7	rps	rps	PROPN
aiua-11533	157	8	)	)	PUNCT
aiua-11533	157	9	in	in	ADP
aiua-11533	157	10	the	the	DET
aiua-11533	157	11	adult	adult	NOUN
aiua-11533	157	12	:	:	PUNCT
aiua-11533	157	13	a	a	DET
aiua-11533	157	14	consensus	consensus	NOUN
aiua-11533	157	15	approach	approach	NOUN
aiua-11533	157	16	from	from	ADP
aiua-11533	157	17	the	the	DET
aiua-11533	157	18	transatlantic	transatlantic	ADJ
aiua-11533	157	19	rps	rps	PROPN
aiua-11533	157	20	working	working	NOUN
aiua-11533	157	21	group	group	NOUN
aiua-11533	157	22	.	.	PUNCT
aiua-11533	158	1	ann	ann	PROPN
aiua-11533	158	2	surg	surg	PROPN
aiua-11533	158	3	oncol	oncol	PROPN
aiua-11533	158	4	.	.	PUNCT
aiua-11533	159	1	2015	2015	NUM
aiua-11533	159	2	;	;	PUNCT
aiua-11533	159	3	22:256	22:256	NUM
aiua-11533	159	4	-	-	SYM
aiua-11533	159	5	63	63	NUM
aiua-11533	159	6	.	.	PUNCT
aiua-11533	160	1	17	17	NUM
aiua-11533	160	2	.	.	PUNCT
aiua-11533	161	1	singer	singer	NOUN
aiua-11533	161	2	s	s	PROPN
aiua-11533	161	3	,	,	PUNCT
aiua-11533	161	4	antonescu	antonescu	PROPN
aiua-11533	161	5	cr	cr	PROPN
aiua-11533	161	6	,	,	PUNCT
aiua-11533	161	7	riedel	riedel	PROPN
aiua-11533	161	8	e	e	PROPN
aiua-11533	161	9	,	,	PUNCT
aiua-11533	161	10	brennan	brennan	PROPN
aiua-11533	161	11	mf	mf	PROPN
aiua-11533	161	12	.	.	PROPN
aiua-11533	161	13	histologic	histologic	ADJ
aiua-11533	161	14	subtype	subtype	NOUN
aiua-11533	161	15	and	and	CCONJ
aiua-11533	161	16	margin	margin	NOUN
aiua-11533	161	17	of	of	ADP
aiua-11533	161	18	resection	resection	NOUN
aiua-11533	161	19	predict	predict	VERB
aiua-11533	161	20	pattern	pattern	NOUN
aiua-11533	161	21	of	of	ADP
aiua-11533	161	22	recurrence	recurrence	NOUN
aiua-11533	161	23	and	and	CCONJ
aiua-11533	161	24	survival	survival	NOUN
aiua-11533	161	25	for	for	ADP
aiua-11533	161	26	retroperitoneal	retroperitoneal	ADJ
aiua-11533	161	27	liposarcoma	liposarcoma	NOUN
aiua-11533	161	28	.	.	PUNCT
aiua-11533	162	1	ann	ann	PROPN
aiua-11533	162	2	surg	surg	PROPN
aiua-11533	162	3	.	.	PUNCT
aiua-11533	163	1	2003	2003	NUM
aiua-11533	163	2	;	;	PUNCT
aiua-11533	163	3	238:358	238:358	NOUN
aiua-11533	163	4	-	-	PUNCT
aiua-11533	163	5	70	70	NUM
aiua-11533	164	1	,	,	PUNCT
aiua-11533	164	2	discussion	discussion	NOUN
aiua-11533	164	3	370	370	NUM
aiua-11533	164	4	-	-	SYM
aiua-11533	164	5	351	351	NUM
aiua-11533	164	6	.	.	NOUN
aiua-11533	164	7	18	18	NUM
aiua-11533	164	8	.	.	PUNCT
aiua-11533	165	1	stojadinovic	stojadinovic	PROPN
aiua-11533	165	2	a	a	PRON
aiua-11533	165	3	,	,	PUNCT
aiua-11533	165	4	leung	leung	PROPN
aiua-11533	165	5	dh	dh	PROPN
aiua-11533	165	6	,	,	PUNCT
aiua-11533	165	7	hoos	hoo	VERB
aiua-11533	165	8	a	a	DET
aiua-11533	165	9	,	,	PUNCT
aiua-11533	165	10	jaques	jaques	PROPN
aiua-11533	165	11	dp	dp	PROPN
aiua-11533	165	12	,	,	PUNCT
aiua-11533	165	13	lewis	lewis	PROPN
aiua-11533	165	14	jj	jj	PROPN
aiua-11533	165	15	,	,	PUNCT
aiua-11533	165	16	brennan	brennan	PROPN
aiua-11533	165	17	mf	mf	VERB
aiua-11533	165	18	.	.	PROPN
aiua-11533	166	1	analysis	analysis	NOUN
aiua-11533	166	2	of	of	ADP
aiua-11533	166	3	the	the	DET
aiua-11533	166	4	prognostic	prognostic	ADJ
aiua-11533	166	5	significance	significance	NOUN
aiua-11533	166	6	of	of	ADP
aiua-11533	166	7	microscopic	microscopic	ADJ
aiua-11533	166	8	margins	margin	NOUN
aiua-11533	166	9	in	in	ADP
aiua-11533	166	10	2,084	2,084	NUM
aiua-11533	166	11	localized	localize	VERB
aiua-11533	166	12	primary	primary	ADJ
aiua-11533	166	13	adult	adult	NOUN
aiua-11533	166	14	soft	soft	ADJ
aiua-11533	166	15	tissue	tissue	NOUN
aiua-11533	166	16	sarcomas	sarcomas	NOUN
aiua-11533	166	17	.	.	PUNCT
aiua-11533	167	1	ann	ann	PROPN
aiua-11533	167	2	surg	surg	PROPN
aiua-11533	167	3	.	.	PUNCT
aiua-11533	168	1	2002	2002	NUM
aiua-11533	168	2	;	;	PUNCT
aiua-11533	168	3	235:424	235:424	NUM
aiua-11533	168	4	-	-	SYM
aiua-11533	168	5	34	34	NUM
aiua-11533	168	6	.	.	NOUN
aiua-11533	168	7	19	19	NUM
aiua-11533	168	8	.	.	PUNCT
aiua-11533	169	1	molina	molina	PROPN
aiua-11533	169	2	g	g	PROPN
aiua-11533	169	3	,	,	PUNCT
aiua-11533	169	4	hull	hull	PROPN
aiua-11533	169	5	ma	ma	PROPN
aiua-11533	169	6	,	,	PUNCT
aiua-11533	169	7	chen	chen	PROPN
aiua-11533	169	8	yl	yl	PROPN
aiua-11533	169	9	,	,	PUNCT
aiua-11533	169	10	et	et	PROPN
aiua-11533	169	11	al	al	PROPN
aiua-11533	169	12	.	.	PROPN
aiua-11533	169	13	preoperative	preoperative	ADJ
aiua-11533	169	14	radiation	radiation	NOUN
aiua-11533	169	15	therapy	therapy	NOUN
aiua-11533	169	16	combined	combine	VERB
aiua-11533	169	17	with	with	ADP
aiua-11533	169	18	radical	radical	ADJ
aiua-11533	169	19	surgical	surgical	ADJ
aiua-11533	169	20	resection	resection	NOUN
aiua-11533	169	21	is	be	AUX
aiua-11533	169	22	associated	associate	VERB
aiua-11533	169	23	with	with	ADP
aiua-11533	169	24	a	a	DET
aiua-11533	169	25	lower	low	ADJ
aiua-11533	169	26	rate	rate	NOUN
aiua-11533	169	27	of	of	ADP
aiua-11533	169	28	local	local	ADJ
aiua-11533	169	29	recurrence	recurrence	NOUN
aiua-11533	169	30	when	when	SCONJ
aiua-11533	169	31	treating	treat	VERB
aiua-11533	169	32	unifocal	unifocal	ADJ
aiua-11533	169	33	,	,	PUNCT
aiua-11533	169	34	primary	primary	ADJ
aiua-11533	169	35	retroperitoneal	retroperitoneal	ADJ
aiua-11533	169	36	liposarcoma	liposarcoma	NOUN
aiua-11533	169	37	.	.	PUNCT
aiua-11533	170	1	j	j	PROPN
aiua-11533	170	2	surg	surg	PROPN
aiua-11533	170	3	oncol	oncol	PROPN
aiua-11533	170	4	.	.	PUNCT
aiua-11533	171	1	2016	2016	NUM
aiua-11533	171	2	;	;	PUNCT
aiua-11533	171	3	114:814	114:814	NUM
aiua-11533	171	4	-	-	SYM
aiua-11533	171	5	20	20	NUM
aiua-11533	171	6	.	.	NOUN
aiua-11533	171	7	20	20	NUM
aiua-11533	171	8	.	.	PUNCT
aiua-11533	172	1	bonvalot	bonvalot	PROPN
aiua-11533	172	2	s	s	PROPN
aiua-11533	172	3	,	,	PUNCT
aiua-11533	172	4	gronchi	gronchi	VERB
aiua-11533	172	5	a	a	PRON
aiua-11533	172	6	,	,	PUNCT
aiua-11533	172	7	le	le	X
aiua-11533	172	8	pechoux	pechoux	NOUN
aiua-11533	172	9	c	c	PROPN
aiua-11533	172	10	,	,	PUNCT
aiua-11533	172	11	et	et	PROPN
aiua-11533	172	12	al	al	PROPN
aiua-11533	172	13	.	.	PROPN
aiua-11533	172	14	preoperative	preoperative	PROPN
aiua-11533	172	15	radiotherapy	radiotherapy	NOUN
aiua-11533	172	16	plus	plus	CCONJ
aiua-11533	172	17	surgery	surgery	NOUN
aiua-11533	172	18	versus	versus	ADP
aiua-11533	172	19	surgery	surgery	NOUN
aiua-11533	172	20	alone	alone	ADV
aiua-11533	172	21	for	for	ADP
aiua-11533	172	22	patients	patient	NOUN
aiua-11533	172	23	with	with	ADP
aiua-11533	172	24	primary	primary	ADJ
aiua-11533	172	25	retroperitoneal	retroperitoneal	ADJ
aiua-11533	172	26	sarcoma	sarcoma	NOUN
aiua-11533	172	27	(	(	PUNCT
aiua-11533	172	28	eortc-62092	eortc-62092	NOUN
aiua-11533	172	29	:	:	PUNCT
aiua-11533	172	30	strass	strass	NOUN
aiua-11533	172	31	):	):	PUNCT
aiua-11533	172	32	a	a	DET
aiua-11533	172	33	multicentre	multicentre	NOUN
aiua-11533	172	34	,	,	PUNCT
aiua-11533	172	35	open	open	ADJ
aiua-11533	172	36	-	-	PUNCT
aiua-11533	172	37	label	label	NOUN
aiua-11533	172	38	,	,	PUNCT
aiua-11533	172	39	randomised	randomise	VERB
aiua-11533	172	40	,	,	PUNCT
aiua-11533	172	41	phase	phase	NOUN
aiua-11533	172	42	3	3	NUM
aiua-11533	172	43	trial	trial	NOUN
aiua-11533	172	44	.	.	PUNCT
aiua-11533	173	1	lancet	lancet	PROPN
aiua-11533	173	2	oncol	oncol	ADJ
aiua-11533	173	3	2020	2020	NUM
aiua-11533	173	4	;	;	PUNCT
aiua-11533	173	5	21:1366	21:1366	NUM
aiua-11533	173	6	-	-	SYM
aiua-11533	173	7	77	77	NUM
aiua-11533	173	8	.	.	PUNCT
aiua-11533	174	1	conference	conference	NOUN
aiua-11533	174	2	presentation	presentation	NOUN
aiua-11533	174	3	bettoli	bettoli	ADP
aiua-11533	174	4	p	p	NOUN
aiua-11533	174	5	,	,	PUNCT
aiua-11533	174	6	liu	liu	PROPN
aiua-11533	174	7	za	za	PROPN
aiua-11533	174	8	,	,	PUNCT
aiua-11533	174	9	jara	jara	PROPN
aiua-11533	174	10	n	n	CCONJ
aiua-11533	174	11	,	,	PUNCT
aiua-11533	174	12	et	et	PROPN
aiua-11533	174	13	al	al	PROPN
aiua-11533	174	14	.	.	PROPN
aiua-11533	174	15	primary	primary	ADJ
aiua-11533	174	16	bladder	bladder	NOUN
aiua-11533	174	17	sarcoma	sarcoma	NOUN
aiua-11533	174	18	:	:	PUNCT
aiua-11533	174	19	a	a	DET
aiua-11533	174	20	multi	multi	ADJ
aiua-11533	174	21	-	-	ADJ
aiua-11533	174	22	institutional	institutional	ADJ
aiua-11533	174	23	experience	experience	NOUN
aiua-11533	174	24	from	from	ADP
aiua-11533	174	25	the	the	DET
aiua-11533	174	26	rare	rare	ADJ
aiua-11533	174	27	cancer	cancer	NOUN
aiua-11533	174	28	network	network	NOUN
aiua-11533	174	29	presentation	presentation	NOUN
aiua-11533	174	30	number	number	NOUN
aiua-11533	174	31	:	:	PUNCT
aiua-11533	174	32	po-1219	po-1219	NOUN
aiua-11533	174	33	:	:	PUNCT
aiua-11533	174	34	european	european	ADJ
aiua-11533	174	35	society	society	NOUN
aiua-11533	174	36	for	for	ADP
aiua-11533	174	37	radiotherapy	radiotherapy	NOUN
aiua-11533	174	38	and	and	CCONJ
aiua-11533	174	39	oncology	oncology	NOUN
aiua-11533	174	40	(	(	PUNCT
aiua-11533	174	41	estro	estro	NOUN
aiua-11533	174	42	)	)	PUNCT
aiua-11533	174	43	congress	congress	PROPN
aiua-11533	174	44	;	;	PUNCT
aiua-11533	174	45	july	july	PROPN
aiua-11533	174	46	31	31	NUM
aiua-11533	174	47	9facultad	9facultad	PROPN
aiua-11533	174	48	de	de	X
aiua-11533	174	49	medicina	medicina	PROPN
aiua-11533	174	50	,	,	PUNCT
aiua-11533	174	51	universidad	universidad	PROPN
aiua-11533	174	52	diego	diego	PROPN
aiua-11533	174	53	portales	portales	PROPN
aiua-11533	174	54	,	,	PUNCT
aiua-11533	174	55	santiago	santiago	PROPN
aiua-11533	174	56	,	,	PUNCT
aiua-11533	174	57	chile	chile	PROPN
aiua-11533	174	58	.	.	PUNCT
aiua-11533	175	1	august	august	PROPN
aiua-11533	175	2	04	04	NUM
aiua-11533	175	3	,	,	PUNCT
aiua-11533	175	4	2020	2020	NUM
aiua-11533	175	5	;	;	PUNCT
aiua-11533	175	6	vienna	vienna	PROPN
aiua-11533	175	7	,	,	PUNCT
aiua-11533	175	8	austria	austria	PROPN
aiua-11533	175	9	.	.	PUNCT
aiua-11533	176	1	correspondence	correspondence	NOUN
aiua-11533	176	2	piero	piero	PROPN
aiua-11533	176	3	bettoli	bettoli	PROPN
aiua-11533	176	4	,	,	PUNCT
aiua-11533	176	5	md	md	PROPN
aiua-11533	176	6	(	(	PUNCT
aiua-11533	176	7	corresponding	correspond	VERB
aiua-11533	176	8	author	author	NOUN
aiua-11533	176	9	)	)	PUNCT
aiua-11533	176	10	piero.bettoli@falp.org	piero.bettoli@falp.org	PROPN
aiua-11533	176	11	postal	postal	ADJ
aiua-11533	176	12	address	address	NOUN
aiua-11533	176	13	7591067	7591067	NUM
aiua-11533	176	14	federico	federico	PROPN
aiua-11533	176	15	bakal	bakal	PROPN
aiua-11533	176	16	,	,	PUNCT
aiua-11533	176	17	md	md	PROPN
aiua-11533	176	18	federico.bakal@falp.org	federico.bakal@falp.org	PROPN
aiua-11533	176	19	fundación	fundación	PROPN
aiua-11533	176	20	arturo	arturo	PROPN
aiua-11533	176	21	lópez	lópez	PROPN
aiua-11533	176	22	pérez	pérez	PROPN
aiua-11533	176	23	,	,	PUNCT
aiua-11533	176	24	santiago	santiago	PROPN
aiua-11533	176	25	,	,	PUNCT
aiua-11533	176	26	chile	chile	PROPN
aiua-11533	176	27	zhihuiamy	zhihuiamy	PROPN
aiua-11533	176	28	liu	liu	PROPN
aiua-11533	176	29	,	,	PUNCT
aiua-11533	176	30	md	md	PROPN
aiua-11533	176	31	zhihuiamy.liu@uhn.ca	zhihuiamy.liu@uhn.ca	PROPN
aiua-11533	176	32	peter	peter	PROPN
aiua-11533	176	33	chung	chung	PROPN
aiua-11533	176	34	,	,	PUNCT
aiua-11533	176	35	md	md	PROPN
aiua-11533	176	36	peter.chung@rmp.uhn.ca	peter.chung@rmp.uhn.ca	PROPN
aiua-11533	176	37	alejandro	alejandro	PROPN
aiua-11533	176	38	berlin	berlin	PROPN
aiua-11533	176	39	,	,	PUNCT
aiua-11533	176	40	md	md	PROPN
aiua-11533	176	41	alejandro.berlin@rmp.uhn.ca	alejandro.berlin@rmp.uhn.ca	PROPN
aiua-11533	176	42	princess	princess	PROPN
aiua-11533	176	43	margaret	margaret	PROPN
aiua-11533	176	44	hospital	hospital	PROPN
aiua-11533	176	45	,	,	PUNCT
aiua-11533	176	46	radiation	radiation	NOUN
aiua-11533	176	47	oncology	oncology	NOUN
aiua-11533	176	48	,	,	PUNCT
aiua-11533	176	49	toronto	toronto	PROPN
aiua-11533	176	50	,	,	PUNCT
aiua-11533	176	51	canada	canada	PROPN
aiua-11533	176	52	natalia	natalia	PROPN
aiua-11533	176	53	jara	jara	PROPN
aiua-11533	176	54	,	,	PUNCT
aiua-11533	176	55	md	md	PROPN
aiua-11533	176	56	njarao@gmail.com	njarao@gmail.com	PROPN
aiua-11533	176	57	sebastian	sebastian	PROPN
aiua-11533	176	58	sole	sole	PROPN
aiua-11533	176	59	,	,	PUNCT
aiua-11533	176	60	md	md	PROPN
aiua-11533	176	61	sebasole@gmail.com	sebasole@gmail.com	PROPN
aiua-11533	176	62	claudio	claudio	PROPN
aiua-11533	176	63	sole	sole	NOUN
aiua-11533	176	64	,	,	PUNCT
aiua-11533	176	65	md	md	PROPN
aiua-11533	176	66	claudio.solep@iram.cl	claudio.solep@iram.cl	PROPN
aiua-11533	176	67	clinica	clinica	PROPN
aiua-11533	176	68	instituto	instituto	PROPN
aiua-11533	176	69	de	de	PROPN
aiua-11533	176	70	radiomedicina	radiomedicina	PROPN
aiua-11533	176	71	(	(	PUNCT
aiua-11533	176	72	iram	iram	NOUN
aiua-11533	176	73	)	)	PUNCT
aiua-11533	176	74	,	,	PUNCT
aiua-11533	176	75	santiago	santiago	PROPN
aiua-11533	176	76	,	,	PUNCT
aiua-11533	176	77	chile	chile	PROPN
aiua-11533	176	78	facultad	facultad	PROPN
aiua-11533	176	79	de	de	PROPN
aiua-11533	176	80	medicina	medicina	PROPN
aiua-11533	176	81	,	,	PUNCT
aiua-11533	176	82	universidad	universidad	PROPN
aiua-11533	176	83	diego	diego	PROPN
aiua-11533	176	84	portales	portales	PROPN
aiua-11533	176	85	,	,	PUNCT
aiua-11533	176	86	santiago	santiago	PROPN
aiua-11533	176	87	,	,	PUNCT
aiua-11533	176	88	chile	chile	PROPN
aiua-11533	176	89	william	william	PROPN
aiua-11533	176	90	wong	wong	PROPN
aiua-11533	176	91	,	,	PUNCT
aiua-11533	176	92	md	md	PROPN
aiua-11533	176	93	wong.william@mayo.edu	wong.william@mayo.edu	PROPN
aiua-11533	176	94	mayo	mayo	PROPN
aiua-11533	176	95	clinic	clinic	PROPN
aiua-11533	176	96	arizona	arizona	PROPN
aiua-11533	176	97	,	,	PUNCT
aiua-11533	176	98	radiation	radiation	NOUN
aiua-11533	176	99	oncology	oncology	NOUN
aiua-11533	176	100	,	,	PUNCT
aiua-11533	176	101	phoenix	phoenix	PROPN
aiua-11533	176	102	,	,	PUNCT
aiua-11533	176	103	usa	usa	PROPN
aiua-11533	176	104	mario	mario	PROPN
aiua-11533	176	105	terlizzi	terlizzi	PROPN
aiua-11533	176	106	,	,	PUNCT
aiua-11533	176	107	md	md	PROPN
aiua-11533	176	108	terlizzimario@yahoo.fr	terlizzimario@yahoo.fr	PROPN
aiua-11533	176	109	paul	paul	PROPN
aiua-11533	176	110	sargos	sargos	PROPN
aiua-11533	176	111	,	,	PUNCT
aiua-11533	176	112	md	md	PROPN
aiua-11533	176	113	p.sargos@bordeaux.unicancer.fr	p.sargos@bordeaux.unicancer.fr	PROPN
aiua-11533	176	114	institute	institute	PROPN
aiua-11533	176	115	bergonie	bergonie	PROPN
aiua-11533	176	116	,	,	PUNCT
aiua-11533	176	117	radiation	radiation	NOUN
aiua-11533	176	118	oncology	oncology	NOUN
aiua-11533	176	119	,	,	PUNCT
aiua-11533	176	120	bordeaux	bordeaux	NOUN
aiua-11533	176	121	,	,	PUNCT
aiua-11533	176	122	france	france	PROPN
aiua-11533	176	123	thomas	thomas	PROPN
aiua-11533	176	124	zilli	zilli	PROPN
aiua-11533	176	125	,	,	PUNCT
aiua-11533	176	126	md	md	PROPN
aiua-11533	176	127	thomas.zilli@hcuge.ch	thomas.zilli@hcuge.ch	PROPN
aiua-11533	176	128	hospitaux	hospitaux	PROPN
aiua-11533	176	129	universiaires	universiaires	PROPN
aiua-11533	176	130	de	de	X
aiua-11533	176	131	geneve	geneve	NOUN
aiua-11533	176	132	,	,	PUNCT
aiua-11533	176	133	radiation	radiation	NOUN
aiua-11533	176	134	oncology	oncology	NOUN
aiua-11533	176	135	,	,	PUNCT
aiua-11533	176	136	geneve	geneve	NOUN
aiua-11533	176	137	,	,	PUNCT
aiua-11533	176	138	switzerland	switzerland	PROPN
aiua-11533	176	139	juliette	juliette	PROPN
aiua-11533	176	140	thariat	thariat	PROPN
aiua-11533	176	141	,	,	PUNCT
aiua-11533	176	142	md	md	PROPN
aiua-11533	176	143	jthariat@gmail.com	jthariat@gmail.com	PROPN
aiua-11533	176	144	centre	centre	PROPN
aiua-11533	176	145	francoise	francoise	PROPN
aiua-11533	176	146	baclese	baclese	PROPN
aiua-11533	176	147	,	,	PUNCT
aiua-11533	176	148	radiation	radiation	NOUN
aiua-11533	176	149	oncology	oncology	NOUN
aiua-11533	176	150	,	,	PUNCT
aiua-11533	176	151	caen	caen	PROPN
aiua-11533	176	152	,	,	PUNCT
aiua-11533	176	153	france	france	PROPN
aiua-11533	176	154	guilaume	guilaume	PROPN
aiua-11533	176	155	ploussard	ploussard	PROPN
aiua-11533	176	156	,	,	PUNCT
aiua-11533	176	157	md	md	PROPN
aiua-11533	176	158	g.ploussard@gmail.com	g.ploussard@gmail.com	X
aiua-11533	176	159	la	la	PROPN
aiua-11533	176	160	croix	croix	PROPN
aiua-11533	176	161	du	du	PROPN
aiua-11533	176	162	sud	sud	PROPN
aiua-11533	176	163	hospital	hospital	PROPN
aiua-11533	176	164	,	,	PUNCT
aiua-11533	176	165	urology	urology	NOUN
aiua-11533	176	166	department	department	NOUN
aiua-11533	176	167	,	,	PUNCT
aiua-11533	176	168	quint	quint	PROPN
aiua-11533	176	169	fonsergrives	fonsergrive	VERB
aiua-11533	176	170	,	,	PUNCT
aiua-11533	176	171	france	france	PROPN
aiua-11533	176	172	sharad	sharad	PROPN
aiua-11533	176	173	goyal	goyal	PROPN
aiua-11533	176	174	,	,	PUNCT
aiua-11533	176	175	md	md	PROPN
aiua-11533	176	176	shgoyal@mfa.gwu.edu	shgoyal@mfa.gwu.edu	PROPN
aiua-11533	176	177	george	george	PROPN
aiua-11533	176	178	washington	washington	PROPN
aiua-11533	176	179	university	university	PROPN
aiua-11533	176	180	hospital	hospital	NOUN
aiua-11533	176	181	,	,	PUNCT
aiua-11533	176	182	radiation	radiation	NOUN
aiua-11533	176	183	oncology	oncology	NOUN
aiua-11533	176	184	,	,	PUNCT
aiua-11533	176	185	washington	washington	PROPN
aiua-11533	176	186	dc	dc	PROPN
aiua-11533	176	187	,	,	PUNCT
aiua-11533	176	188	usa	usa	PROPN
aiua-11533	176	189	conflict	conflict	NOUN
aiua-11533	176	190	of	of	ADP
aiua-11533	176	191	interest	interest	NOUN
aiua-11533	176	192	:	:	PUNCT
aiua-11533	176	193	the	the	DET
aiua-11533	176	194	authors	author	NOUN
aiua-11533	176	195	declare	declare	VERB
aiua-11533	176	196	no	no	DET
aiua-11533	176	197	potential	potential	ADJ
aiua-11533	176	198	conflict	conflict	NOUN
aiua-11533	176	199	of	of	ADP
aiua-11533	176	200	interest	interest	NOUN
aiua-11533	176	201	.	.	PUNCT